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Bovine Tuberculosis (bTB) is a disease of significant economic importance, 
being one of the most persistent animal health problems in the UK and the Republic 
of Ireland and increasingly constituting a public health concern especially for the 
developing world. Limitations of the currently available diagnostic and control 
methods, along with our incomplete understanding of bTB transmission, prevent 
successful eradication. This Thesis addresses the development of a complementary 
control strategy which will be based on animal genetics and will allow us to identify 
animals genetically predisposed to be more resistant to disease. Specifically, the aim 
of my PhD project is to investigate the genetic architecture of resistance to bTB and 
demonstrate the feasibility of whole genome prediction for the control of bTB in 
cattle. Genomic selection for disease resistance in livestock populations will assist 
with the reduction of the in herd-level incidence and the severity of potential 
outbreaks.  
The first objective was to explore the estimation of breeding values for bTB 
resistance in UK dairy cattle, and test these genomic predictions for situations when 
disease phenotypes are not available on selection candidates. Through using dense 
SNP chip data the results of Chapter 2 demonstrate that genomic selection for bTB 
resistance is feasible (h2 = 0.23(SE = 0.06)) and bTB resistance can be predicted 
using genetic markers with an estimate of prediction accuracy of r(g, ĝ) = 0.33 in 
this data. It was shown that genotypes help to predict disease state (AUC ≈ 0.58) and 
animals lacking bTB phenotypes can be selected based on their genotypes.  In 
Chapter 3, a novel approach is presented to identify loci displaying heterozygote 
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(dis)advantage associated with resistance to M. bovis, hypothesising underlying non-
additive genetic variation, and these results are compared with those obtained from 
standard genome scans. A marker was identified suggesting an association between 
locus heterozygosity and increased susceptibility to bTB i.e. a heterozygote 
disadvantage, with the heterozygotes being significantly more in the cases than in the 
controls (x2 = 11.50, p<0.001).  
Secondly, this thesis focused on conducting a meta-analysis on two dairy 
cattle populations with bTB phenotypes and SNP chip genotypes, identifying 
genomic regions underlying bTB resistance and testing genomic predictions by 
means of cross-validation. In Chapter 4, exploration of the genetic architecture of the 
trait revealed that bTB resistance is a moderately polygenic, complex trait with 
clusters of causal variants spread across a few major chromosomes collectively 
controlling the trait. A region was identified on chromosome 6, putatively associated 
with bTB resistance and this chromosome as a whole was shown to contribute a 
major proportion (hc
2= 0.051) of the observed variation in this dataset. Genomic 
prediction for bTB was shown to be feasible even when only distantly related 
populations are combined (r(g,ĝ)=0.33 (SE = 0.05)), with the chromosomal 
heritability results suggesting that the accuracy arises from the SNPs capturing 
linkage disequilibrium between markers and QTL, as well as additive relationships 
between animals (~80% of estimated genomic h2 is due to relatedness). To extend 
the analysis, in Chapter 5, high density genotypes were inferred by means of 
genotype imputation, anticipating that these analyses will allow the identification of 
genomic regions associated with bTB resistance more closely, and that would 
increase the prediction accuracy. Genotype imputation was successful, however, 
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using all imputed genotypes added little information.  The limiting factor was found 
to be the number of animals and the trait definitions rather than the density of 
genotypes.   
Thirdly, a quantitative genetic analysis of actual Single Intradermal 
Comparative Cervical Test (SICCT) values collected during bTB herd testing was 
conducted aiming to investigate if selection for bTB resistance is likely to have an 
impact on the SICCT diagnostic test. This analysis demonstrated that the SICCT has 
a negligibly low heritability (h2=0.0104 (SE = 0.0032)) and any effect on the 
responsiveness to the test is likely to be small. 
In conclusion, breeding for disease resistance in livestock is feasible and we 
can predict the risk of bTB in cattle using genomic information. Further, putative 
QTLs associated with bTB resistance were identified, and exploration of the genetic 
architecture of bTB resistance revealed a moderately polygenic trait.  These results 
suggest that given that larger datasets with more phenotyped and genotyped animals 
will be available, we can breed for bTB resistance and implement the genomic 
selection technology in breeding programmes aiming to improve the disease status 
and overall health of the livestock population. Using the genomics this can be 






Bovine Tuberculosis (bTB) is one of the most persistent animal health 
problems in many countries around the world and remains a major challenge for the 
UK and the Republic of Ireland (RoI) despite the on-going eradication programmes. 
Limitations in the currently available diagnostic and control methods hinder 
eradication and therefore, it is becoming increasingly clear that complementary 
strategies will be needed to control bTB. My PhD project addresses the hypothesis 
that genetic selection for disease resistance in the light of genomic advances, may 
offer a complementary strategy for the control of bTB in cattle, by reducing infection 
risks. Genomic selection is a new technology that allows to identify animals that are 
genetically predisposed to be more resistant to disease by utilising information of 
genetic markers (Single Nucleotide Polymorphisms, SNPs) spread across the 
genome, without requiring regular collection of phenotypic information or 
knowledge of the exact genes controlling the trait. Such an approach will contribute 
to a reduction in herd-level incidence as well as a reduction in the severity of an 
outbreak.  
More specifically, the aims of my PhD project were to study the genetic 
architecture of resistance to bTB, and to explore the feasibility of genomic selection 
for livestock populations that will be more resistant to disease. My results have 
demonstrated that genomic selection for bTB resistance is feasible, and using genetic 
markers, bTB resistance can be predicted for situations when disease phenotypes are 
not available. Furthermore, a single-SNP approach capturing non-additive genetic 
variation identified a locus suggesting an association between locus heterozygosity 
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and increased susceptibility, however, it was found that it is unlikely that bTB is 
controlled by a single gene. Therefore, to extend my analysis, two populations only 
distantly related were combined in a meta-analysis. Genomic prediction for bTB was 
shown to be feasible even when only distantly related populations are combined and 
a genomic region underlying bTB resistance was identified. Exploration of the 
genetic architecture of the trait revealed that bTB resistance is a moderately 
polygenic, complex trait with clusters of causal variants spread across a few major 
chromosomes collectively controlling the trait. High density genotypes inferred using 
cost effective methods such as genotype imputation will allow for the SNPs to be 
more closely linked to the QTLs (Quantitative Traits Loci). However, in the present 
data the limiting factor was found to be the number of animals and the trait 
definitions rather than the density of genotypes.  Lastly, a quantitative genetic 
analysis of actual Single Intradermal Comparative Cervical Test (SICCT) values, 
which is the test used for bTB diagnosis in the UK, was conducted. This analysis 
demonstrated that the SICCT has a negligibly low heritability and any effect of the 
selection for bTB resistance, on the responsiveness to the diagnostic test, is likely to 
be small. 
In conclusion, breeding for disease resistance in livestock is feasible and we 
can predict the risk of bTB in cattle using genomic information. BTB resistance was 
shown to be a moderately polygenic trait, however, the prediction accuracy was 
found to arise from true linkage between the markers and the QTLs, as well as 
familial relationships between animals. These results suggest that given that larger 
datasets with more phenotyped and genotyped animals will be available, we can 
breed for bTB resistance and implement the genomic selection technology in 
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breeding programmes aiming to improve the disease status and overall health of the 
livestock population. Using the genomics this can be continued as the epidemic 
declines. 







1.1 Bovine Tuberculosis (bTB)  
Bovine Tuberculosis (bTB) is a bacterial disease caused by Mycobacterium 
bovis (M. bovis), an aerobic Gram+ bacillus and member of the M. tuberculosis 
complex. Cattle (Bos taurus) predominantly become infected through the respiratory 
route and the main lesions observed are tubercles formed in the lungs and draining 
lymph nodes (Divers and Peek 2008). BTB is a zoonotic disease and has an impact 
on animal performance and welfare, causing significant financial losses to the dairy 
cattle industry worldwide due to production losses and the cost of eradication 
programmes (Allen et al. 2010).  
1.1.1 Overview 
BTB is one of the most persistent animal health problems in many countries 
including the UK and the Republic of Ireland (RoI) (Allen et al. 2010). It is estimated 
that the total cost of eradication programmes for the years 2010-2011 has exceeded 
£275 million (UK and RoI) (Abernethy et al. 2013), and overall, the number of new 
outbreaks in Great Britain has increased since 1996 (3.9% incidence rate, 2015), with 
no clear evidence of a decline despite the control measures (Fig. 1) 
(https://www.gov.uk/government/statistics/historic-statistics-notices-on-the-
incidence-of-tuberculosis-tb-in-cattle-in-great-britain-2015). Whilst human 
tuberculosis is usually caused by Mycobacterium tuberculosis, humans can also get 
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infected by M. bovis, and therefore bTB is a zoonotic disease and constitutes a 
growing public health concern worldwide. Zoonotic transmission occurs through 
unpasteurised milk consumption (Buddle et al. 2003) and for the developing world 
bTB has been listed as the fourth most important livestock disease (Perry et al. 2002) 
with M. bovis causing 10-15% of TB in humans (Michel et al. 2010).  
Mycobacteria of the tuberculosis complex are among the most persistent 
pathogens known, having developed impressive mechanisms for evolution and 
adaptation (Raman et al. 2009). Garnier et al. (2003) reported that M. bovis has a 
sequence length of 4,345,492 bp with 3,952 protein encoding genes. M. tuberculosis, 
the causative agent of TB in humans, and M. bovis are distinct lineages of the 
Mycobacterium tuberculosis complex, and M. bovis has most likely descended from 
M. tuberculosis after a series of deletion mutations in its genome, although the 
average sequence divergence between them is low (<0.05%) (Brosch et al. 2001; 
Garnier et al. 2003; Gonda et al. 2006; Hewinson et al. 2006). M. bovis shows 
reduced diversity in the UK and the RoI, where the dominant clonal complex is the 
Eu1 carrying the SB0140 spoligotype (Smith et al. 2006; Smith et al. 2011). 
Spoligotyping is a molecular technique for genotyping and classifying M. 
tuberculosis complex strains through identifying polymorphisms in the direct repeat 
region of their genome (Smith et al. 2006). A possible explanation suggested for the 
extreme clonality observed, is the population bottleneck introduced by the bTB 
eradication programmes (Smith et al. 2006).  
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1.1.2 On bTB transmission and pathogenesis  
BTB is a chronic, primarily respiratory infectious disease. Cow to cow 
transmission mainly occurs through respiratory secretions. M. bovis is an 
intracellular pathogen and after being inhaled, aerosol droplets carrying 
Mycobacteria reach the lungs where the primary target-cells are the alveolar 
macrophages (Fig. 2) (Koul et al. 2004). There, Mycobacteria act as a type of 
intracellular parasite managing to survive within the macrophages by disrupting cell-
signalling pathways, overriding immune response (Koul et al. 2004) and establishing 
a chronic infection. The typical lesions observed are tubercles formed mainly in the 
lungs and the lymph nodes that drain the region (Divers and Peek 2008). Tubercles 
contain Mycobacteria and immune cells enclosed within multiple layers of fibrous 
tissue, and their structure assists in preventing spread of the infection (Fayyazi et al. 
2000; Saunders et al. 2000; Cassidy et al. 2005). Although inhalation is the main 
route of transmission, younger cattle may also be infected by ingestion, through 
consumption of infected milk (Divers and Peek 2008). 
Transmission of bTB can also occur from a wildlife reservoir into cattle 
populations, which sustains infection. Therefore, the wildlife reservoir is one of the 
major factors that hinder eradication. The Eurasian badger (Meles meles) is the main 
wildlife reservoir for the disease in the UK and Ireland 
(https://www.gov.uk/government/publications/2010-to-2015-government-policy-
bovine-tuberculosis-bovine-tb). Other wildlife species such as the red deer (Cervus 
elaphus) and the possums (Trichosurus vulpecula) (New Zealand) are wildlife 
reservoirs of the disease around the world. Furthermore, pets, and specifically cats 
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and dogs, can become infected with M. bovis mainly through drinking unpasteurised 
infected milk or contact with infected animals (farm animals or wildlife) 
(https://www.gov.uk/government/publications/bovine-tuberculosis-tb-in-domestic-
pets), and there are reports on transmission to humans through contact with cats 
infected with M. bovis (de Lisle et al. 1990; Monies et al. 2006). Lastly, multidrug 
resistant M. bovis strains and the possibility of human-to-human transmission 
introduce new challenges to bTB control (Cosivi et al. 1998). M. bovis has a capacity 
for causing major epidemics as it is indicated by its basic reproductive number being 
greater than one (Cox et al. 2005), and therefore it is necessary to develop and 
employ efficient diagnostic and control strategies.   
1.1.3 Diagnosis of bTB 
The main clinical manifestations of bTB are emaciation, chronic cough, 
lymph node enlargement, and udder infection (Divers and Peek 2008). However, 
bTB is a chronic disease and the clinical symptoms can be very rarely observed in 
veterinary practice. Thus, there is a range of approaches that are available and used 
for diagnosing bTB including the tuberculin skin test, post-mortem examination, 
bacteriology and histological analysis, and interferon-gamma testing. Important 
epidemiological parameters that indicate the qualities of a diagnostic test are its 
sensitivity and specificity, representing the power of the test to correctly identify the 
infected and the healthy individuals as such, respectively. Limitations in the 
sensitivity and specificity of the available diagnostic methods along with our 
incomplete understanding of bTB transmission hinder successful eradication. In the 
UK, the cattle industry has traditionally relied on diagnosis through compulsory 
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tuberculin skin testing and abattoir carcass inspections (de la Rua-Domenech et al. 
2006).  
Skin testing using the Single Intradermal Comparative Cervical Test (SICCT) 
has been the cornerstone of bTB surveillance: animals with a positive outcome to the 
test are culled and movement restrictions are applied to the herd (Allen et al. 2010). 
The test is based on the interpretation of the local inflammatory response and skin 
swelling due to the delayed-type hypersensitivity reaction to the tuberculin antigen 
that is inoculated (i.e. Purified Protein Derivative, PPD) (Allen et al. 2010). Two 
important elements of the test are the test design and the re-testing intervals. 
Historically, several variations of the test have been developed, including the single 
and the double dose tests, intradermal or subcutaneous administration, cervical 
inoculation or at the caudal fold, use of the mammalian or the bovine PPD (VLA 
Weybridge or Prionics ID-Lelystad), a single tuberculin or a comparative test. 
Lesslie et al. (1975) demonstrated through their classical tuberculin testing trials that 
the bovine tuberculin, and specifically the comparative version of the test, improved 
the specificity of the test and its power to discriminate between tuberculous and non-
tuberculus animals, in herds where M. avium, skin tuberculosis and Johne’s disease 
were also present, with a number of animals in the trial being vaccinated for Johne’s 
disease. The comparative version of the test has been employed in the UK in order to 
take into account the non-specific reactions to M. avium sbsp avium, which is also 
present in the environment and might cause false positives. Over the years, a 
complex re-testing protocol following identification of reactors or inconclusive 
reactors in a herd has been developed. The basis of this protocol is the 60-days 
interval between subsequent tests, in order to avoid the suppressive effect of the test 
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itself causing reduced reactivity to the tuberculin for a subsequent time interval (i.e. 
the “desensitisation effect”) (Radunz and Lepper 1985; Kerr et al. 1946; Monaghan 
et al. 1994; Doherty et al. 1995; Thom et al. 2004). However, the underlying 
mechanisms of desensitisation, and when reactivity returns to its previous levels, 
along with how these could be exploited in the modern re-testing protocol to shorten 
those intervals for a more stringent test, are poorly studied.   Obligatory testing 
intervals range from 6 months (Intensive Action Areas) to 4 years, depending on the 
county disease risk (from 1.1.2013). However, while SICCT as applied has very 
good specificity (>99% Sp), it suffers from insufficient sensitivity (~55-70% Se) (i.e. 
allowing for false negatives) (Neill et al. 1994; Olea-Popelka et al. 2004; De la Rua-
Domenech et al. 2006). Although SICCT has been effective at the whole-herd level, 
i.e. in diagnosing infected herds, it has not been very successful in diagnosing the 
infection status at the level of the individual animal, and cattle that were negative to 
the test although infected (i.e. false negatives), maintain an infectious challenge in 
the herd.  
At post-mortem examination in the abattoir the main lesions observed are 
tubercles that can be found in the lungs and the lymph nodes. However, carcass 
inspection also has insufficient sensitivity (~30-50% Se) (Neill et al. 1994; Olea-
Popelka et al. 2004; De la Rua-Domenech et al. 2006). Laboratory confirmation of 
infection for the tuberculin test reactors or suspect abattoir lesions is based on a 
combination of bacteriology, histological analysis and culture of tissue samples. 
However, this is problematic due to the highly specific requirements of the slow-
growing Mycobacteria in vitro (Cosivi et al. 1998).   
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One of the most recent diagnostic tools is the interferon-gamma (IFN-γ) test, 
which is an enzyme linked immune-sorbent assay (ELISA) that detects IFN-γ in 
whole blood, released as a reaction to tuberculin (Allen et al. 2010). Although the 
IFN-γ test has reportedly higher sensitivity than the standard interpretation SICCT, it 
has substantially lower specificity (~96% Sp) (Downs et al. 2011). Therefore, its use 
has been suggested in combination with the skin test, as a complementary diagnostic 
test (Sheridan 2011). 
1.1.4 bTB control strategies 
Control of bTB remains a major challenge despite the on-going eradication 
programmes in the UK. Eradication strategies are compromised by the presence of 
the wildlife reservoir. Studies on the effectiveness of culling badgers in the UK to 
reduce bTB prevalence in cattle (the Randomised Badger Culling Trial (RBCT), 
1998-2005) have shown both positive and negative effects. Although beneficial 
effects were observed within the badger culling areas, there were negative effects on 
the adjoining lands, with an increase in cattle bTB incidence possibly due to the 
social perturbation and immigration of badgers caused by the culling (Cox et al. 
2005; Donnelly et al. 2007; Jenkins et al. 2010; Sheridan 2011). Moreover, recent 
studies have argued that control strategies that focus on a single route of transmission 
are not likely to be very successful (Brooks-Pollock et al. 2014).  
One strategy that could complement eradication is vaccination. Bacillus 
Calmette Guerin (BCG) vaccine, initially developed for humans, is based on an 
attenuated M. bovis strain containing numerous deletions that make it non-virulent 
(Buddle et al. 2003; Behr et al. 2015). However, BCG vaccination is precluded 
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because it is not fully protective, while vaccinated animals are currently 
indistinguishable from naturally infected animals using the standard tuberculin tests 
(Cosivi et al. 1998; Buddle et al. 2003; Hewinson et al. 2006). The possibility of 
developing tests that will allow Differentiating Infected from Vaccinated Animals 
(DIVA) is under assessment and currently, there are no licenced cattle vaccines for 
use against bTB in the UK.   
Identification of infected animals using the available diagnostic methods is 
further complicated by the various demonstrations of bTB infection associated with 
the progress of disease, that have an impact on the responsiveness to the diagnostic 
skin test and the effectiveness of carcass inspections. For example, although some 
animals react to the skin test, they do not show any detectable lesions in abattoir 
inspections (Non-Visible Lesions reactors, NVLs) (Radunz et al. 1985; Comer et al. 
1994; Doherty & Cassidy 2002). This is an intrinsic problem of the abattoir 
inspection-based diagnosis, as identification of a bTB case cannot solely rely on this 
method.  Moreover, there are Non-Specific Reactors (NSRs) that complicate reaction 
to the SICCT and the interpretation of test results, which can be due to a number of 
factors including natural, experimental, or vaccinal exposure to paratuberculosis (see 
below), M. avium, skin TB (M. microti), or other environmental mycobacteria that 
share proteins with the bovine tuberculin (Monaghan et al. 1994). Further, there is a 
time period of 30-50 days required post infection for the animal to develop reactivity 
to SICCT (Monaghan et al. 1994) and 21-35 days to develop detectable reaction to 
the IFN-γ test (Dean et al. 2005). Thus, animals that are recently infected and are still 
at initial stages of infection fail to respond to the SICCT although infected (Vallee 
and Panisset 1920; Francis 1947). Anergy describes animals that although they have 
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severe and generalised disease, they do not react to tuberculin due to various reasons 
including parturition (due to the periparturient immunosuppression), stress, treatment 
with glucocorticoids, BVD virus infection, and malnutrition (Kerr 1949; Buddle et 
al. 1994; Skuce et al. 2011). Finally, latency, which has mostly been studied in 
humans, is a condition where the mycobacteria remain inactive for a long period of 
time. Individuals with latent infection show no clinical signs and they are not able to 
spread the disease unless the disease becomes active (Flynn et al. 2001). 
The outcome of the diagnostic tests can be compromised by the presence of 
simultaneous infections. Paratuberculosis (Johne’s disease), caused by 
Mycobacterium avium sbsp paratuberculocis is also prevalent in the UK (~34.7% 
prevalence; http://archive.defra.gov.uk/), and cattle infected with Paratuberculosis 
can be responsive to the bovine and avian tuberculins (Lesslie et al. 1975; Monaghan 
et al. 1994). Vaccination against it might be interfering with the interpretation of the 
tuberculin skin test (Köhler et al. 2001), while paratuberculosis infection also 
decreases the specificity and sensitivity of the IFN-γ test (Alvarez et al. 2009).  
Moreover, recent studies have shown that when coinfection with parasites occurs, 
and in particular with the liver fluke (Fasciola hepatica), the bTB skin test might be 
less sensitive (Claridge et al. 2012).  
BTB diagnosis and control is an ongoing challenge for the UK cattle industry. 
Therefore, in a situation where conventional control strategies have not been 
effective, it is becoming increasingly clear that complementary strategies will be 




Figure 1. The change of bTB incidence in GB between the years 1996 to 
2015. In the graph we see the number of new incidents of bTB leading to the 
withdrawal of Officially bTB Free (OTF) herd status, as a percentage of tests 
carried out in OTF herds. The spike observed in 2001 is due to the 
suspension of bTB testing during the Foot and Mouth Disease (FMD) 













1.2 Genetic selection for disease resistance 
1.2.1 Genomic prediction - overview  
Following exposure to M. bovis only a proportion of animals develop disease, 
implying variability among individuals in terms of their response to infection 
(Pollock et al. 2002). Various studies have confirmed that the variation in bTB 
resistance among dairy cattle is in part genetic and it is exploitable, and have 
demonstrated moderate to strong heritability (Bermingham et al. 2009; Brotherstone 
et al. 2010; Tsairidou et al. 2014) (Table 1). Moreover, variation has been found 
among cattle family lines (Phillips et al. 2002), and between Holstein cattle, zebus 
(Bos indicus) and zebus x Holstein crosses, with Holsteins being more susceptible 
than zebus or crosses (Ameni et al. 2007). Thus, a proportion of the observed 
phenotypic variation can be attributed to host genetics. 
Improvement of livestock through selective breeding of the best animals has 
been long practised by farm animal breeders. Genetic selection utilises both 
phenotypes (i.e. bTB state) and pedigree information (Henderson 1975; Goddard and 
Hayes, 2009). Estimated Breeding Values (EBVs) can then be calculated using 
statistical techniques such as Best Linear Unbiased Prediction (BLUP). However, it 
requires information on phenotypes or indicator traits which is not always feasible 
and particularly for traits difficult to measure or when the diagnostic test has 
imperfect specificity and sensitivity. For example in the case of bTB, phenotypes are 
difficult to collect as infection can only be confirmed post mortem and the SICCT 
has imperfect sensitivity.  Furthermore, and particularly when within-herd prevalence 
is low (i.e. p ~ 6-10% for bTB), selecting phenotypes is inefficient as exposure to the 
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pathogen is required to express the resistant genotype. With incomplete exposure to 
infection some animals do not have the opportunity to express their resistant 
phenotype (Bishop and Woolliams 2010). Thus, such selection would work only on 
the subset of animals in herds affected by bTB, or their close relatives, and it would 
require that the population is undergoing an epidemic. Even then, selection intensity 
would be low if only a small proportion of herds were affected (Bishop and 
Woolliams 2010). Lastly, even if selection based on phenotypes were to be 
undertaken and had some success in controlling the epidemic, this success would 
reduce the potential for making further progress through a reduced number of 
informative phenotypes. Therefore, in the case of bTB resistance, it is appealing to 
be able to identify relatively resistant animals in the absence of phenotypic data from 
an epidemic.  
The idea of Genomic Selection (GS) as established by Meuwissen et al. 
(2001), introduced a new potential to the world of research towards genetic 
improvement of livestock (Goddard et al. 2007). In contrast to selection based on 
routine phenotyping, genomic selection is a technology that addresses the problem of 
identifying relatively resistant individuals by obtaining EBVs for animals without 
observing phenotypes. Genomic selection utilises genomic EBVs estimated directly 
from SNP data rather than pedigree data, calculated as the sum of the effects of 
genetic markers (Single Nucleotide Polymorphisms, SNPs) across the genome 
(Hayes et al. 2009; Jia et al. 2012). Regions containing genes controlling quantitative 
traits, such as disease resistance, are called Quantitative Trait Loci (QTL). The 
central idea is that markers across the genome will be sufficiently close to the QTLs 
and will assist predicting the effect of the QTLs through Linkage Disequilibrium 
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(LD) (Goddard 2009). The most commonly used method for calculating EBVs is 
Genomic BLUP (GBLUP) (Meuwissen et al. 2001; Daetwyler et al. 2010).  The 
process can be summarised in two steps: Initially, GEBVs are calculated on a 
training population with both phenotypic and genotypic information e.g. from an 
epidemic. Then, for the selection candidates, GEBVs can be predicted with a certain 
accuracy without phenotypic records (Meuwissen et al. 2001), by combining 
knowledge on their genotypes and the marker effects which have already been 
calculated in the training population (Hayes et al. 2009; Luan et al. 2009). In other 
words, through the genomic prediction methodology, EBVs can be estimated by 
combining knowledge on genotypes of the selection candidates and marker effects, 
and these can then be used as predictors of disease susceptibility for every animal. 
The estimation of marker effects relies on the LD between the markers and the 
QTLs, and consequently on relatedness. LD is expected to break down over 
generations due to recombination events. However, although the estimated marker 
effects will need to be re-calibrated after a number of generations to avoid a decline 
in the prediction accuracy, regular collection of phenotypes and exposure to infection 
for all animals will not be required every generation, at least for several rounds of 
selection, and it will be possible to perform selection even in the absence of an 
epidemic. Further, high density genotyping becomes increasingly available at lower 
cost. The denser the markers are, the closer they will be to the QTLs and thus, the 
LD and the prediction accuracy will be more likely to be maintained across more 
generations. 
Genomic selection in dairy cattle breeding presents further advantages over 
phenotypic selection. It improves the rate of genetic gain by obtaining sufficient 
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accuracy within a shorter generation interval, since the GEBVs can be calculated as 
soon as DNA samples are available. Hence, it allows differentiation between full-
sibs, (i.e. prediction of the Mendelian segregation term), without the delay of 
phenotypic recording (Hayes et al. 2009; Daetwyler et al. 2008). Moreover, it 
reduces emphasis on any particular sire family and therefore, helps in controlling the 
rate of inbreeding (Daetwyler et al. 2008).  
1.2.2 The Genomic selection opportunity  
The hypothesis in the present study is that genetic selection for disease 
resistance in the light of genomic advances, may offer a complementary bTB control 
strategy, by reducing infection risks and hence contributing to a reduction in herd-
level incidence as well as a reduction in the severity of the outbreak. Genomic 
selection is a new technology that allows to perform selection for disease resistance 
and overcome the limitations imposed by selection based on phenotypes or the 
knowledge of exact QTLs. Specifically, in the case of bTB, measuring resistance 
phenotypes under field conditions is challenging as data collection is opportunistic 
and relies on outbreaks. BTB is endemic but not present in all herds, thus only a 
small subset of herds each year can contribute data, while many herds have 
incomplete pedigree recording. Disease resistance traits often have low heritabilities 
which are further underestimated in field data due to the imperfect diagnostics 
(Bishop and Woolliams 2010). The phenotypes of interest are not directly observable 
and the indicator traits that are used i.e. the diagnostic tests, are imperfect in terms of 
their sensitivity and specificity. With genomic selection we can identify extreme (i.e. 
very resistant or very susceptible) animals and use GEBVs as predictors of disease 
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susceptibility without the requirement for exposure to infection and thus, genomic 
selection can be performed for animals without phenotypes, in the absence of an 
epidemic.  
When genetic architecture allows, resistant animals can be selected through 
identifying the QTLs that control resistance to the disease, i.e. Marker Assisted 
Selection (MAS). One example of successful application of MAS for disease 
resistance is selection against Infections Pancreatic Necrosis (IPN) in the Atlantic 
salmon, where resistance to IPN was found to be controlled by a single QTL 
(http://impact.ref.ac.uk/CaseStudies/CaseStudy.aspx?Id=23913; Houston et al. 
2010). However, the degree of success of MAS based on individual QTL 
associations depends on the proportion of the total genetic variation that they explain. 
Most disease resistance traits are expected to be complex traits, under polygenic 
control, i.e. affected by many genes with small individual effect (the theoretical 
model for this is known as the “infinitesimal model” where each variant explains 
only a very small proportion of the total variation) (Villanueva et al. 2005; Goddard 
2009). In such cases, the ability to cope with large numbers of loci with small effects 
makes genomic selection more attractive than MAS. When using genomic selection 
and whole genome prediction for disease resistance traits, the QTLs do not need to 
be known, and SNP genotypes can be used to identify animals genetically 
predisposed to be more resistant e.g. to bTB infection. However, although widely 
implicated for production traits, the use of the genomic selection technology for 
disease resistance has been limited so far, although there are published examples of 
genomic selection for reduction of clinical mastitis in Norwegian Red cattle 
(Heringstad et al. 2003; Luan et al. 2009).  
26 
 
The aims of this PhD were to study the genetic architecture of resistance to 
bTB, i.e. to test whether single QTLs explain large amounts of variation following 
the IPN example, or if instead it is a complex trait following the mastitis example, 
and to explore the feasibility of genomic selection for livestock populations that will 
be more resistant to disease. Therefore, this Thesis presents seven chapters: Chapter 
1 provides a general introduction. Chapter 2 demonstrates the feasibility of genomic 
selection for resistance to bTB. Chapter 3 examines a single-SNP approach capturing 
non-additive genetic variation. Chapter 4 progresses the idea of genomic selection by 
combining distantly related populations in a meta-analysis and exploring the genetic 
architecture of bTB resistance. To extend this analysis, Chapter 5 investigates the use 
of high density genotypes inferred by means of genotype imputation. Chapter 6 
presents a quantitative genetic analysis of field SICCT data examining the potential 
impacts of selection for bTB resistance on the diagnostic test. Chapter 7 provides a 
general discussion of the overall Thesis.   
 
 
Table 1. Heritability estimates reported in previous studies on bTB 
susceptibility. 
Species  h2 ± SE Scale Ref. 
Red deer Cervus elaphus    0.48 ± 0.10 lesion score Mackintosh et al. 2000 
Cattle Bos taurus 0.18 ± 0.04 liability Bermingham et al. 2009 
Cattle Bos taurus 0.18 ± 0.04 liability Brotherstone et al. 2010 
Cattle Bos taurus 0.21 ± 0.06 observed Bermingham et al. 2014 




Genomic prediction for tuberculosis resistance in dairy cattle 
2.1 Introduction 
BTB eradication in the UK is impaired by limitations of the available 
diagnostic and control methods.  Following exposure to M. bovis only a proportion of 
animals develop disease, implying variability among individuals in terms of their 
response to infection (Pollock et al. 2002). As described in Chapter 1 (section 1.2.2) 
selection of those animals that are genetically more resistant to bTB can be 
conducted using genetic markers and by applying the genomic selection technology. 
In contrast to traditional phenotypic selection, genomic selection allows us to obtain 
EBVs for animals without observed phenotypes and therefore, without exposure to 
infection to be required, at least for several rounds of selection. 
Genomic selection utilises genomic EBVs estimated directly from SNP data, 
calculated as the sum of the effects of genetic markers (Single Nucleotide 
Polymorphisms, SNPs) across the genome. This is a conceptually different approach 
to single-SNP approaches. For example in GWA analysis (e.g. Bermingham et al. 
2014), the objective is to identify causative variants, while in genomic selection 
entire breeding values are estimated using all markers in the genome. Several 
methods have been suggested for the calculation of EBVs either assuming that all 
markers explain the same amount of variance or incorporating prior knowledge on 
the distribution of the SNP effects (Meuwissen et al. 2001; Hayes et al. 2010; Moser 
et al. 2015). One method for estimating EBVs assuming the same amount of variance 
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is explained by all the markers, is Genomic BLUP (GBLUP) (Meuwissen et al. 2001; 
Daetwyler et al. 2010).  Through the genomic prediction methodology, EBVs can be 
estimated by combining knowledge of marker effects estimated from a training 
population comprising both genotypes and phenotypes, with the genotypes of 
selection candidates. These can then be used as predictors of disease susceptibility 
for every animal.  
Previous studies have confirmed the presence of potentially exploitable 
genetic variation in bTB susceptibility among dairy cattle (Brotherstone et al. 2010; 
Bermingham et al. 2012). The hypothesis in the present study is that genetic selection 
for disease resistance may offer a complementary bTB control strategy, by reducing 
infection risks and hence contributing to a reduction in herd-level incidence. The aim 
of this study was to estimate EBVs for bTB resistance using GBLUP, by utilising 
dense SNP chip data on UK dairy cattle and to test these genomic predictions in the 
absence of disease phenotype. This is the first step in the investigation of the 
feasibility of genomic selection for bTB resistance on the basis of predicted EBVs.  
2.2 Materials and Methods 
2.2.1 Animals 
Phenotypic data for 1,151 cows from 165 dairy cattle herds in Northern 
Ireland were collected in a case-control study design, with a sample prevalence of 
0.51 in the compiled dataset over two years of data collection (Bermingham et al. 
2014). This prevalence is close to the cumulative incidence within Northern Ireland 
which was 0.66% in 2012 and 0.51% in 2013 (DARDNI 2013 Annual report). 
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Information available included bTB skin test data, as described below, the age of the 
cow on the day of the test, the year when the herd was tested, the season of the test, 
the reason for which the herd was tested and animal breed as nominated by the 
farmers. Animals were tested between August 2008 and September 2009, ranging in 
age from 1 to 11 years and with a mean of 4.8 years, either as part of the annual herd 
test, herd check tests or reactor herd tests (Abernethy et al. 2006). Most animals were 
assigned to be Holstein females, with a small number designated as Friesians 
(n=164). A breakdown of data by these variables is given in Table 1. 
The animal study was licensed by the Department of Health, Social Security 
and Public Safety for Northern Ireland (DHSSPSNI) under the UK Animals 
(Scientific Procedures) Act 1986 [ASPA], following a full Ethical Review Process 
by the Agri-Food & Biosciences Institute (AFBI) Veterinary Sciences Division 
(VSD) Ethical Review Committee. The study is covered by DHSSPSNI ASPA 
Project Licence (PPL-2638 ‘Host Genetic Factors in the Increasing Incidence of 
Bovine Tuberculosis’), and scientists and support staff working with live animals 
during the studies all hold DHSSPSNI ASPA Personal Licences. 
2.2.2 Phenotype definitions 
Cattle  that showed a positive reaction to the Single Intradermal Comparative 
Cervical test (SICCT), that had bTB lesions confirmed by post-mortem examination 
of carcasses at slaughter and were confirmed as M. bovis positive by culture and 
molecular tests, were defined as cases (592 animals). In this study a positive SICCT 
was defined as a skin test reaction to M. bovis antigens that after 72h exceeds the 
reaction to M. avium antigens by >4mm according to the standard interpretation of 
30 
 
the test (Morrison et al. 2000; Bermingham et al. 2014). Controls were repeatedly 
SICCT negative, resident on the farm >6 months (559 animals), and were in herds 
where cases were observed (Bermingham et al. 2014). Controls were age-matched 
and preferentially selected from herds with higher disease prevalence in order to 
increase their probability of exposure to the pathogen (Bishop et al. 2012). 
2.2.3 Genotyping 
All individuals were genotyped for 727,252 SNPs using the BovineHD 
Illumina Bead Chip. Quality control parameters applied included a minimum 
Gentrain Call (GC) score of 0.60, a minimum minor allele frequency of 0.05, and a 
minimum call rate of 0.90 for all loci. Animals with a call rate <90% or a minimum 
GC score of 0.65 were excluded (Bermingham et al. 2014). The map of the SNP 
positions was based on the bovine genome assembly (Bos taurus UMD 3.0). 
2.2.4 Structure exploration  
Principal component analysis (PCA) was conducted in R (R version 2.14) to 
explore data structure by means of calculating the principal components. PCA allows 
identification of cryptic structure and unrecognised outlier groups representing 
subpopulations that are genetically distinct.  PCA was conducted on the 1,151×1,151 
identity-by-state (IBS) pairwise relatedness matrix using the BovineHD BeadChip 
genotypes (see section 2.2.6.2). Principal components were calculated as the 
eigenvectors of the IBS genomic matrix and the first principal component was 
plotted against the second principal component. PCA did not identify any sub-
structure due to designated animal breed i.e. Holstein or Friesian, however, it 
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revealed the presence of two clusters, the main one, and a secondary smaller cluster 
comprising 40 individuals (Bermingham et al. 2014, Fig. S1). The hypothesis was 
that the observed structure might be due to the presence of Friesians in the dataset, 
however, none of the animals in the smaller cluster were described as Friesians. 
Thus, the structure observed in the data was not due to those breeds believed to have 
been sampled. Identification of the outliers showed that 39 of them originated from 
the same herd and further enquiries revealed that crossbreeding with beef cattle 
breeds may have taken place in this herd. Thus, to address the possibility of breed 
differences, these animals, along with one additional animal from a different herd 
that was also clustering with this group were deleted in some of the following 
analyses as described in the definition of datasets below.  
2.2.5 Definition of datasets 
Three slightly different datasets were used in this analysis. Firstly, the full 
dataset comprising all 1,151 individuals was used. Secondly, a reduced dataset was 
derived from the full dataset, removing the 40 individuals that were identified as 
outliers by the PCA and for which there was information that they could be 
crossbreds. This was done in order to address the hypothesis that the presence of beef 
cross-bred animals may introduce genetic structure to the population and hence alter 
prediction accuracy. Finally, the analysis was repeated using only animals designated 
as being Holsteins, after having removed the animals reported by the farmers  as 
Friesians  (n=164).  For each dataset the corresponding adjusted phenotypes were 
obtained, a new G matrix was calculated and the heritability was re-estimated (see 
section 2.2.6).  
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2.2.6 Calculating direct genomic estimated breeding values (EBV) 
The aim of the analysis was to estimate the EBVs and then assess their 
predictive accuracy by cross validation. To conduct the cross validation, and to 
ensure that the sampling of phenotypes would not be biased by the fixed (non-
genetic) effects, a two-step approach was followed to calculate the EBVs. Firstly, the 
data was pre-corrected for fixed effects, and then EBVs were obtained from the pre-
adjusted data (de los Campos et al. 2012).  
2.2.6.1 Pre-correction 
An initial fixed effects model was used to obtain adjusted phenotypes, 
corrected for identifiable non-genetic factors.  The fixed effects model included 
animal age, test year, season, test reason and breed as fixed effects, and was fitted 
using the ASReml package (Gilmour et al. 2009) as follows:  
            ijkmpq i j k m p ijkmpqY a D S R B e        (1) 
where Yijkmpq represents the binary bTB status (0: control, 1: case) of the q
th 
individual; μ is the overall mean; ai is the age of the individual (9 d.f.); Dj is the 
effect of the year of testing (1 d.f.); Sk is the season of testing (2 d.f.); Rm is the 
reason for which testing was initiated in the herd (2 d.f.); Bp is the assigned breed of 
the individual (1 d.f.) and eijkmpq is the residual error. Since all the animals were 
female, sex was not included in the fixed effects. The herd of origin was not included 
in the fixed effects as a consequence of choosing the controls to originate from herds 
of higher prevalence. The residual effects, which are independent of the fixed effects, 
were obtained and used as phenotypes for the subsequent analyses.  
33 
 
2.2.6.2 EBVs estimation 
The genomic estimated breeding values were calculated for all individuals 
using the adjusted phenotypes from model (1). A random effects model was fitted in 
ASReml as follows:   
        i i iy m u e    (2) 
where m is the overall mean,  yi is the residual effect for the ith individual as 
calculated from model (1), ui is the genomic estimated breeding value with u ~ MVN 
(0, Gσa
2) and ei  is its residual value with e ~ MVN (0, Iσe
2). As pedigree 
relationships were unknown in this population, genetic similarities between animals 
were described using the marker-based IBS genomic relationship (G) matrix which 
has the following elements: 
  


































where xik (xjk) is the genotype of the i
th (jth) animal defined as 0, ½, or 1 from 
an arbitrary reference allele at the kth SNP, n the total genomic SNPs, and pk is the 
frequency of the reference allele at the kth SNP. Obs(hom)ik is the observed 
homozygosity (1 or 0) for the ith animal at the kth SNP and E(hom)k is the expected 
homozygosity for the kth SNP calculated as E(hom)k =(1 - 2pk(1-pk)) (Uemoto et al. 
2013). To construct G, SNPs found only in the homozygote state in the sample and 
those found on the X chromosome were removed (601,280 SNPs were finally 
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retained in the analysis). In ASReml the provision of the inverse G matrix is required 
which was calculated in R. 
2.2.7 Heritability estimation 
For the purpose of estimating the heritability of bTB resistance from the full 
dataset, the fixed and random effects were fitted simultaneously in a mixed model in 
ASReml, where all the fixed effects from model (1) were fitted as before and the 
relationship information from the G matrix was incorporated as a random effect with 
distributional assumptions as in model (1).  
2.2.8 Cross validation  
Genomic prediction accuracy can be assessed through cross validation, a non-
parametric method that allows assessment of the predictive ability of the EBVs. By 
partitioning the data into a training set and a validation set, EBVs can be predicted 
for the validation set without reference to their phenotypic information. Prediction 
accuracy can then be calculated by correlating the predicted breeding values and the 
observed phenotypes, corrected for trait heritability (Legarra et al. 2008). A five-fold 
cross validation was conducted as follows.  
Firstly, to create the training set in each of the three datasets the individuals 
were partitioned into five random groups of near-equal size, with the randomization 
performed separately within the case and control sub-populations. Phenotypes were 
then masked for each subset in turn, creating five datasets (or folds) in which four-
fifths of the animals had a phenotype (training-set, y1), and one-fifth had no 
phenotype (validation-set, y2). 
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Secondly, using the GBLUP model (2) predicted EBVs were calculated for 
each validation-set in turn based on the G matrix alone and conditional on the 
phenotypic information recorded on the training-set animals, (ŷ2|y1) (Legarra et al. 
2008; Luan et al. 2009; Daetwyler et al. 2013).  
For each of the five test-sets the correlation between the cross-validated 
predicted EBVs (ŷ) and the adjusted phenotypes (y), i.e. r(y,ŷ), was calculated. The 
expected accuracy (r(g,ĝ)) between the breeding value of an individual (g) and its 
estimate (ĝ), was derived from the correlation as E[r(g,ĝ)] ≈ r(y, ŷ)/h, where h is the 
square root of the heritability (Luan et al. 2009). The accuracy for each test set was 
calculated using the heritability obtained for each corresponding cross validation fold 
and then the average accuracy across all the individuals was obtained.  
In order to reduce random sampling effects and assess the sampling 
properties of the accuracy, the cross validation analysis as described above was 
replicated six times, where for each replicate a new randomisation was performed so 
that the individuals comprising each of the groups were different. Finally the average 
accuracy across all six replications with its empirical 95% confidence interval was 
obtained, where the confidence interval was calculated from a one sample t-test (5 
d.f.) for the six accuracy values obtained from the six replications. 
2.2.9 Assessing predictive ability using ROC curves 
Genomic predictions can be further assessed through the properties of the 
Receiver Operator Characteristic (ROC) curves and the corresponding area-under-
the-ROC-curve (AUC). A ROC curve is the plot of the probability of a positive test 
result given that the individual is diseased (sensitivity) versus the probability of a 
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positive test result given that the individual is healthy (1-specificity), for all 
successive thresholds (Metz 1978). The AUC is a measure of the performance of the 
predictor, i.e. the AUC is the probability of correctly identifying the case in a pair of 
infected and healthy individuals (Janssens et al. 2006). Using the R package, the 
predicted EBVs for each of the omitted (validation) groups from the cross validation 
procedure and the binary phenotype for all the 1,151 individuals were used to 
calculate the ROC curves, along with their corresponding AUC values, for each of 
the six randomisations for the full dataset.  
2.2.10 Theoretical expectations 
2.2.10.1 The maximum AUC value (AUCmax)  
Insight into the information obtained by calculating the ROC curves and their 
corresponding AUC can be gained by considering these values relative to the 
theoretical maximum AUC value that could be obtained given the characteristics of 
the trait and the population under study. There is a maximum AUC value (AUCmax) 
that would be achieved if the test classifier was a perfect predictor of genetic risk 
(Wray et al. 2010). This maximum varies for each disease, since it depends on the 
disease prevalence (q) and the heritability of the trait on the underlying liability scale 
(hL
2). hL




introduced by Robertson and Lerner (1949),  where ho
2  is the heritability on the 
observed scale, q is the disease prevalence in the sample and iq  is the mean in 
standard deviation units of the upper proportion q of the population, assuming a 
normal distribution. The online calculator provided by Wray et al. (2010) was used to 
obtain expected values for AUCmax and AUChalf, which is defined as the AUC 
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expected from a genomic profile that accounts for only a half of the known genetic 
variance (i.e. a reliability of 0.5). These values can be used as a basis of comparison 
for the actual AUC values obtained in the present study.  
2.2.10.2 Prediction accuracy 
Daetwyler at al. (2010) presented a formula for estimating the expected 
GBLUP accuracy: 
 2 2(g, ) /    ˆ   P P er g N h N h M                (3) 
where NP is the number of individuals in the training population, h
2 is the 
heritability on the observed scale, and Me is defined as the number of independent 
genome segments. The formula for Me is given by Meuwissen et al. (2009) where  
represents the sum across chromosomes:  
 2 / ln 4           e e i e i
i
M N L N L  (4) 
Me depends on the chromosome length in Morgans Li (Lee et al. 2011) and on 
the effective population size Ne. Formulae (4) and (5) were applied to different 
putative effective population sizes for this sample of animals in order to obtain 
estimates for the number of independent chromosome segments and the expected 




2.3 Results  
2.3.1 Calculation of EBVs and genomic prediction accuracy 
The GBLUP analysis gave an estimate for the heritability of bTB 
susceptibility of h2 = 0.23 ± 0.06 on the observed scale and hL
2 = 0.34 on the liability 
scale for the full data set, h2 = 0.23 ± 0.07 and hL
2 = 0.34 for the dataset after 
removing the 40 individuals identified as a distinct sub-population from the PCA, 
and h2 = 0.21 ± 0.07 with hL
2 = 0.34 for the reduced data set with the Friesian 
individuals excluded.  
Table 2 shows the correlations between the adjusted phenotypes and the 
predicted EBVs, the corresponding heritability estimates and accuracy values with 
their standard deviations obtained as averages across the five cross validation groups 
for each of the six replications. More detailed information is presented in Tables 3, 4, 
and 5. Accuracies of 0.33 (95% C.I.: 0.26, 0.40), 0.33 (95% C.I.: 0.28, 0.37), and 
0.36 (95% C.I.: 0.33, 0.38) were obtained for the three datasets, respectively. 
Analysis after removing the 164 animals designated as Friesians provided more 
homogenous results across the cross validation repeats (Fig. 1). As it will be 
discussed below, the values obtained are in line with theoretical expectations given 
the size of the dataset.  
Further, for the full data and the dataset after removing the Friesians, for each 
of the cross validation folds and across the six replications, the observed phenotypes 
were regressed on the predicted EBVs (Tables 6, 7, and 8). For the full dataset, these 
values were close to the theoretical value of 1.0 indicating that the predicted EBVs 
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were unbiased. After removing the Friesians the SD reduced, however, although the 
regression coefficients might indicate some bias, the number of records in this 
analysis was smaller.    
 2.3.2 ROC curves and AUC values 
ROC curves, showing the utility of EBVs as predictors of the binary 
phenotype, are shown in Figure 2. The ROC curves result from plotting for all 
successive decision thresholds, the true positive fraction versus the false positive 
fraction which can be defined as the conditional probability of a positive test given 
the presence of disease, and the conditional probability of a positive test given the 
absence of disease respectively, and thus, are independent from the decision 
threshold and the prevalence of the disease (Metz 1978). In the context of estimated 
EBVs, the ROC curves are the plots of the conditional probability of EBVs 
predicting a case given a diseased true phenotype versus the probability of EBVs 
predicting a case given a healthy true phenotype. Examples of individual ROC 
curves for each of the five cross validation test sets within one cross validation run 
are shown in Figure 3. In these ROC curve plots, the comparison of interest is with 
the outcome that would be expected by chance (diagonal line of no discrimination). 
The curves for all randomisations lie above this diagonal line. Therefore, for the 
population under study the use of genotypes provides information in the prediction of 
disease state, i.e. the markers help to predict resistance. The AUC values were 0.56, 
0.59, 0.58, 0.57, 0.57 and 0.59 for the six different randomizations applied in dataset 
1 (Fig. 2). Hence, there was a probability close to 0.58 of correctly classifying a case 
cow and a control cow based on SNP genotype alone using these data.  
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2.3.3 Theoretical expectations 
2.3.3.1 AUC values 
For the data-set in the present study the disease prevalence was 0.51 (592 
cases out of 1,151 animals in total) and hL
2 was estimated to be 0.34 for a heritability 
on the observed scale of 0.23.  For a prevalence p = 0.5, the selection intensity (iq) 
would be 0.798 (Falconer et al. 1997). An AUCmax = 0.77 and AUChalf = 0.69, can 
then be obtained using the online calculator provided by Wray et al. (2010). 
Therefore, the maximum achievable accuracy in this dataset would be 0.77. Our 
AUC value of 0.58 is somewhat less than AUChalf, i.e. this is consistent with the 
accuracy value which also was notably less than 0.7 which is the accuracy 
corresponding to AUChalf.   
2.3.3.2 Prediction accuracy 
Expected accuracies of the genomic predictions are shown in Table 9. This 
approach combines the effective population size, with the accuracy and the 
heritability. With NP being the average number of individuals in the training 
population (920.8 i.e. 4/5 of full dataset), and h2 the heritability on the observed scale 
(0.23), the number of independent chromosome segments Me was calculated for 
different values of effective population size (Table 9). If ∆Fg is the rate of inbreeding 
per generation, then for a rate of inbreeding per year ∆Fy = 0.0017 (Kearney et al. 
2004) and a five years generation interval for dairy cattle, ∆Fg ≈ 0.01 and thus, a 
suggestive value for the effective population size would be Ne ≈ 50. Using formulae 
4 and 5, with Ne ≈ 50 and Me = 639.79, the expected accuracy would be r(g,ĝ) = 
0.50.  Reversing the calculations, an expected accuracy of r(g,ĝ) = 0.34, gives an 
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effective population size of Ne ≈ 150. This value may not be an unreasonable value 
for the Holstein-Friesian cows in this sample, given that the population under study 
is a sample derived as a random selection of non-pedigree dairy cattle and hence 
possibly not as highly selected as cattle recorded in pedigree databases. Thus, there 
are likely to be Friesian cows in the dataset along with the possibility of a small 
number of crossbred animals.  
For the dataset with the animals designated as Friesians excluded, the 
expected accuracies were slightly lower, and the observed accuracy was consistent 
with an effective population size of ca. 100 individuals, however, the heritability was 
also lower compared to the full dataset (Table 9).  
2.4 Discussion 
This study provides evidence that genomic selection for bTB resistance is 
potentially feasible in populations where phenotypic information in unavailable for 
selection candidates, and even when no pedigree is available.  Genomic selection can 
be considered as a two-step procedure. Initially, on a reference population with both 
phenotypic and genotypic information, EBVs can be calculated as the genome-wide 
sum of marker effects (Luan et al. 2009). Then, for selection candidates the EBVs 
can be predicted without the need for phenotypes, since the marker effects have 
already been calculated in a relevant reference population (Habier et al. 2007). With 
this design, the results of the present study are important in the context of bTB 
control. Predicting EBVs in the absence of phenotypes is highly beneficial in the 
case of bTB, as collection of appropriate phenotypic information requires that a 
population undergoes an epidemic and that all animals (including controls) are 
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exposed to the pathogen (Bishop et al. 2010). These conditions can only be met for a 
subset of animals in the national population and will become increasingly difficult to 
satisfy as disease prevalence decreases in later stages of eradication programmes.  
The predictive accuracy of the EBVs is at levels that justify further studies on 
larger populations in order to obtain predictions that could be used in evaluation of 
selection candidates for their bTB resistance. In order to obtain an accuracy of 0.7, 
the theoretically required number of animals needed in the training population can be 
calculated by rearranging formula (3). Given a heritability of 0.23 and with Ne = 50, 
~2,670 individuals would be needed in the training population comprising both cases 
and controls with both phenotypes and genotypes. But if the Ne were to increase to 
100, the size of the required training population would increase to ~4,747 
individuals, as might be expected, and if Ne was 150 then NP would be ~6,685. 
However, if for example the Ne was 100 but we targeted a prediction accuracy of 0.5, 
then the size of the training population needed would reduce to ~1,647. Although in 
our study, the size of the training population (920.8) was somewhat smaller, the 
outcomes of the analyses suggest that genomic selection is potentially feasible. 
However, implementation of genomic selection should wait until we have a greater 
number of individuals in the training population, to enable us to achieve higher 
accuracy. 
2.4.1 Estimated heritability 
The data set of UK dairy cattle analysed in this study through the GBLUP 
approach, provided a heritability estimate of 0.23 (0.34 on the liability scale) for the 
trait of tuberculosis resistance. This value indicates stronger evidence for genetic 
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variation than previous estimates (Bermingham et al. 2009; Brotherstone et al. 2010), 
and our estimate is lower than the value reported for deliberately challenged red deer 
(Mackintosh et al. 2000). However, direct comparison between these studies, some 
with pedigree information and some without, should be undertaken with caution. 
Health traits often have low reported heritabilities and the estimates obtained are 
influenced by the experimental design and data recording strategy, the imperfect 
diagnostic tests, and the incomplete exposure to the pathogens (Bishop and 
Woolliams 2010; Bishop et al. 2012). However, the common conclusion of 
intermediate heritability of tuberculosis resistance makes genomic selection for bTB 
resistance an appealing approach to assist in bTB control.  
2.4.2 ROC curves properties 
A ROC curve is a representation of the different combinations of sensitivity 
and specificity for successive thresholds between a positive and a negative test result. 
Although the ROC curves and their AUCs based on genotypic information in this 
study show only a modest increase in the probability of correctly classifying cases or 
controls compared to random expectations, these values should also be considered 
relative to the AUCmax (Wray et al. 2010). This represents an upper limit of 
predictive ability given the properties of the dataset and the trait under study, 
assuming that the classifier (i.e. the EBVs) were a perfect predictor of genetic risk. 
Since AUCmax depends on disease prevalence and trait heritability, the authors argue 
that prediction accuracy should be preferred as a measure for evaluating genomic 
predictions (Wray et al. 2007).  
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2.4.3 Cross validation prediction accuracy 
Random error due to sampling effects was minimized by averaging the 
accuracies across several replications with different randomizations so that the 
individuals comprising each of the five groups were different each time. The 
differences observed between the randomizations indicate that even with ca. 1000 
individuals, random sampling effects still contribute significantly to the cross 
validation outcomes (Fig. 1). Conducting more randomisations was preferred to 
increasing the number of groups i.e. cross validation folds, because the test set would 
be reduced, thereby increasing variability across the cross validation folds through 
samples. 
When the full dataset was used, the accuracy obtained was consistent with the 
theoretical accuracy obtained using the formula by Daetwyler et al. (2008) for an 
effective population size of Ne = 150, given the properties of the dataset (i.e. sample 
size and trait heritability). This Ne value is somewhat higher than that often suggested 
for the Holstein cattle population (c.f. Ne ca. 50; McParland et al. 2007), but it is 
possible that this is representative of the sample population as it may have been 
inflated due to the structure present in the dataset revealed by PCA, and also from the 
designation of several individuals as Friesian. Both factors would increase LD and 
consequently the apparent Ne. Further, as indicated in 2.3.3.2, the population under 
study is not a pedigree or a highly selected population, with the animals included in 
the study sampled from random commercial farms. 
It should be noted that results from the different variations of the datasets 
used were coherent across the analyses. When the cows designated as Friesians were 
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removed, in addition to giving slightly increased accuracy, the dataset behaved more 
consistently across replicates (Fig. 1), and the corresponding implied Ne was reduced 
(Ne ca. 100) but with a lower heritability. This small increase in the accuracy was 
despite the fact that the dataset was smaller; presumably reflecting a more uniform 
population with linkage disequilibrium extending across longer chromosomal 
regions. Removing the PCA outliers had little impact on the prediction accuracy, 
however the animals removed (14 cases and 26 controls) may have been too few to 
greatly influence the results. 
2.4.4 Prediction accuracy and epidemic properties 
2.4.4.1 Imperfect diagnostics 
Some insight into how the epidemic properties might have an impact on the 
prediction accuracy can be gained if we consider the diagnostic test and that it might 
be imperfect in terms of its sensitivity and specificity. Although the qualities of the 
diagnostic test might not be strictly considered as a property of the epidemic itself, 
analyses gain information on the epidemic in part through the diagnostic test and the 
control measures that are adopted incorporating their use. Therefore, the diagnostics 
and the epidemic properties become interdependent. With an imperfect diagnostic 
test the estimated prediction accuracy in the sample under study will be different 
from the true accuracy that would be achieved in the population under a genomic 
selection scenario.  
The heritability on the observed scale is calculated from the sample and thus, 
might be different from the true heritability of the trait in the population. The 
observed heritability depends on the disease prevalence in the sample which depends 
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on the sensitivity and specificity of the diagnostic test and can be calculated from the 
true prevalence as: p’=(1-Sp)+(Sp+Se-1)p (Bishop and Woolliams 2010; Bishop et 
al. 2012). The heritability on the liability scale is calculated from the heritability on 
the observed scale following hL
2p2ip
2[p(1–p)]-1 (Robertson and Lerner 1949), where 
p is the sample prevalence (p’). With imperfect diagnostics the heritability on the 
liability scale is underestimated and specifically when the true prevalence is less than 
0.5, it has been shown that imperfect specificity has a greater impact on 
underestimating the heritability on the liability scale (Bishop and Woolliams 2010). 
For bTB however, the diagnostic comparative tuberculin skin test has very good 
specificity, thus the impact of the imperfect sensitivity on the heritability estimation 
would be expected to be less detrimental. Moreover, in the present study, the cases 
were confirmed through post mortem examination and laboratory confirmation and 
thus the achieved specificity was very good. Therefore, and although still sensitive to 
changes of the sample size, the estimated accuracy in the present study is not 
influenced by the diagnostic test sensitivity and specificity.  
2.4.4.2 The case-control design 
The study design can have an impact on the prediction accuracy through the 
estimated marker effects. When using the case-control design, selection intensity is 
applied on the groups of cases and controls, increasing the between-group genetic 
variance in the sample, and this can influence the SNP effects as follows: (a) The 
overall precision of estimated SNP effects is improved due to increasing the 
between-group variance in the case-control sample compared to a random sample 
from the general population, and will offer an improvement in accuracy. (b) The 
power of estimating the effects of rare variants that might be linked to susceptibility 
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is improved, through increasing their frequency in the sample by increasing the 
fraction of cases. (c) Some bias is introduced to the SNP effects that would be 
observed in the general population due to reducing the overall frequency of 
heterozygotes and shifting the allele frequencies towards intermediate values. (d) 
When using a predictor of susceptibility on the observed scale, the accuracy of 
predicting phenotypes estimated in the case-control sample will be greater than the 
accuracy that would be achieved in the population. However, the heritability on the 
observed scale also decreases as prevalence decreases when going from the 
case/control sample with sample prevalence of ~0.5, to the real population with 
lower true prevalence. When in the present study, the prediction accuracy for the 
EBVs was scaled by the observed heritability (E[r(g,ĝ)] ≈ r(y, ŷ)/h), the change of 
the prevalence when moving from the case-control sample to the population, was not 
expected to have a detrimental impact on the accuracy of the EBVs due to these 
compensating changes (Woolliams J., personal communication, September 7, 2015).  
2.4.5 Conclusion 
Our results demonstrate that genomic selection for bTB resistance is feasible 
in principle even in populations with no pedigree recording, and it can be applied to 
animals lacking bTB phenotypes. Genomic prediction accuracies in the present study 
reflected the expected values given the size of the dataset and the LD structure of the 
genotypes which is a function of the effective population size for the Holstein breed. 
Access to a greater number of animal phenotypes, thereby creating larger training 




 Year Season Test reason 





Cases 359 233 309 115 168 155 231 206 
Controls 384 175 253 96 210 124 251 184 
Totals 743 408 562 211 378 279 482 390 
 
Table 1. The number of animals in the dataset, classified by year of test, 
season of test and reason for test. 
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 r(g,ĝ)   SD r(y,ŷ) h
2
 r(g,ĝ)  SD r(y,ŷ) h
2
 r(g,ĝ)  SD 
Run 1 0.10 0.21 0.22   0.12 0.13 0.21 0.29   0.05 0.13 0.18 0.34   0.22 
Run 2 0.15 0.19 0.36   0.08 0.15 0.20 0.35   0.10 0.15 0.17 0.38   0.10 
Run 3 0.15 0.20 0.34   0.14 0.12 0.21 0.29   0.17 0.14 0.18 0.35   0.18 
Run 4 0.14 0.20 0.33   0.17 0.14 0.20 0.34   0.25 0.15 0.17 0.37   0.16 
Run 5 0.13 0.20 0.31   0.11 0.16 0.19 0.40   0.21 0.15 0.17 0.37   0.18 
Run 6 0.17 0.19 0.42   0.18 0.12 0.21 0.28   0.19 0.13 0.18 0.32   0.07 
Average 0.14 0.20 0.33   0.07 0.14 0.21 0.33   0.05 0.14 0.18 0.36   0.02 
 
Table 2. Correlations between adjusted phenotypes and predicted EBVs (r(y,ŷ)), heritabilities (h2) and prediction accuracies 
(r(g,ĝ)), for each of the six replicates of full cross-validation. SD represents the sampling standard deviation among folds within 
a run, and for the average represents the SD over the mean accuracy values for each replicate. In this table are shown the 
parameter values for each of the cross validation runs and the averages across all replications for the full data set, the reduced 





Run 1 Run 2 Run 3 Run 4 Run 5 Run 6 
  r(ŷ2,y2) h
2 and SE r(g,ĝ) r(ŷ2, y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) 
Group 1 0.08 0.23 0.08 0.17 0.13 0.20 0.08 0.30 0.20 0.16 0.08 0.50 0.11 0.22 0.08 0.24 0.07 0.22 0.08 0.15 0.19 0.18 0.08 0.45 
Group 2 0.08 0.22 0.08 0.16 0.17 0.19 0.08 0.40 0.08 0.20 0.07 0.17 0.12 0.25 0.08 0.24 0.20 0.25 0.08 0.40 0.11 0.23 0.08 0.23 
Group 3 0.15 0.17 0.07 0.33 0.18 0.17 0.08 0.44 0.12 0.25 0.08 0.25 0.22 0.13 0.07 0.62 0.14 0.13 0.07 0.39 0.24 0.12 0.07 0.70 
Group 4 0.16 0.18 0.07 0.36 0.12 0.22 0.08 0.24 0.18 0.17 0.08 0.44 0.10 0.19 0.07 0.23 0.10 0.19 0.07 0.23 0.13 0.21 0.08 0.29 
Group 5 0.05 0.25 0.08 0.09 0.17 0.17 0.07 0.41 0.16 0.20 0.08 0.36 0.15 0.19 0.07 0.33 0.16 0.19 0.07 0.36 0.18 0.20 0.08 0.41 
Average 0.10 0.21   0.22 0.15 0.19   0.36 0.15 0.20   0.34 0.14 0.20   0.33 0.13 0.20   0.31 0.17 0.19   0.42 
 
Table 3. For the data set including all the individuals, the correlation, heritability with its standard error and corresponding prediction 





Run 1 Run 2 Run 3 Run 4 Run 5 Run 6 
  r(ŷ2, y2) h2 and SE r(g, ĝ) r(ŷ2, y2) h
2
 and SE r(g, ĝ) r(ŷ2, y2) h
2
 and SE r(g, ĝ) r(ŷ2, y2) h
2
 and SE r(g, ĝ) r(ŷ2, y2) h
2
 and SE r(g, ĝ) r(ŷ2, y2) h
2
 and SE r(g, ĝ) 
Group 1 0.15 0.18 0.08 0.36 0.13 0.26 0.09 0.25 0.06 0.27 0.08 0.12 0.05 0.25 0.08 0.10 0.17 0.22 0.08 0.36 0.08 0.25 0.08 0.15 
Group 2 0.13 0.20 0.08 0.29 0.18 0.15 0.08 0.45 0.13 0.17 0.08 0.31 0.20 0.15 0.08 0.50 0.12 0.22 0.08 0.26 0.15 0.23 0.08 0.32 
Group 3 0.14 0.20 0.08 0.31 0.20 0.18 0.08 0.46 0.17 0.18 0.08 0.40 0.25 0.13 0.08 0.69 0.23 0.14 0.08 0.62 0.03 0.26 0.08 0.06 
Group 4 0.12 0.22 0.08 0.26 0.15 0.21 0.08 0.32 0.19 0.15 0.08 0.50 0.14 0.20 0.08 0.31 0.08 0.28 0.09 0.15 0.14 0.19 0.08 0.32 
Group 5 0.11 0.23 0.08 0.24 0.13 0.21 0.08 0.28 0.06 0.30 0.09 0.10 0.06 0.29 0.09 0.11 0.21 0.11 0.07 0.62 0.21 0.14 0.08 0.56 
Average 0.13 0.21 
 
0.29 0.15 0.20 
 
0.35 0.12 0.21 
 
0.29 0.14 0.20 
 
0.34 0.16 0.19 
 




Table 4. For the data set in which animals clustering separately in the PCA were removed, the correlation, heritability with its 
standard error and corresponding prediction accuracy for each of the five test-groups from the Cross Validation procedure are 




Run 1 Run 2 Run 3 Run 4 Run 5 Run 6 
 
r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2 y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2 y2) h2 and SE r(g, ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) r(ŷ2,y2) h2 and SE r(g,ĝ) 
Group 1 0.17 0.14 0.08 0.44 0.18 0.16 0.08 0.45 0.17 0.13 0.07 0.47 0.15 0.19 0.08 0.33 0.04 0.26 0.09 0.08 0.15 0.16 0.08 0.38 
Group 2 0.23 0.13 0.08 0.63 0.18 0.13 0.07 0.51 0.15 0.19 0.08 0.34 0.07 0.20 0.08 0.17 0.13 0.17 0.08 0.31 0.14 0.16 0.08 0.35 
Group 3 0.09 0.18 0.08 0.21 0.15 0.18 0.08 0.36 0.13 0.22 0.09 0.28 0.17 0.14 0.08 0.47 0.18 0.14 0.08 0.49 0.12 0.17 0.08 0.30 
Group 4 0.15 0.18 0.08 0.36 0.14 0.16 0.08 0.33 0.05 0.26 0.09 0.09 0.14 0.19 0.09 0.32 0.20 0.15 0.08 0.52 0.16 0.19 0.09 0.38 
Group 5 0.02 0.25 0.09 0.04 0.12 0.23 0.09 0.25 0.19 0.12 0.08 0.57 0.21 0.13 0.08 0.58 0.17 0.16 0.08 0.44 0.10 0.22 0.09 0.21 
Average 0.13 0.18 
 
0.34 0.15 0.17 
 
0.38 0.14 0.18 
 
0.35 0.15 0.17 
 
0.37 0.15 0.17 
 




Table 5. For the dataset when the 164 animals designated as Friesians were removed, the correlation, heritability with standard 
errors and corresponding prediction accuracy for each of the five test groups in the Cross Validation procedure resulting from the 
six randomisation replications. The data for the remaining 987 animals were re-randomised to training and test sets, which were 
~790 and ~198 respectively. In the initial fixed effects model breed was removed from the fixed effects and a new G matrix 




Figure 1.  Mean prediction accuracy values with corresponding standard 
deviations for each of the six randomisation replications in the cross 
validation procedure for the data set including all the individuals, the data set 
in which animals clustering separately in the PCA were removed, and for the 






Run 1 0.74 0.41 1.17 0.87 
Run 2 1.14 0.27 1.31 0.45 
Run 3 1.08 0.43 1.22 0.75 
Run 4 1.16 0.78 1.26 0.55 
Run 5 1.16 0.78 1.31 0.71 
Run 6 1.42 0.75 1.06 0.24 
Average  1.11 0.22 1.22 0.10 
 
Table 6. For the regression of phenotypes on predicted EBVs, average 
regression coefficients among test sets for each of the cross validation runs 
and the average across all replications, with the corresponding standard 
deviations where the SD for the average is the SD of the means presented 
for the six runs. Left part of the table: full data set, right part: dataset from 










Group 1 Group 2 Group 3 Group 4 Group 5 
    a b a b a b a b a b Intercept SD Regr coef SD 
Run 1 -0.002 0.580 -0.014 0.502 0.002 1.099 0.017 1.237 0.006 0.279 0.011 0.410 
Run 2 -0.014 0.937 0.004 1.345 0.009 1.302 -0.004 0.766 0.004 1.333 0.009 0.268 
Run 3 0.023 1.474 -0.006 0.511 -0.007 0.783 -0.001 1.506 -0.002 1.108 0.012 0.433 
Run 4 0.012 0.834 -0.011 0.656 -0.003 2.530 -0.007 0.701 0.011 1.063 0.010 0.784 
Run 5 0.012 0.834 -0.011 0.656 -0.003 2.530 -0.007 0.701 0.011 1.064 0.010 0.784 
Run 6 0.002 1.491 0.006 0.636 0.004 2.598 -0.006 0.950 -0.005 1.400 0.005 0.746 
 
Table 7. For the regression analysis on the full dataset, intercept (a) and regression coefficients (b) for the regression of 
adjusted phenotypes (observed) on cross-validated EBVs (predicted), for each cross validation fold across the six replication 




Group 1 Group 2 Group 3 Group 4 Group 5 
    a b a b a b a b a b Intercept SD Regr coef SD 
Run 1 0.001 1.371 0.005 2.429 0.005 0.635 -0.006 1.325 0.002 0.114 0.004 0.873 
Run 2 0.000 1.629 -0.008 1.918 0.007 1.185 -0.001 1.001 -0.002 0.834 0.005 0.450 
Run 3 -0.001 1.747 0.010 1.093 0.007 0.860 -0.001 0.261 -0.017 2.157 0.011 0.745 
Run 4 0.002 1.077 0.004 0.542 0.000 1.754 -0.009 1.055 0.010 1.870 0.007 0.549 
Run 5 -0.002 0.228 0.002 1.095 -0.008 1.769 0.005 2.071 0.007 1.385 0.006 0.709 
Run 6 -0.006 1.229 0.005 1.200 -0.006 1.043 0.000 1.176 0.010 0.651 0.007 0.240 
 
Table 8. For the regression analysis on the datset without the Friesians, intercept (a) and regression coefficients (b) for the 
regression of adjusted phenotypes (observed) on cross validated EBVs (predicted), for each cross validation fold across the 





Figure 2. ROC curves (a plot of the true positive rate, i.e. the sensitivity, 
against the false positive rate, i.e. 1-specificity), and the corresponding AUC 
(the probability of correctly assigning an individual as diseased or as healthy 





Figure 3. For the full data set, the ROC curves for each of the five cross 







(NP = 920.8 and h2 = 0.23) 
Excluding Friesians 
(NP = 789.6 and h2 = 0.21 ) 
Assumed Ne ∑Me r(g,ĝ) ∑Me r(g,ĝ) 
  50   639.79 0.50   639.79 0.45 
100 1136.53 0.40 1136.53 0.36 
150 1600.18 0.34 1600.18 0.31 
 
Table 9. Training population size (Np), heritability, number of independent 
genome segments (∑Me) and corresponding expected accuracy (r(g,ĝ)) for 
different assumed effective population sizes. Left part of the table: full data 




An analysis of heterozygote advantage for tuberculosis 
resistance in dairy cattle  
3.1 Introduction 
Animals that are more resistant to bTB can be selected using genetic markers 
likely to be in linkage disequilibrium with a QTL. In the previous chapter it was 
demonstrated the feasibility of genomic prediction for bTB resistance exploiting 
information across the entire genome. An alternative approach for selecting more 
resistant individuals is through identifying the individual QTL(s) that are associated 
with the trait under study. This knowledge can then be employed in Marker Assisted 
Selection (MAS).  
 
There are previous examples of successful implementation of selection for 
disease resistance based on specific markers. Studies on Infectious Pancreatic 
Necrosis (IPN) in the Atlantic salmon revealed the presence of a single QTL, 
explaining almost all the genetic variation (Houston et al. 2010), and the results of 
those studies have been successfully used in MAS 
(http://impact.ref.ac.uk/CaseStudies/CaseStudy.aspx?Id=23913). Plans for selection 
for resistance to Scrapie in sheep were based on the PrP locus 
(http://adlib.everysite.co.uk/resources/000/054/063/NSP_english.pdf). Selection 
against malignant hyperthermia in pigs has been based on a single QTL (the 
‘halothane’ gene) and the elimination of the responsible RYRT allele from the 
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population (Fujii et al. 1991). Further, individual loci have been associated with the 
genetic variation in resistance to Escherichia coli strains in pigs, and have become 
part of commercial breeding programmes (Jørgensen et al. 2004; The Danish Pig 
Research Centre Annual Report 2014).   
 
Another consideration for the exploration of the genetic architecture of bTB 
resistance is that different loci have different properties, i.e. they might act in an 
additive, or a non-additive way. Assuming a biallelic locus with three possible 
genotypes (AA, AB and BB), when allele effects are additive, the more copies of the 
beneficial allele are present in the genotype, the greater the fitness will be (wAA 
corresponding to the AA genotype in Fig. 1a, where w represents the fitness of the 
genotype). Through the mechanisms of natural selection, those alleles that confer 
fitness benefits (i.e. better survival and reproductive success) are expected to 
proliferate in the population. Therefore, in these cases natural selection will be 
directional and will move the beneficial allele to fixation (Fig. 2a). When the locus 
acts in a non-additive way, one of the alleles is dominant over the other, and the 
heterozygote is more similar phenotypically to the homozygote for the dominant 
allele (allele A in Fig. 1b). There are different degrees of dominance, and when the 
heterozygote is identical to the homozygote dominance is complete.  In 
overdominance (or heterozygote advantage) the heterozygote is superior to both 
homozygotes (wAB in Fig. 1c), and selection is balancing (Fig. 2b). In 
underdominance (or heterozygote disadvantage) the heterozygote is inferior to both 
homozygotes (wAB in Fig. 1d) and selection is disruptive (Fig. 2c) (Charlesworth and 
Charlesworth 2010; Altrock et al. 2011). 
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Heterozygote advantage implies that a variant is expected to be maintained in 
the population although it has reduced fitness when homozygote, with the allelic 
frequency (q) reaching a stable equilibrium (q*) where ∆q (i.e. the change in allelic 
frequencies per generation) becomes zero. Selection pressure against the alleles for 
the inferior homozygote is offset by the selection pressure for the allele from the 
heterozygote. Reversely, heterozygote disadvantage favours extreme values for a 
trait over intermediate values. The equilibrium allelic frequency has the minimum 
mean fitness and is unstable. Thus, the population is driven by chance deviations to 
fixation of one of the two alleles (moving from q* towards 0 or 1) depending on their 
initial frequencies in the population. A classic example of heterozygote advantage is 
sickle cell anaemia, where although the homozygote genotype for a mutation in the 
β-globin gene is typically lethal, the heterozygote has better fitness in terms of 
increased resistance to malaria (Charlesworth and Charlesworth 2010). Another 
example of heterozygote advantage and balancing selection is the Crooked Tail 
Syndrome (CTS), where heterozygotes for the causative mutation were showing 
muscular hypertrophy in a highly selected Belgian Blue cattle population while the 
homozygote mutants did not survive (Fasquelle et al. 2009). In sheep, the callipyge 
locus shows a more complex overdominance with the heterozygote individuals (and 
specifically only the heterozygotes that have inherited the CLPG mutation from their 
sire, i.e. polar overdominance) expressing muscular hypertrophy (Cockett et al. 
1996). Heterozygote disadvantage has been observed for the Rhesus blood group 
system in humans as well as in the establishment of chromosomal rearrangements 
(Charlesworth and Charlesworth 2010, Altrock et al. 2011), but has not been 
encountered before in the context of disease resistance. 
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The objective of this study was to explore the properties of the individual loci 
which lead to differences between animals, and to test the hypothesis that it is a 
single QTL affecting bTB resistance, by means of a Genome Wide Association 
(GWA) analysis. GWA analysis is a technique that exploits large-scale SNP data to 
identify associations between genetic polymorphisms and a trait, and it has been 
widely used in human and animal studies (Andersson et al. 2009). However, non-
additive genetic variation is not captured in the standard GWA analysis. 
Hypothesising underlying non-additive genetic variation, a novel approach is 
presented to identify loci displaying heterozygote (dis)advantage associated with 
resistance to bTB and compare such loci with results obtained from standard genome 
scans.  
3.2 Materials and Methods 
3.2.1 Data description 
The dataset comprises 1,151 Holstein-Friesian cows (592 confirmed cases 
and 559 controls with multiple negative tuberculin test results), from 165 herds in 
Northern Ireland (for a more detailed description of this data see previous chapter). 
All individuals were genotyped with the 700K BovineHD Illumina Bead Chip and 
after initial quality control, 617,885 SNPs were retained for subsequent analyses 
(Table 1).  
3.2.2 Constructed datasets 
Four different datasets were constructed. Firstly, the full dataset was 
analysed, comprising all 1,151 cows (Dataset 1).  
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Secondly, Classical Multidimensional Scaling (CMDS) was conducted, 
which is a method for visualising the dissimilarities between the individuals based on 
their genome-wide IBS pairwise distances matrix (“cmdscale” and “as.dist” 
functions in “GenABEL”, R/2.15.2).  CMDS revealed a secondary distinct cluster of 
40 individuals (39 of which originated from the same herd and were possibly 
crossbreds), as was observed previously for this dataset (see previous chapter section 
2.2.4). Therefore, a reduced dataset (n=1,111) was constructed after removing the 
animals clustering separately to address the hypothesis that there might be genetic 
structure in the data which could potentially lead to false positives (Dataset 2).  
 
Thirdly, a subset of animals (n= 929) was derived from the full dataset after 
removing all the herds that did not contribute any controls (Dataset 3). One herd that 
contributed only three controls and no cases was retained in the dataset. Lastly, 
Dataset 3 was further reduced to derive a balanced set (n= 670) after randomly 
removing individuals within each of the remaining herds, so that an equal number of 
cases and controls would be contributed by each herd (Dataset 4) (Table 1). 
3.2.3 Analysis 
3.2.3.1 Standard GWA analysis 
Standard Genome Wide Association (GWA) analyses were conducted using 
the GenABEL package (R version 2.15.2) (a) for the full dataset (Dataset 1) and (b) 
for the subset after removing all the herds contributing no controls (Dataset 3).  
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Firstly, the full population was analysed for SNPs across the genome having 
an effect on bTB resistance, as what has been shown in a previous study on the same 
population (Bermingham et al. 2014). After Quality Control (QC) (MAF= 0.05, 
callrate = 0.95), 1,150 individuals and 549,687 markers passed all criteria. Genome 
wide associations were tested using the “mmscore” function in GenABEL taking 
into account relatedness between individuals as described below. A Q-Q plot was 
obtained and the genome wide degree of inflation (λ) was calculated for the 
distribution of P-values (1 d.f. x2 test statistic) (http://svitsrv25.epfl.ch/R-
doc/library/GenABEL/html/estlambda.html). The standard GWA analysis was 
repeated on Dataset 3 using the same quality control criteria as above, and with the 
IBS matrix being calculated only for the individuals retained in this dataset.   
3.2.3.2 Heterozygote advantage GWA analysis  
In order to capture non-additive genetic variation, a modified approach for 
Genome Wide Association (GWA) analysis was developed with the genotypes being 
recoded so that there would be only two genotypic classes: heterozygotes (A1A2) and 
homozygotes (including both major and minor allele homozygotes: A1A1 and A2A2). 
The same quality control (QC) criteria were applied to all the datasets (MAF= 0.05, 
callrate = 0.95, one female was found to be a male with odds >1000, and was 
discarded). The number of individuals and the number of SNPs that passed QC for 
each of the constructed datasets and were retained in subsequent analyses can be 
found in Table 1. The modified GWA analyses were performed on each of the 
constructed datasets using the GenABEL package (R version 2.15.2) as follows: 
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In analysis 1, the full Dataset 1 was analysed using the “polygenic” and 
“mmscore” functions in GenABEL. The “polygenic” function was used to estimate 
the residuals under the polygenic model for the “mmscore” function which takes into 
account relatedness between individuals. The following model was used:  
 y e               (1) 
where y is the binary bTB status (0: control, 1: case), μ is the overall mean, β 
is the vector of fixed effects as described in Chapter 1, a is the additive genetic effect 
derived from the markers with a ~ MVN (0, Kσa
2), and e is the residual error. K is 
the Identity by State IBS kinship matrix of the kinship coefficients representing the 
probability that an allele sampled with replacement between all pairs of individuals is 
IBS. K was calculated using the “ibs” function in GenABEL, from the markers with 
the original (i.e. non-recoded) genotypes as follows: 
jk k
1 k k
( )(x p )1












 where N is the number of SNPs, xik is a genotype of i
th individual at the kth 
SNP coded as 0, 1/2, 1, and pk is the frequency of the reference allele 
(http://www.genabel.org/manuals/GenABEL). Subsequently, the “mmscore” 
function was used to conduct a score test for associations between the SNPs across 
the genome and the trait under study based on their P-values 
(http://svitsrv25.epfl.ch/R-doc/library/GenABEL/html/mmscore.html).  
In analysis 2, additional approaches were followed to correct for the 
substructure observed in the CMDS:  
66 
 
(a) Dataset 1 was analysed using the “egscore” function which is a score 
test for association between the SNPs across the genome and the trait under study, 
adjusting for stratification by principal components derived from the genomic 
kinship matrix calculated as above (http://www.genabel.org/manuals/GenABEL). 
Model (1) was followed as described above. Fitting as covariates the two primary 
axes calculated from the CMDS analysis, was additionally tested. The genome-wide 
degree of inflation due to hidden substructure (λ) was estimated to be 1.000002 (SE= 
1.137279*10-5) (i.e. indicating no serious inflation in the data), nevertheless, it was 
taken into account for the correction of the distribution of P-values.  
 
(b) Dataset 2 constructed by removing the animals clustering separately, 
was analysed using the “polygenic” and “mmscore” functions, and the IBS kinship 
matrix as described above, calculated only for the individuals retained in the 
analysis. After removing the minor cluster, λ had a value of 1 (SE= 7.3*10-6) and 
thus, no further correction for substructure was required.  
In analyses 3 and 4, GWA analysis for heterozygote advantage was repeated 
as described above on Datasets 3 and 4, using the “polygenic” and the “mmscore” 
functions, and with the IBS kinship matrix being calculated only for the individuals 
retained in each of the constructed datasets.  
3.2.4 Significance thresholds 
Significance thresholds were obtained after the Bonferroni correction for 
multiple testing as –log10(0.05/N) and –log10(1/N) for the genome-wide and the 
suggestive thresholds respectively, where N is the total number of SNPs, and as        
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–log10(0.05/n) for the chromosome-wide significance threshold where n is the 
number of SNPs on the chromosome. The SNPs of interest were identified as those 
that exceeded the chromosome-wide and suggestive significance thresholds. 
3.2.5 Genotypic frequencies and HWE test 
For those SNPs of interest that were identified in the heterozygote advantage 
analysis, the genotypic frequencies were calculated for each of the genotypic classes 
and significant loci were tested for Hardy-Weinberg Equilibrium (HWE). Under the 
assumption of random mating, the HWE test provides information about selection 
affecting the allele frequencies. Selection might have occurred from conception and 
before birth, through for example a mutation that is lethal for the homozygotes, or 
after birth, through reduced fitness throughout life. In those cases the next generation 
of parents would not be in HWE. However, if mating is random one generation 
would be enough to return to HWE, thus, departure from HWE informs about 
selection that has occurred recently. The chi-square test was applied to test for 
departure of the observed phenotypic frequencies from the HWE expectations, for (a) 
the full dataset, (b) separately for cases and controls, and (c) pairwise between cases 
and controls. 
3.2.6 Predicted genotypic means 
A linear mixed model was fitted in ASReml (Gilmour et al. 2002) with the 
non-recoded genotypes for the SNP of interest fitted as a fixed effect in order to 
obtain the predicted mean effects associated with each of the three genotypic classes 
(A:A = 0, A:G = 1 and G:G = 2). From the analysis were excluded 92 individuals 
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with missing genotypes for the SNP.  Relatedness was accounted for through the IBS 
relationship matrix (G) calculated as in Chapter 1 (see section 2.2.6.2).  
Further, Generalised Linear Mixed models (GLMMs) were fitted to take into 
account the binary (case/control) character of the data, and specifically threshold 
models (TMs) using the probit and logit link functions (assuming that the underlying 
liability distribution was normal or logistic respectively), as well as the 
complementary log-log link function (assuming an underlying extreme value 
distribution). Additionally, the SNP genotypes were fitted as two covariates aiming 
to capture additive and non-additive effects for that locus. 
Lastly, a linear mixed model with an interaction component was fitted to test 
for interaction between the SNP identified from the heterozygote advantage analysis 
and a significant SNP identified by the standard GWAS.  
3.2.7 Region exploration and gene expression  
As will be described in the results, one SNP in particular was found to be of 
interest and this SNP was mapped onto the cattle genome using the Ensembl and 
NCBI genome browsers. The functionality of the gene and its expression pattern 
were examined through Polymerase Chain Reaction (Roche Taq DNA polymerase) 
(Jensen K., personal communication, January 18, 2013). Genomic location and 
sequencing information was obtained using the ENSEMBL browser. Monocytes and 
macrophages were used to detect expression in three states: (a) resting, (b) at 2 hrs. 
post-activation with E. coli derived Los, and (c) at 6 hrs. post-activation, and all were 
compared to negative controls. The PCR consisted of 40 cycles of an initial 
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dematuration step at 95 oC, an annealing step at 40 oC – 60oC, and a final extension 
step at 72oC. 
3.3 Results 
3.3.1 Standard GWA analysis 
The standard GWA analysis identified a SNP (rs109042660) on chromosome 
13 (BTA13) which was significant at the chromosome-wide significance level          
(-log10(P-value) = 5.57,  while the genome-wide, suggestive and chromosome-wide 
significance thresholds were 7.06, 5.76, and 5.53, respectively) (Table 2). 
Additionally, and in agreement with Bermingham et al. (2014), 6 more SNPs on the 
same chromosome (rs42494342, rs42494357, rs110465273, rs137562332, 
rs132841890 and rs109809949) were found to be within the ten most significant 
SNPs, although they did not reach any significance threshold in the present analysis 
(Fig. 3a, Table 2). However, different quality control criteria and statistical 
association methods were followed in the two studies. The corresponding Q-Q plot is 
presented in Figure 3c. GWA analysis on the dataset after removing the herds 
contributing no controls did not show any significant associations (Fig. 3b). 
3.3.2 GWA analysis for heterozygote advantage 
GWA analysis for heterozygote advantage on all the animals, identified a 
SNP on BTA6 (rs43032684) which was significant at the chromosome-wide level    
(-log10(P-value) = 6.29) (Table 3, Fig. 4a). The second most significant SNP 
identified was on BTA25 (rs109960101), but it did not reach significance (-log10(P-
value) = 4.94) (Table 3).  
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After CMDS analysis, the identified SNP on BTA6 was consistently found to 
be significant in all the approaches used to control for substructure (Table 3, Fig 4). 
In the analysis for the reduced dataset after removing the herds contributing no 
controls, a pattern on BTA6 was still visible and the SNP of interest was the third 
most significant SNP identified in this analysis but it did not reach suggestive 
significance (-log10(P-value) = 5.25), while another SNP on BTA17 was now 
significant at the suggestive level (-log10(P-value) = 6.12) (Table 3, Fig. 5a). GWA 
analysis for heterozygote advantage on the balanced dataset did not show any 
significant associations (Fig. 5b).  
3.3.3 Genotypic frequencies, HWE test and Genotypic means 
Further analysis was done on the single SNP (A/G) of interest (rs43032684) 
and the genotypic frequencies for the original genotypes (i.e. before recoding for 
homozygotes and heterozygotes), were calculated for each of the genotypic classes 
(Table 4). The chi-square statistic was used to test for significant departure from 
HWE expectations. For the data comprising all the animals, there was a significant 
departure from HWE (x2=10.12, p<0.01) (Table 5a). When HWE test was performed 
separately for cases and controls, a significant departure from HWE expectations was 
observed for the controls (x2=28.63, p<0.001) but not for the cases (p>0.5) with the 
genotypic frequencies in the cases being consistent with the expectations (Table 5b 
and c). In the controls, the heterozygotes were fewer than expected under HWE 
(Table 5). The hypothesis that the genotypes would be similarly distributed in cases 
and controls was tested, to investigate if a case and a control would be equally likely 
to have a certain genotype with a probability of 0.5, reflecting the distribution of 
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cases and controls in the sample.  Pairwise chi-square test between cases and controls 
for each genotypic class, showed that the heterozygotes are significantly fewer than 
expected under HWE in the controls (x2 = 11.50, p<0.001) while the GG 
homozygotes were  more than expected in the controls (x2=15.06, p<0.001).  
The predicted genotypic means corresponding to the linear and the threshold 
models used are presented in Table 6. The predicted values for the genotypes would 
be 0 if all the animals in the genotype were healthy and 1 if all the animals were 
infected. Thus, the values obtained in the present analyses indicate that while the 
homozygotes show similar values in all the analyses, the heterozygotes show a value 
more towards 1, i.e. were more likely to have a diseased phenotype, showing a 
heterozygote disadvantage pattern which is consistent with results from the HWE 
test.  
The ASReml analysis for rs43032684 provided a Wald F Statistics after 
adjusting for other effects, of 13.45 (P <0.001), for the proportion of variation 
explained by the SNP in the LM model (Table 6). In all the LM or TMs used, the F 
values show that the SNP genotype had a significant effect on the phenotype of the 
animal (i.e. being a case or a control). When fitting the SNP genotypes as covariates 
after adjusting for additive effects, this result was more significant (F=17.24,           
P <0.001) for the dominance effect of the SNP on the liability scale. The SNP 
identified was found to explain 1.7% of the total phenotypic variance. Finally, the 
interaction with a significant SNP (BTA13) identified by a standard GWA analysis 
(Bermingham et al. 2014), was not found to be significant (P >0.1).  
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3.3.4 Region exploration and PCR 
The Ensembl and NCBI genome browsers were used to search the region of 
the SNP identified through the heterozygote disadvantage GWA analysis, for 
candidate genes of known function. The SNP (chromosomal position on BTA6: 
10,245,091 bp) was found to be adjacent to several candidate genes (Fig. 6). A closer 
look at the area surrounding the SNP showed that the SNP resides within two partly 
overlapping Copy Number Variations (CNV) regions (Fig. 7). These CNV regions 
have been previously associated with resistance to gastrointestinal nematodes in 
cattle (Fig. 7) (Ensemble, UMD 3.1 assembly; Hou et al. 20011; Hou et al. 2012).  
More specifically, the SNP has two alleles (G/A) and resides within the 
peroxiredoxin-6-like pseudogene (LOC 784039, chromosomal position: 10,223,720-
10,246,027 bp, transcript length: 840 bps) (Fig. 8). The pseudogene contains two 
exons and the SNP resides down-stream of exon 1. Pseudogenes usually derive from 
a parental gene through the mechanisms of (a) reverse RNA transcription and re-
insertion into genomic DNA or (b) through gene duplication. Insertions, deletions or 
point mutations cause the pseudogenes to be non-functional homologues of the 
functional parental genes (Gerstein et al. 2006). In order to identify the parental gene 
of PRDX6L the sequence of the PRDX6L was blasted in Ensemble against the 
peroxiredoxin-6 gene (PRDX6 on BTA16), which confirmed that PRDX6 is the 
parental gene of PRDX6L (Jensen K., personal communication). 
Initial PCR results showed no clear expression of the pseudogene in 
monocytes or macrophages, while the parental gene was shown to be expressed. PCR 
was repeated with monocytes cell templates from five different animals at 50 cycles, 
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in order to increase amplification of the product. Although the process might have 
benefited from the use of specific primers, there was an indication of expression of 
the pseudogene, however, there was no obvious pattern across the different animals 
(Fig. 9).  
3.4 Discussion  
3.4.1 Heterozygote disadvantage GWA analysis 
Individuals more resistant to bTB can be selected using markers across the 
genome.  In the present study, the hypothesis that effects of individual loci may lead 
to differences between animals was investigated. Firstly, the standard GWA analysis 
approach was followed to identify markers associated with bTB resistance, carrying 
alleles with additive effects. This analysis recovered the same SNPs as presented by 
Bermingham et al. (2014) for the same population, although the two studies were 
using different quality control criteria and statistical association methods.  
Secondly, in the present study, the possibility of loci with non-additive effects 
associated with bTB resistance was investigated. Heterozygosity has been linked to 
better health and improved performance i.e. hybrid vigour, counteracting inbreeding 
depression which is the loss of heterozygosity (Falconer and Mackay 1997, p. 247; 
Toro and Maki-Tanila 2007, p. 88; Woolliams 2007, p. 148). Reduced diversity and 
inbreeding depression have been shown to have negative impacts on fitness traits 
(Wiener et al. 1994). Conversely, diversity has been suggested to be maintained 
through heterozygote advantage for example in the case of the Major 
Histocompatibility Complex (MHC) region, where genetic diversity is beneficial for 
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the efficiency of the immune system (Codner et al. 2011). These impacts can be 
observed when there is some degree of dominance between the alleles within a locus, 
and such an effect would not be detected in standard association analyses when 
regressing phenotypes on allele counts. 
In a previous study (Driscoll et al. 2011) microsatellites were used to test 
candidate genes for association with bTB susceptibility in particular for effects with 
heterozygote advantage. However, this study was a smaller study with 384 cattle of 
multiple breeds including 160 SICCT reactors. Compared to Driscoll et al. (2011), 
the novelties of this Chapter are: (a) SNPs across the entire genome were used, and 
(b) the underlying non-additive genetic variation was explored so that both the cases 
of a heterozygote advantage and disadvantage could be investigated.  In the present 
analysis, there was no evidence for a heterozygote advantage for bTB resistance. 
Thus, heterozygosity was not found to be beneficial for bTB in cattle. The SNP 
identified on BTA6 in this study shows a heterozygote disadvantage, suggesting an 
association between locus heterozygosity and increased susceptibility to bTB. This 
SNP was significant at the chromosome-wide level after all the methods followed for 
correction for population structure. Driscoll et al. (2011) identified two microsatellite 
markers that showed heterozygote advantage (INRA111 with chromosomal position 
on BTA11: 40,311,694-40,311,817 bp, and BMS2753 on BTA9: 76,800,661-
76,800,769 bp), associated with bTB susceptibility. This study found no evidence of 
such SNPs on chromosomes 11 or 9, and the most significant SNP on either BTA9 
and BTA11, was rs110974556 on BTA9 with chromosomal position 40,944,275 bp, 
which is ~36 Mbp away from BMS2753, and which did not approach significance.    
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For further quality control, the SNP genotype call graph for the SNP showing 
heterozygote disadvantage was examined for any ambiguity in the SNP genotypes, 
which could have an undue impact on the results. The three genotypic classes for the 
SNP were found to form three distinct clusters, indicating good genotyping accuracy 
(Fig. 10).  
Significantly fewer than expected heterozygotes for rs43032684 were found 
in the controls i.e. heterozygotes were more likely to be diseased. The magnitude of 
the observed difference for the heterozygotes is indicative of dominance effects, and 
suggests a fitness disadvantage for the heterozygotes. It would be a disadvantage 
(and not an advantage) because the departure from HWE is observed in the controls 
i.e. in healthy individuals. The dominance hypothesis was confirmed through the 
ASReml analysis which provided a significant F-test statistic. The predicted 
genotypic means confirmed the heterozygote disadvantage for the heterozygotes 
which showed a value more towards 1, i.e. more likely to be diseased, which is 
consistent with the results from the HWE test. The heterozygote advantage GWA 
analysis presented in this study is not restricted to identify SNPs showing a 
heterozygote advantage and it can equally identify a disadvantage, since the recoding 
of the genotypic classes is selected randomly. This result shows that when adjusted 
for a “heterozygote abnormality” this SNP is significantly associated with bTB 
resistance.  
Compared to results from standard genome scans there was no interaction 
observed with a significant SNP identified from a standard GWA analysis 
(Bermingham et al. 2014) on the same population. The heterozygote disadvantage 
GWAS presented here, allowed identifying a novel putative QTL. The SNP 
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identified was found to explain 1.7% of the total phenotypic variance, which 
although sounds quite small, in comparison to results from standard GWAS studies, 
this is a relatively large effect. However, this could be an overestimate of the 
proportion of variance explained by the SNP due to the inherent error in the estimate 
of the genotypic values.  The sample size has a large impact on the power of the 
GWA analysis to detect associations (Spencer et al. 2009) and further studies are 
needed to confirm these findings and validate the QTL on larger case-control 
datasets.  
3.4.2 Biological interpretation 
The SNP showing heterozygote disadvantage was found to reside within a 
pseudogene. Understanding the properties of pseudogenes can give insight into how 
the identified SNP and pseudogene might have a biological meaning. Pseudogenes 
are non-functional homologs of a functional gene (Vanin 1985). They are defective 
due to genetic lesions such as insertions, deletions and premature stop codons that do 
not allow them to encode functional polypeptides. However, they may maintain some 
functionality and be involved in gene expression regulation (Korneev et al. 1999; 
Hirotsune et al. 2003; Kandouz et al. 2004). There are non-processed pseudogenes 
which are mutated duplicates of a parental gene, or processed pseudogenes which are 
the products of reverse mRNA transcription (Vanin 1985; Bischof et al. 2006). 
Processed pseudogenes usually occur on a different chromosome compared to the 
functional parental gene (Vanin 1985). The pseudogene identified in the present 
study on BTA6 was found to have a parental gene (PRDX6) on BTA16 and thus, 
more likely to be a processed pseudogene. The product of the parental gene PRDX6 
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is an enzyme (peroxiredoxin-6) involved in lipid internalising and degradation. It is 
expressed in the respiratory epithelium in the lungs, in alveolar type II cells and in 
alveolar macrophages, and is localised in the lysosomes (Sorokina et al. 2009; 
Chatterjee et al. 2011).  A peptide within the PRDX6 protein sequence (amino acids 
31-40), necessary for the lysosomal localisation of the protein, was found to be 100% 
conserved in humans, rats, mice and cattle (Sorokina et al. 2009).  
Mycobacteria, in order to overcome the immunological reaction of the host 
and survive within the macrophages, manipulate host signalling processes through 
mediator molecules. These mediator molecules are lipids and glycolipids released 
from the bacterial cell-wall that accumulate within the host’s macrophages and into 
the membrane of the phagosome containing the internalised mycobacteria (the 
process called phagocytosis) (Fig. 11). Mycobacterial mediator lipids interfere with 
the fusion of the phagosome with the lysosome, which contains enzymes and would 
result in killing the mycobacteria, therefore inhibiting the mycobacterial killing 
processes (Anes et al. 2003; Koul et al. 2004; Raman et al 2010). The capacity of 
phagocytosis and the rate of intracellular killing of mycobacteria have a strong 
influence on the outcome of infection i.e. controlled or uncontrolled infection 
(Gammack et al. 2004), and blocking of phagocytosis and phagosomal maturation 
has been shown to impair clearance of infection (Raman et al. 2009). In the PCR 
there was clear expression of the parental gene in monocytes. For the pseudogene 
there was indication of expression but with no clear pattern across the different 
animals, and thus PCR results were not conclusive. Therefore, although in this study 
expression of the pseudogene was not confirmed, given the role of its parental gene 
in lipid internalising, hypothetical functionality of the pseudogene could have an 
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effect on the internalising of the virulence factors, inhibiting mycobactericidal 
reaction.  
3.4.3 Conclusion 
A SNP was identified on BTA6 suggesting an association between locus 
heterozygosity and increased susceptibility to bTB in cattle, and implying a fitness 
disadvantage for the heterozygotes at this locus. The SNP resides within a CNV 
region associated to nematode resistance in cattle. Further, the SNP was found to 
reside within a pseudogene. However, despite the apparent functional relevance, it 
was not possible to demonstrate functionality of the pseudogene. The novel method 
presented in this Chapter for identifying loci displaying heterozygote (dis)advantage 
associated with disease resistance, captures non-additive genetic variation and allows 





Figure 1. Graphs representing the different QTL properties: (a) additive 
model ((AA – BB) / 2), (b) dominance (AB - (AA + BB) / 2), (c) overdominant 





Figure 2. The effects of the three types of selection on the genotypic 
frequencies before (red line) and after (blue line) selection: (a) directional 
selection, (b) balancing selection, and (c) disruptive selection 
(http://en.wikipedia.org). On the X axis are represented the genotypic values 














1 1151 592 559 617885 1150 549687 
2 1111 552 559 617885 1110 549835 
3 929 370 559 617885 929 550108 
4 670 335 335 617885 669 550502 
 
Table 1. The number of animals and number of SNPs retained in the 
analyses after Quality Control (QC) for each of the constructed datasets: (1) 
Dataset 1 is the full dataset, (2)  Dataset 2 is reduced by removing the 
animals clustering separately in the CMDS, (3) Datset 3 is reduced by 
removing the herds with no controls, and (4) Dataset 4 is balanced with an 







Figure 3. Manhattan plots from the standard GWA analysis on (a) the full 
dataset and (b) after removing herds contributing no controls; (c) Q-Q plot 
showing observed compared to expected x2 values under the null hypothesis 





SNP  Chr - log10 (P-value) 
BovineHD1300020589 rs109042660 13 5.57 
BovineHD1300020586 rs42494342 13 5.52 
BovineHD1300020584 rs42494357 13 5.50 
BovineHD1300020585 rs110465273 13 5.50 
BovineHD1300020590 rs137562332 13 5.50 
BovineHD1300020591 rs132841890 13 5.49 
BovineHD4100010384 rs43705552 13 5.36 
BovineHD1300020588 rs109809949 13 5.20 
Genome-wide threshold   7.06 
Suggestive threshold   5.76 
Chromosome-wide threshold   5.53 
 
Table 2. The 8 most significant SNPs identified from the standard GWA 











1 6.29 4.94 - 
2a 6.43 - - 
2b 6.09 5.05 - 
3 5.25 - 6.12 
Genome-wide 
threshold 
7.09 7.09 7.09 
Suggestive   
threshold 
5.79 5.79 5.79 
Chromosome-
wide threshold 
5.78 5.34 5.58 
 
Table 3. Association P-values for the SNPs of interest from the GWA 
analyses for heterozygote advantage on (1) Dataset 1 comprising all animals, 
(2a) Dataset 1 taking structure into account by fitting PCs, (2b) Dataset 2 
formed by removing the animals in the minor cluster from the CMDS, and (3) 
Dataset 3 formed by removing the herds contributing no controls. The 
genome-wide, suggestive and corrsponding chromosome-wide significance 







Figure 4. Manhattan plots of the SNP associations with the trait of interest, 
from the GWA analyses for heterozygote advantage on (a) Dataset 1 
comprising all animals (Analysis 1), (b) Dataset 1 taking structure into 
account by fitting PCs (Analysis 2a), (c) Dataset 2 after removing the animals 
in the minor cluster from the CMDS (Analysis 2b). The yellow line represents 









Figure 5. Manhattan plots of the SNP associations with the trait of interest, 
from the GWA analyses for heterozygote advantage on (a) Dataset 3 after 
removing the herds contributing no controls , and (b) Dataset 4 with an equal 
number of cases and controls in each herd.  
 
 
rs43032684 Cases Controls Total Fraction of total 
A/A 239 286 525 0.46 
A/G 254 154 408 0.36 
G/G 62 63 125 0.11 
Total 555 503 1058 - 
NA 36 56 92 0.08 
 
Table 4. Genotypic frequencies for the SNP showing heterozygote 




(a) AA AG GG Total P-value pA 
Observed 525 409 125 1059 <0.01 0.69 
Expected 502.73 452.38 102.43  x2=10.12  
 
(b) AA AG GG Total P-value pA 
Observed 239 255 62 556 >0.7 0.66 
Expected 241.46 249.16 64.27  x2=0.24  
 
(c) AA AG GG Total P-value pA 
Observed 286 154 63 503 <0.01 0.72 




Table 5. Observed and expected under HWE genotypic frequencies for the 
SNP showing heterozygote disadvantage for (a) all the animals, (b) only the 
cases, and (c) only the controls. 
 
LM (SE) Probit (SE) Logit (SE) Comp. log-log (SE) 
GG 0.59 (0.05) 0.61 (0.05) 0.60 (0.05) 0.62 (0.05) 
AG 0.72 (0.03) 0.73 (0.03) 0.73 (0.03) 0.76 (0.03) 

















Table 6. Predicted genotypic means for the three genotypic classes for the 
SNP of interest obtained from the ASReml analyses using a linear model and 
threshold models (values transformed back to the observed scale), with the 






Figure 6. Ensemble genome browser region 6:8,300,000-10,300,000 bp 





Figure 7. Ensemble genome browser, region: 6: 10,245,041-10,245,141 bp 
containing the SNP of interest as well as three previously identified Copy 
Number Variation (CNV) regions associated with gastrointestinal nematodes 




Figure 8.  Location of the peroxiredoxin-6-like pseudogene (LOC784039) 
containing two exons, and position of the SNP identified in the heterozygote 






Figure 9. RT-PCR amplification of PRDX6L from bovine monocyte cDNA, for 







Figure 10. Genotype calls scoring graph for sequencing quality control for 
the SNP showing heterozygote disadvantage, where the samples are 
displayed in three distinct shaded areas based on their genotype calls. The 
three genotypic classes are represented by three distinct clusters (samples in 
the red region are AA genotypes, samples in the purple region are AG, and 
samples in the blue region are GG). Black dots represent genotypes that 





Figure 11. Graphical representation fo the process of infection with M. bovis. 
Macrophages are the primary target cells of mycobacteria. When 
mycobacteria are internalised within the macrophages in a structure called 
phagosome, effective immune response and deactivation of the pathogen 
requires fusion of the phagosome with the lysosomes which are sub-cellular 
structures containing enzymes. After successful fusion, the phagolysosome 






A meta-analysis for bovine tuberculosis resistance in dairy 
cattle 
4.1 Introduction 
Genetic selection of individuals resistant to bovine Tuberculosis (bTB) could 
offer a complementary strategy for the control of tuberculosis in cattle. Previous 
studies have shown the presence of host genetic variation underlying resistance to 
bTB (Brotherstone et al. 2010; Bermingham et al. 2012; Tsairidou et al. 2014) and 
several loci have been associated with individual variation in bTB resistance 
(Bermingham et al. 2014; Finlay et al. 2012). Selection could either be directly on 
animal phenotypes (traditional phenotypic selection using pedigrees), or on genetic 
markers. There are two approaches for using genetic markers, either selection on a 
small number of loci, or genomic prediction using a large number of markers spread 
throughout the genome.  However, with resistance to bTB being a complex trait and 
therefore likely to be influenced by a large number of genes, further studies are 
needed in order to identify additional loci influencing the trait and make MAS more 
efficient. In chapter 1 of this Thesis, it was shown that genomic selection is feasible; 
breeding values were estimated and their prediction accuracy was tested in the 
absence of disease phenotypes (Tsairidou et al. 2014). However, before 
implementation, the prediction accuracy needs to be improved. Therefore, more 





The identification of variants underlying the control of bTB resistance and the 
accuracy of genomic prediction are both likely to benefit from larger sample sizes. 
This may be achieved through meta-analyses which combine results from different 
studies using potentially different populations. By means of simultaneous analysis of 
individuals distantly related, assisted by a larger sample size, this approach may 
reveal new information concerning the genetic architecture of bTB resistance. This 
approach, i.e. the simultaneous analysis of distantly related individuals, has been 
found to be powerful in both animal and human studies (Sanna et al. 2008; Willer et 
al. 2008; Riggio et al. 2014), where it has been used to confirm the presence of QTLs 
previously identified and to detect new loci affecting the trait under study.  
The aim of this study was to investigate the genomic control of bTB 
resistance and to explore the feasibility of genomic selection for bTB resistance, 
combining information across datasets in a meta-analysis. Specifically, we anticipate 
that meta-analyses will provide additional information on specific loci affecting 
resistance and it will enable enhanced genomic predictions of resistance.  This was 
done by combining data from two independent populations and analysing this joint 
dataset using different approaches, ranging from Regional Heritability (RH) 
mapping, through chromosomal heritability estimation, to whole genome prediction 




4.2 Materials and Methods 
4.2.1 Description of data 
4.2.1.1 Animals and phenotypes 
Two populations were used in the analyses:  Population 1 comprised 1,151 
female Holstein-Friesians originating from commercial herds in Northern Ireland, 
confirmed bTB cases (positive to the SICCT and confirmed by post mortem 
examination) or controls (animals that provided multiple negative test results) 
(Bermingham et al. 2014); Population 2 comprised 287 Holstein and Friesian bulls 
from the Republic of Ireland with estimated breeding values (EBVs) calculated from 
their daughter phenotypes for SICTT (Finlay et al. 2012). Each bull had two EBVs, 
with and without pedigree information used in their estimation, each with a 
reliability, and a set of SNP genotypes as will be described below. In Population 2, 
the number of daughters per bull varied, ranging from 4 to 1046 daughters, with a 
mean of 35 daughters per bull (Fig. 3) and reliabilities without pedigree ranging from 
0.03 to 0.9. 
4.2.1.2 Phenotypes 
To combine the two populations and analyse them together, an initial fixed 
effects model was used for the first population, pre-correcting for all known non-
genetic fixed effects (age, year of testing, season, reason for testing, and breed) and 
the residuals of this model were used as phenotypes in subsequent analyses. For 
Population 2, the de-regressed EBVs (i.e. EBVs divided by their reliability) were 




estimation (pedigree-derived de-regressed EBVs) or without (pedigree-free de-
regressed EBVs). All phenotypes were standardised by their origin-specific standard 
deviation in order to be analysed simultaneously. 
4.2.1.3 Genotypes 
Population 1 was genotyped using the Illumina high-density Bead Chip, 
while Population 2 was genotyped with the Illumina Bovine50 SNP chip. To 
combine genotypes from these two populations, the Illumina forward strand 
genotypes were obtained for both populations and used to construct the pooled 
datasets. In total, genotype data from 777,962 SNPs were available for the 1,151 
cows of Population 1 and 54,001 SNPs were available for the 287 bulls of Population 
2 (Table 1). 
4.2.1.4 Population structure exploration 
Principal component analysis was conducted in R (R version 2.15.2), using 
the IBS matrix calculated on all the 1,438 individuals and using only the SNPs 
present in both the high density and the low density SNP chips. Plotting the first 
versus the third principal component, captured the structure previously observed 
when analysing the two populations independently (Bermingham et al. 2014 Fig. S1; 
Finlay et al. 2012 Fig. 1), while plotting the first versus the second principal 
component showed no structure (Fig. 2). The bulls in Population 2 were found to 
follow a similar pattern to Population 1 and no population-specific clustering was 
observed, however there was a secondary minor cluster of animals, possibly 




4.2.1.5 Constructed datasets 
Two datasets were constructed for subsequent analyses. Dataset 1 comprised 
all animals (n=1,438), where the SNPs present in both SNP chips were used (i.e. 
36,690 autosomal SNPs). These SNPs were retained after conducting quality control 
on Population 1 (MAF<0.05, call rate<95%, HWE p<0.000001, all SNPs 
homozygote, all SNPs heterozygote, or all missing were removed) and accepting all 
genotypes for Population 2 (QC1, Table 1).  
Dataset 2 was constructed after removing the bulls with less than 8 daughters. 
After deregressing the EBVs, bulls with very few daughters might have an undue 
influence on the data, possibly adding noise rather than information. In breeding 
value prediction from progeny records, reliability is n/(n+k) where n is the number of 
offspring and k can be calculated as k = (4 – h2) / h2 (Mrode 2005, p. 7). If the true 
heritability of bTB resistance is ~0.2, as indicated by several field studies 
(Brotherstone et al. 2010; Bermingham et al. 2012; Bermingham et al. 2014; 
Tsairidou et al. 2014), then to achieve a reliability of >0.3 at least 8 daughters would 
be needed. Therefore, the bulls with <8 daughters which had reliabilities ranging 
from 0.03 to 0.08, were removed, and 175 bulls were retained in subsequent analysis 
in order to address the hypothesis that these individuals might be adding noise. A 
second round of quality control was carried out (QC2) which applied the same 
criteria used in Population 1 above, to both Population 1 and Population 2. The final 




4.2.2 Data analysis 
Data analyses comprised investigations of bTB resistance at different levels 
of the genome, using the combined datasets. These were (i) identification of 
individual loci influencing resistance, both as individual SNPs and collectively as 
groups of SNPs, (ii) exploration of the contribution of individual chromosomes to 
variation in bTB resistance and (iii) the genetic control of bTB resistance at the 
whole genome level by means of genomic prediction of bTB resistance within and 
across populations. 
4.2.2.1 Regional Heritability (RH) mapping 
Regional Heritability (RH) mapping (Nagamine 2012) is a flexible variance 
component-based means of identifying genomic regions affecting complex traits, 
particularly when individual SNPs contribute only a small proportion of genetic 
variation, but groups of SNPs may collectively be significantly associated with the 
trait. RH can also be an effective means of combining disparate datasets (Riggio et 
al. 2014a), avoiding the need to assume the same linkage phase between markers and 
causative mutations across populations. RH was used to identify regions including 
groups of SNPs collectively affecting bTB resistance. Populations 1 and 2 were 
initially analysed independently to obtain genomic heritability estimates. For 
Population 2, pedigree-free or pedigree-derived, de-regressed EBVs were used as 
phenotypes. An overall genomic heritability estimate for the combined dataset was 





RH mapping methodology was applied as described by Nagamine et al. 
(2012). The population of origin was fitted as a fixed effect, whereas additive 
genomic (whole genome) and additive regional effects were fitted as random, with 
genomic and local IBS relationship (G, GL) matrices (Leutenegger et al. 2003) 
calculated for each window describing  the variance/covariance of these effects i.e. yi 
= m + βi + ui + ri + ei, where yi is the adjusted phenotype of individual i, βi indicates 
the population to which i belongs to, ui its additive genomic effects (u ~ MVN(0, 
σu
2G)), and ri its additive regional effects (r ~ MVN(0, σr
2GL)). The data was 
analysed with three different window sizes: a 50-SNP window size (25-SNP step), 
30-SNP (15-SNP step), and 20-SNP (10-SNP step). The RH was calculated for every 






r was the variance explained by the window and σ
2
p 
was the phenotypic variance. Putative regions associated with bTB resistance were 
identified through a Likelihood Ratio Test (LRT), tested for every window against 
the null hypothesis of only a polygenic inheritance described by the genomic matrix 
G. The regions with the maximum RH estimate and LRT (RHmax and LRTmax) were 
identified for each chromosome. Suggestive and genome-wide significance 
thresholds were obtained after the Bonferroni correction for multiple testing.  
Analyses were repeated for both pedigree-free and pedigree-derived EBVs 
for Population 2 and results were compared. For completeness, RH mapping was 
repeated for Dataset 1 using the overlapping SNPs between the HD and the low 
density SNP chips but after applying QC2 (section 4.2.1.5). This more stringent 
quality control resulted in the removal of additional SNPs so that 35,021 autosomal 
SNPs were retained in this analysis (Table 1). In this analysis, the pedigree-free de-




Dataset 2, i.e. where bulls from Population 2 with less than 8 daughters were 
removed, was analysed in the same way as Dataset 1 with the difference that 
Population 2 pedigree-derived EBVs were not considered. 
 4.2.2.2 Genome-wide Association (GWA) analyses 
GWA analysis was performed to identify individual loci associated with bTB 
resistance in the combined populations. A mixed linear animal model was fitted in 
GenABEL (R version 2.15.2) for Dataset 1 comprising all 1,438 individuals, and 
35,459 SNPs. The “check.marker” function in GenABEL was used for further 
quality control and SNPs with a minor allele frequency of <0.05, with >5% missing 
data, or significantly out of Hardy–Weinberg Equilibrium (fdrate=0.2) were 
excluded from subsequent analysis. Samples with >5% missing SNPs or with >95% 
IBS were also discarded. In total 1,438 individuals and 35,286 SNPs passed all QC 
criteria and were retained in the analysis. The population of origin and three principal 
components were fitted as fixed effects to account for population structure and so 
that the combination of principal components used would account for the outlier 
group of animals (potential crossbreds) previously observed in Population 1. The 
model was fitted as follows: 
 
1 1+      2 3m PC PC PC  +      y p u e  
 
where pi indicates the population of origin, PC1, PC2 and PC3 are the three 
principal components and ui is the genomic estimated breeding value with u ~ MVN 
(0, Gσa




degree of inflation (λ), but adjustments were negligible as the value of λ was 1 (SE= 
8.95x10-5) indicating a successful correction for substructure through fitting principal 
components. The genome wide and suggestive significance thresholds were obtained 
after the Bonferroni correction for multiple testing as –log10(0.05/N), and –log10(1/N) 
respectively, where N was the total number of SNPs. The phenotypes used for 
analysis were the pre-corrected phenotypes for Population 1, and the pedigree-free 
deregressed EBVs for Population 2, standardised by their population specific 
standard deviation.   
4.2.2.3 Chromosomal heritability estimation 
Chromosome-level heritabilities were calculated to help interpret the genomic 
predictions, as this approach gives insight into properties of the genomic heritability 
and the proportion of genetic variance due to population structure (Yang et al. 2011). 
Chromosomal heritability estimation follows the same procedure as RH mapping, 
except that variation is partitioned at the level of the whole chromosome, rather than 
the SNP window. For the combined Datasets 1 and 2 the heritability for each 
chromosome was calculated as described below:  
Method (a). Heritabilities were calculated separately for each chromosome 
(hc(sep)
2) using single-chromosome specific Gc matrices and fitting the following 
model in an ASReml analyses: yi = β + gc + e, where β indicates the population of 
origin and gc represents the genetic effects of chromosome j with gc ~ MVN(0, 
σc
2Gc), where c goes from 1 to 29. This was done for both Datasets 1 and 2.  
Method (b). All variance components (29 chromosomes) were fitted as 




likelihood (AIREML) programme, with starting values obtained from the variance 
estimates in (a). The heritability (hc
2) was estimated as the variance corresponding to 
each chromosome divided by the phenotypic variance after fitting the model: y = β + 
∑gc +e with gc ~ MVN(0, σc
2Gc). This was done for Datasets 1 and 2.  
Method (c). For Dataset 2 each chromosome was fitted separately with 
distributional assumption for gc as in method (a), plus a polygenic term representing 
the remaining 28 chromosomes, (i.e. genomic-chri), y = β + gc + g-c + e, with          
g-c ~ MVN(0, σc
2G-c) where G-c was calculated on the SNPs complementary to gc. 
For each chromosome, the marginal contribution of genetic variance explained by 
each chromosome was tested (H0). The Genomic matrix excluding the chromosome 
under study was used, i.e. y = β + g-c + e, and LRT was conducted (where L1 was the 
log-likelihood from the full model for each chromosome and L0 was the log-
likelihood from the reduced model) to test for significant improvement when the 
chromosome was included in the model. A similar approach was followed for 
Dataset 1 however each chromosome was fitted plus the whole G matrix. Excluding 
each time the chromosome under study from the G matrix (i.e. approach followed for 
Dataset 2) is considered to be the optimal analysis. 
Method (d). For Dataset 2 only the chromosomes with non-zero variance in 
Method (c) were fitted, simultaneously, using the AIREML programme with starting 
values from Method (a).  
Method (e). For Dataset 2 only the chromosomes with non-zero variance 
when all the 29 chromosomes were analysed simultaneously in Method (b), were 
fitted together with the G-c matrix on the remaining chromosomes. The proportion of 




variance explained by these chromosomes over the total phenotypic variance in the 
same analysis. 
Method (f). For Dataset 1, the chromosomes with non-zero variance in 
Methods (a), (b) and (c) were fitted simultaneously.  
Under the assumption of the infinitesimal model for the trait of interest and 
genetic effects distributed randomly across the genome when fitted separately, the 
magnitude of the chromosomal heritability should be proportional to the length of the 
chromosome. However, with genetic structure (relatedness) within the population, 
the estimated genetic effects will not be independent on different chromosomes. 
Therefore, the chromosomal heritability estimation analysis allows us to explore the 
origin of the accuracy of genomic prediction, i.e. if this accuracy is due to markers 
tagging closely true QTLs or if a proportion of the accuracy is due to relatedness, 
whereby markers on one chromosome may capture effects on other chromosomes. 
The proportion of genetic variation that can be attributed to population structure 
(relatedness) can be inferred from the regressions of chromosomal heritability on 




2 were regressed on chromosome length (Lc), and the proportion of genetic 
variance due to population structure was then calculated as b0/b0(sep), where b0 and 
b0(sep) are the intercepts of the two regressions (Daetwyler et al. 2012).  
4.2.2.4 Genomic prediction 
The accuracy of the within-population and across-populations genomic 
prediction was tested by means of Cross Validation (CV) (Luan et al. 2009). Two 




then randomly assigned to five groups of near-equal size irrespective of their 
population of origin (5-fold CV), each time using one group as the validation set and 
the remaining four groups as training sets, and using the model y = m1 + u + e, 
where u is the vector of genomic estimated breeding values with u ~ MVN (0, σu
2G). 
This procedure was replicated 50 times, each time with a different randomisation of 
the individuals in the groups. (b) Prediction accuracy was estimated across 
populations using either Population 2 or Population 1 as the validation set.   
The average accuracy across 50 randomisations was calculated in (a), and the 
expected accuracy in (b), as E[r(g,ĝ)] ≈ r(y,ŷ)/h, where r(y,ŷ) is the correlation 
between the cross-validated predicted EBVs (ŷ) and the phenotypes and h is the 
square root of the corresponding heritability; the heritability used was within fold for 
(a) and within population for (b). The standard error of the accuracies in (a) was 
calculated as the empirical standard deviation of the 50 accuracy estimates.    
These methods were applied to both Datasets 1 and 2. Further, in Dataset 1, 
the procedure was repeated using pedigree-derived EBVs for Population 2, and the 
results were compared with those obtained when pedigree information was not taken 
into account in the calculation of the EBVs.  
4.3 Results 
4.3.1 Genomic heritability estimates 
Genomic heritability estimates, for the different datasets and trait definitions 
are presented in Table 2. Population 1 yielded a heritability on the observed scale of 




regressed EBVs were used as phenotypes, and 0.11 (SE = 0.1) when the pedigree 
derived de-regressed EBVs were used. When retaining only the 175 bulls with ≥8 
daughters for Population 2, the genomic heritability was 0.60 (SE = 0.22), however, 
the smaller sample size contributed to the larger SE.  
For the combined Dataset 1 comprising all animals, when the pedigree-free de-
regressed EBVs were used for Population 2, the genomic heritability was 0.14 (SE = 
0.05), and for the pedigree-derived de-regressed EBVs it was 0.11 (SE = 0.04). For 
the combined Dataset 2 after removing the lower reliability bulls, the genomic 
heritability was 0.19 (SE = 0.06) (Table 2). These values are indicative of genetic 
variation but care should be taken in their interpretation due to the different trait 
definitions, hence expected values of the traits, in the different populations and 
datasets.  
4.3.2 Regional heritability estimates 
Windows contributing the maximum heritability and with the maximum LRT 
test value were identified for each chromosome, for the three window sizes. For the 
combined Dataset 1 and when the pedigree-free de-regressed EBVs were used for 
Population 2, RHmax ranged from 0.005 to 0.032 for the 20-SNP window, from 0.004 
to 0.029 for the 30-SNP window, and from 0.006 to 0.028 for the 50-SNP window 
(Table 3). When pedigree-derived de-regressed EBVs were used for Population 2, 
RHmax ranged from 0.172 to 0.409, from 0.009 to 0.359, and from 0.007 to 0.353 for 
the 20, 30 and 50-SNP windows (Appendix 4.1). However, as demonstrated by 





The strongest evidence for association was on chromosome 6 (BTA6) for the 
50-SNP window (Fig. 4a and b), significant at the suggestive significance threshold 
(LRTmax= 9.19, suggestive threshold= 8.96) when using the pedigree-free 
deregressed EBVs for Population 2, with the window (position: 45,216,251-
48,752,176, Fig. 5) explaining 2.7% of the phenotypic variance (Tables 3 and 4). 
This result was not observed by either Bermingham et al. (2014) or Finlay et al. 
(2012). With pedigree-derived de-regressed EBVs, BTA6 gave an LRTmax= 7.16 for 
the 50-SNP window and h2r =0.238, with this value again likely to be an 
overestimate (see Appendix 4.1). LRT results from the RH mapping analysis on 
Population 2 alone are shown in Appendix 4.2. 
For completeness, RHM was repeated for Dataset 1, but with the difference 
that the same quality control criteria were applied to both populations. In this 
analysis the strongest evidence for association was on BTA6 for the 50-SNP window 
(Fig. 4c and d), significant at the suggestive significance threshold (LRTmax=10.04, 
suggestive threshold=8.90). The window (position: 44,698,534- 47,983,800), as 
found previously and shown in Fig. 5, explained 2.7% of the phenotypic variance 
(Tables 5 and 6). Approximately the same region (position: 44,461,834 - 47,306,228) 
for the 30-SNP window was again significant at the suggestive level (LRTmax=10.30, 
suggestive threshold=9.83).  
In Dataset 2, after removing the low reliability bulls, the strongest evidence 
for association was again on BTA6 for all the different window sizes tested, 
however, no region reached significance after the Bonferroni correction (see 
Appendix 4.3). RHmax ranged from 0.008 to 0.029 for the 20-SNP window, from 




window (see Appendix 4.3).  
When the two populations in Dataset 2 were re-analysed, but setting the 
covariance between the two populations in the G matrix to zero, BTA3 and BTA14 
provided high LRT values while for BTA6 the LRT was reduced compared the 
previous analysis (see Appendix 4.4).  
4.3.3 GWA analysis 
GWA analysis on all the animals and after taking into account possible 
population sub-structure through fitting principal components,  did not yield any 
significant associations at the chromosome or genome-wide levels                                  
(-log10(P-value) = 4.24. The most significant SNP identified was compared to the 
genome-wide and suggestive significance thresholds of 5.85 and 4.55 respectively 
(see Appendix 4.5).   
4.3.4 Chromosomal heritability estimates 
Chromosomal heritability estimates for the different methods described in 
4.2.2.3 are presented in Table 7 for Dataset 2 (for Dataset 1 results see Appendix 
4.6). Fitting chromosomes individually following Method (a) in 4.2.2.3, resulted in a 
gross overestimation of the individual chromosome and total heritability, compared 
to fitting them simultaneously (Fig. 6 and Fig. 9). Method (b), where all 
chromosomes are fitted simultaneously, corrects for the correlation of genotypes 
across chromosomes. Method (c), fitting a single G-c for all remaining chromosomes, 
also takes into account that the chromosome under study might be correlated with 




useful particularly in situations where there is not enough information available (e.g. 
very small sample size) for fitting a large number of components simultaneously as 
in Method (b). However, constraining all chromosomes to have the same pattern of 
variance may not be appropriate as for example large QTLs under selection may be 
segregating in some chromosomes but not in other chromosomes, and the pattern of 
relationship on one chromosome may be different to the pattern of relationship on 
another chromosome. Therefore, Method (b) provides the most reliable estimates and 
is considered to be the optimal approach for obtaining chromosomal heritability 
estimates. 
There was a tendency for chromosomes which contained the most significant 
regions identified in 4.3.2, to also have the highest chromosomal heritability. All the 
methods (with the exception of Method (a)) were in good qualitative agreement 
providing the largest chromosomal heritability estimate for BTA6 (Fig. 9), 
confirming findings from the RH mapping, a. The chromosomal heritability 
estimates for BTA6 were 0.059, 0.051, 0.048, 0.053 and 0.053 from Methods (a), (b), 
(c), (d) and (e) respectively. These estimates were consistent with a regional 
heritability of 0.027 for BTA6.  The sum of the individual chromosome heritabilities 
is in the same range as the trait heritability: 0.284 for fitting all 29 chrs in Method 
(b), and 0.289 for fitting 20 non-zero variance chromosomes in Method (e), see 
Table 9. The chromosomes accounting for most of the observed variation were 
BTA3, BTA6 and BTA14, providing LRT values significant at the suggestive level 
(both the REML programme and ASReml provided similar log-likelihood estimates, 
with genome-wide significance threshold: 9.82 and suggestive threshold: 4.47) 




When the 20 chromosomes with non-zero variance in Method (b) were fitted 
simultaneously with the genomic matrix on the remaining chromosomes, these were 
found to explain 29% of the total phenotypic variance, suggesting that there are a few 
major chromosomes affecting resistance to bTB (σ220 / σ
2
P = 0.29, where σ
2
20 is the 
sum of the variance explained by the 20 chromosomes fitted simultaneously and σ2P 
the total phenotypic variance). In this analysis, for three of those chromosomes 
(BTA11, BTA20, and BTA25) the chromosomal heritability became zero, and only 
17 of the 20 chromosomes contributed to σ220 (Table 9).  
The genetic architecture of the trait can be investigated through the slope of 
the regression of hc(sep)
2 on chromosome length. For highly polygenic traits and in the 
absence of population structure the proportion of variance explained by each 
chromosome (i.e. the variance captured by the G matrix calculated on each 
chromosome) is expected to be proportional to its length (Yang et al. 2011; 
Daetwyler et al. 2012). However, in both the analyses of Dataset 1 and Dataset 2, 
chromosomal heritability was not found to be related to chromosome length. The 
slope was not significantly different from zero, with P-value>0.1 for Dataset 1 and 
P-value>0.1 for Dataset 2. This, along with the substantial number of chromosomes 
with zero heritabilities, suggest that bTB resistance is not strictly infinitesimal, and is 
controlled by certain chromosomes (Fig. 7, Fig. 10). When the heritability was 
regressed on the chromosomal length fitting the SE as weighting factors, the 
intercept or regression slope did not change considerably.    
The regression of the difference of the heritability estimates when (a) the 
chromosomes are fitted individually (h(sep)








(i.e. relatedness) (Yang et al. 2011), and represents the impact of markers accounting 
for variation in the phenotype even though they are on different chromosomes from 
where the QTL may be.  For both the analyses of Datasets 1 and 2, the slope of this 
regression was not significantly different than zero (P-value > 0.01 for Dataset 2) 
indicating that there was no evidence for population stratification due to systematic 
differences in allele frequencies between the two subpopulations (Fig. 8, Fig. 11). 
The intercept of this regression is due to cryptic relatedness (Yang et al. 2011), and 
was found to be significantly different than zero (P-value < 0.01).  
From the ratio of the intercepts b0 and b0(sep) (Daetwyler et al. 2012), the 
proportion of genetic variance due to population structure was estimated to be 0.80 
(0.85 for Dataset 1) suggesting that ~80% of estimated genomic h2 is due to 
relatedness. These results suggest that although the markers capture some effects of 
individual loci through linkage disequilibrium (LD), additive pedigree-correlated 
relationships are likely to play an important role in the total genetic variation 
captured by the markers.  
4.3.5 Genomic prediction 
Cross Validation (CV) methods were used to test the accuracy of the within-
population and across-populations genomic predictions (Luan et al. 2009). Increasing 
the size of the training set is expected to be beneficial in a cross validation. 
Therefore, the two populations were combined in a 5-fold cross validation and 
predictions within and across populations were compared.  
The average prediction accuracies obtained on the combined populations 




r(g,ĝ)=0.38 (s.d. 0.05) for the pedigree based EBVs (Table 10 and Fig. 12), 
compared to 0.33 when Population 1 alone was analysed (Tsairidou et al., 2014). 
Consistent with results mentioned above, including pedigree information in the 
EBVs resulted in greater estimates. Across populations prediction, even when using 
EBVs with pedigree information, resulted in reduced accuracy (r(g,ĝ)=0.1), and 
when EBVs with no familial information were used the correlations for across 
population predictions were close to zero (Table 10). These results suggest that 
genomic prediction is feasible but less accurate when applied across disparate 
populations. A possible explanation for that is that the accuracy depends on the 
genetic relationship between the validation set and the training set, and there might 
be systematic differences in linkage phases across the populations. Prediction 
accuracy was improved when individuals from the population to be predicted were 
included in the training set. 
When analysing the combined Dataset 2 with the low reliability bulls 
removed the average correlation with phenotype, obtained across 50 randomisations, 
was 0.14 and the average accuracy was r(g,ĝ)=0.34 (s.d. 0.04) (Table 10 and Fig. 
13). For the cross validation across populations the correlation and accuracy were 
0.011 and 0.03 when predicting for Population 2. However, the reverse prediction 
did not provide a credible value (Table 10).  
4.4 Discussion 
In the present analysis, where two disparate datasets were combined, it was 
demonstrated that bTB resistance is a moderately polygenic trait. A large effect was 




confirm the analyses presented in earlier chapters that genomic prediction for bTB 
resistance is feasible, however for the present data across population prediction was 
found to be of little value. Exploration of the properties of the chromosomal 
heritabilities suggests that a high proportion of the predictive ability of the SNPs is 
due to additive genetic relatedness rather than markers closely tagging causal 
mutations. 
4.4.1 Genomic heritability and regional heritability mapping 
For Population 1 the genomic heritability estimate was 0.23 (SE = 0.06), 
while for Population 2, retaining only the 175 bulls with ≥8 daughters resulted in the 
genomic heritability estimate of 0.60 (SE = 0.22). These values are indicative of 
genetic variation but care should be taken in their interpretation due to the different 
trait definitions, hence expected values of the traits, in the different populations and 
datasets. Population 1 is a case/control study while the Population 2 is a random 
sample of bulls.  Bermingham et al. (2014) reported an estimated heritability of bTB 
resistance in Population 1 of 21.0% (95% CI: 8.6–33.4) on the observed scale.  For 
Population 2, de-regressed EBVs estimated with no pedigree information are 
daughter averages corrected for fixed effects, and the heritability is essentially an 
estimate of the population average reliability (i.e. n/(n+(4-h2)/h2)) where n is the 
harmonic mean number of daughters and h2 is the true trait heritability for a single 
phenotype. For a harmonic mean of 17.24 daughters per sire in this subset, this 
heritability of 0.60 implies a heritability of single phenotype E[h2]=0.32. 
For the combined analyses the genomic heritability estimates were 0.14 (SE 




from individual populations. A possible explanation could be that assuming a 
covariance between the two populations in the IBS matrix added noise rather than 
information. To address this hypothesis the heritability analysis was repeated setting 
the across-population covariance in the G matrix to zero. This analysis yielded a 
heritability of 0.23 (SE = 0.06), similar to the estimate obtained when analysing 
Population 1 alone, suggesting that there is enough information in the SNPs present 
in the low density SNP chip and that when assuming no covariance between the two 
populations, Population 2 is outweighed due to its unreliable heritability estimate. 
Population 2 was a rather heterogeneous population with big differences in the 
reliabilities as derived from progeny testing in cattle, and therefore appears not to 
add information for the estimation of the heritability, which had a large standard 
error due to the small sample size. Therefore, the estimate of h2=0.23 as yielded from 
Population 1 is likely to be closer to the true heritability for bTB resistance. 
Assuming no covariance between the two populations may be more appropriate for 
the purposes of estimating genomic heritabilities and particularly when populations 
are distant and marker effects are likely to be different in the two populations.  
When assuming no across-population covariance, the LRT for BTA6 was 
reduced compared to the analysis presented in 4.2.2.1, while BTA3 and BTA14 
provided high LRT values (see Appendix 4.4). This result suggests that for BTA6 
there may be ancestral haplotypes common to both populations, which in this case 
allowed for a gain in power when combining the populations.  
When each of the populations were analysed independently, associations 
could be identified on BTA13 for Population 1 as reported by Bermingham et al. 




replicated in this analysis. GWA analysis on the combined populations did not detect 
any significant associations, which is an example of increased power of RH mapping 
to identify genomic regions associated with the trait under study compared to single-
SNP approaches (Nagamine et al. 2012; Uemoto et al. 2013). However, allele 
frequencies and SNP-mutation linkage phases may also differ between populations. 
4.4.2 Genomic architecture of resistance 
The chromosomal heritability estimation analysis revealed an intermediate 
situation for the genetic architecture of bTB resistance, where the trait was not found 
to be highly polygenic while there were not shown any major gene associations. 
Resistance to bTB was found to be affected by major effects on a few chromosomes 
while relatedness was found to be also playing an important role. The utility of 
taking into account the genetic architecture of the trait under study has been 
highlighted before in the literature, and prediction accuracy might benefit from 
incorporating this knowledge and the distribution of QTL effects in the analysis as 
prior information (Hayes et al. 2010; Moser et al. 2015).  
Fitting chromosomes individually following method (a) in 4.2.2.3, resulted in 
a gross overestimation of the individual chromosome and total heritability, compared 
to fitting them simultaneously (Fig. 6 and Fig. 9). One possible explanation is that 
this is due to correlations of SNPs on different chromosomes as the result of 
population structure (Yang et al. 2011). From the chromosomal heritability analysis 
17 chromosomes were found to explain 29% of the total phenotypic variance. To test 
the hypothesis that a similar number of chromosomes would be found to contribute 




a false map was provided in the analysis so that the SNPs that passed QC had their 
positions randomised over all 29 chromosomes (using the “sample” function in R). 
IBS matrices were calculated for every (false) chromosome and they were fitted 
simultaneously (as in Method (b)). A greater number of iterations was required to 
achieve convergence than when using the true map. In this analysis, all chromosomes 
were found to be contributing the same amount of variation, with all chromosomes 
detecting a baseline variance. These results suggest that the variance in the original 
analysis is genuinely associated with those SNPs on those particular 17 
chromosomes, with some chromosomes contributing near zero variance and a few 
chromosomes contributing considerably more.  
4.4.3 Genomic prediction 
Genomic prediction accuracy is largely affected by the sample size, but the 
genetic distance between the validation and the training populations is also important 
as the more distant the populations are, the greater the systematic differences in allele 
frequencies and linkage phase across populations will be. Genomic prediction was 
found to be feasible within populations but across population prediction resulted in 
reduced accuracy and sometimes resulted in negative values. This finding was 
consistent with the genomic heritability estimate being higher when the between 
population IBS covariances were set to zero. Using Population 1 (n=1,151), to 
predict for the smaller validation set (Population 2) was feasible; however, the 
achieved accuracy was very low. When a very small sample was used as the training 
set (i.e. Population 2 after removing the bulls with less than 8 daughters), it did not 
provide reliable accuracy estimates. Further, this estimate is corrected by the 




Thus, inferences on across-population predictions should be drawn with caution.  
When using the 5-fold cross validation in the combined populations, the 
prediction accuracy was not significantly improved by the increased sample size, 
compared to the estimates from a 5-fold cross validation within Population 1 alone. 
However, although the two populations were only distantly related and thus 
predictions were made across more diverse populations, combining the two 
populations was not found to have a negative impact on the prediction accuracy and 
the prediction accuracy was maintained. Furthermore, including in the training set 
individuals from the validation population, has been reported before to improve the 
accuracy of across populations predictions (Riggio et al. 2014b). In the present study, 
when using the cross validation in the combined populations, the training sets contain 
individuals from both populations, and this approach provided improved accuracy 
(r(g,ĝ)=0.34 compared to 0.03 when predicting from Population 1 alone).   
4.4.4 Genomic region and candidate genes associated with bTB 
resistance 
BTB is a chronic inflammatory disease of the lungs and the respiratory 
system with the macrophages being the primary target cells of the M. bovis bacteria 
and the innate immune response playing an important role in the outcome of 
infection. The region identified (position: 45,216,251-48,752,176 bp) through the RH 
mapping approach, contains a number of annotated genes. Based on their relevance 
regarding bTB, three putative candidate genes were identified: DHX15, SLC34A2, 
and ECSOD. These genes are involved in immune response and have been 




Specifically, they have been previously linked to chronic respiratory disease and 
conditions of chronic inflammation of the airways, with mutations in these genes 
affecting normal lung function and response to infection. In the following paragraphs 
the specific candidate genes are presented in more detail. 
The most promising candidate is the DHX15 gene which affects IFN 
production and innate immune response (Table 11). It is a member of the helicase 
family and codes for the pre-mRNA-splicing factor ATP-dependent RNA helicase 
DHX15 enzyme. It functions as a Pattern Recognition Receptor (PRRs), recognising 
and binding viral RNA (dsRNA), activating the immune response (myeloid dendritic 
cells) and inducing interferon production (Type I IFN), playing an important role in 
the innate immune system response (Lu et al. 2014). PRRs and their coding genes 
have been suggested in the literature as potential candidates for selection for disease 
resistance (Kaiser 2010, p. 16). Moreover, preliminary results from qPCR analysis 
studying the expression levels of this gene in BCG-activated macrophages, have 
provided indication that DHX15 is up-regulated (2-3 fold up-regulation) throughout 
infection (Mühlbauer L., personal communication, July 8, 2015). A previous gene 
expression study showed that DHX15 was expressed 5.6 times more in M. bovis 
infected alveolar macrophages compared to M. tuberculosis infected bovine 
macrophages (Widdison et al. 2008).  
Secondly, the Solute Carrier family 34 member 2 (SLC34A2) encodes the 
sodium-dependent phosphate transport protein 2B and is mainly expressed in the 
lungs (see Appendix 4.8), and specifically in the type II alveolar cells. Mutations in 
this gene that disrupt phosphate metabolism in the phospholipid degradation process 




with excessive calcification in the alveolar space and an autosomal recessive disorder 
called Pulmonary Alveolar Microlithiasis (PAM) which leads to the development of 
chronic inflammation and chronic respiratory failure (Huqun et al. 2006). Moreover, 
another member of the same family, Solute Carrier family 6, member 6 (SLC6A6), 
has been previously associated with susceptibility to bTB in a previous study on data 
from Population 2 (Finlay et al. 2012). SLC6A6 codes for the sodium- and chloride-
dependent Taurine Transporter (TauT) which is a carrier protein for the taurine 
amino acid across lipid layers (such as membranes). TauT deficiency has been linked 
to differences in immunological inflammatory response and response to bacterial 
infection.  However, SLC6A6 is on a different chromosome (BTA22) and this result 
was not replicated in the present meta-analysis. Further, a third member of the solute 
carrier family is SLC11A1 gene on BTA2, encoding the Natural Resistance 
Associated Macrophage Protein 1 (NRAMP1), is expressed in lysosomes of 
monocytes and macrophages and is involved in the activation of macrophages and 
the innate immune response.  Although in the present study it was not found to be 
significant, in previous studies polymorphisms at four loci in SLC11A1 have been 
associated with susceptibility to the M. tuberculosis (Li et al. 2011). Further NRAMP 
has been associated with susceptibility to infection with M. bovis BCG in mice 
(Vidal et al. 1993), and with the within-macrophages survival of M. bovis BCG, 
Brucella abortus and Salmonella dublin in cattle (Qureshi et al. 1996; Allen et al. 
2010). 
The third candidate, the ECSOD or SOD3 gene, is a member of the 
Superoxide Dismutase multigene family and codes for the Extracellular Superoxide 




concentrations, playing an important role in antioxidant defence and functioning as 
an anti-inflammatory (anti-oxidant) protein protecting the lung from oxidative stress. 
Polymorphisms in this gene have been shown to be important in lung function and 
were previously associated with lung diseases such as the Chronic Obstructive 
Pulmonary disease (COPD) where ECSOD polymorphisms have been identified as 
COPD genetic risk factors (Wilk et al. 2007; Oberlay-Deegan et al. 2009). COPD is a 
persistent chronic inflammatory disease of the airways and its pathology is linked to 
the production of Reactive Oxygen Species (ROS) by the inflammatory cells e.g. 
macrophages (free radicals production) (Oberlay-Deegan et al. 2009). Furthermore, 
SOD3 is a copper-enzyme. Cu deficiency and oxidative stress on the erythrocytes 
have been linked to increased Heinz body haemolytic anaemia (Suttle et al. 1987), 
while genetic differences in copper metabolism have been previously associated with 
growth retardation and increased susceptibility to infection (Woolliams et al. 1986a 
and b).  
Lastly, this region identified through the regional heritability mapping 
approach is ~35 Mb away from the SNP identified on BTA6 from the heterozygote 
disadvantage analysis for bTB resistance presented in Chapter 3. However, that was 
an analysis capturing non-additive genetic variation and therefore, it was not 
surprising that that SNP was not detected in the present analysis.  
4.4.5 Phenotypes and breed definitions 
The animals comprising the populations under study were designated as 
Holsteins or Friesians (for Population 1 see Chapter 1 section 2.2.1). The presence of 




results since when Population 1 was analysed separately with the Friesian cows 
removed only minor effects could be observed on the heritability and accuracy 
estimates (h2=0.21 (SE = 0.07) and r=0.36 (95% C.I.: 0.33, 0.38), Tsairidou et al. 
2014). Moreover, the principal component analysis on the combined data did not 
show any substructure attributable to Holstein-Friesian breed differences, while the 
presence of beef cattle crossbreds was presented in the PCA and addressed by 
correcting through the G matrix and by fitting principal components as fixed effects 
in the models used.  
In the present study we have combined individual phenotypic performance 
records (i.e. case / control data) and EBVs calculated from half-sib offspring 
averages (i.e. mean of individual measurements on several daughters). EBVs may be 
expected to improve the prediction accuracy as a “more accurate phenotype” as they 
include information from multiple progeny from each sire, hence using EBVs 
corresponds to the use of a trait with higher heritability (given that there are enough 
daughters, reliability will be such that r2 > h2). However, one of the direct 
consequences of using BLUP (Best Linear Unbiased Prediction) in the calculation of 
the EBVs is that the EBVs are shrunk towards the mean depending on the amount of 
information available (i.e. their reliability). The reliability is an estimate of the 
squared correlation between the EBV (ĝ) and the unknown True Breeding Value 
(TBVs, g), and it inversely reflects the prediction error variance associated with the 
estimation of the EBVs (so that ĝ = g + (ĝ - g), where (ĝ - g) is the prediction error). 
The EBVs estimated through BLUP have smaller variance compared to the TBVs so 
that var(ĝi)<var(gi), and that is due to the shrinkage towards the mean which 




truly superior animals, EBVs from BLUP are lower than their TBVs, and vice versa 
for truly inferior animals. Therefore, the use of deregressed EBVs (i.e. EBVs divided 
by their corresponding reliability ĝ / r2i) has been suggested in the literature as 
showing advantages over the use of EBVs specifically when the datasets comprise 
EBVs for individuals with varying r2i (Garrick et al. 2009; Ostersen et al. 2011). 
Secondly, Garrick et al. (2009) point to the problem of deregressed EBVs having an 
excess weighing towards the parent average. In the present study, the influences of 
parent average effects were accounted for through the use of pedigree-free 
deregressed EBVs, which were calculated in the absence of ancestral information 
and thus, they did not have excess weighting towards any parental information. 
Garrick et al. (2009) proposed weighting the de-regressed EBVs in order to 
correct for their heterogeneous variances. Weights can be calculated as a function of 
individual animal reliability (
2
ir ) and the proportion of genetic variance that is not 
accounted for by the markers (c), (Equation [10] in Garrick et al. 2009). A value 
suggested for c in the literature is that of 0.1 from a study on a pure-bred pig 
population using the Illumina PorcineSNP60 BeadChip (Ostersen et al. 2011). 
Assuming a c=0.2 corresponding to the Bovine50 SNP chip (Daetwyler 2009, Thesis 
Chapter 7, p. 152) and using the individual bulls’ reliabilities and h2=0.23, the 
weights calculated for the bulls in Population 2 after removing those with <8 
daughters, were found to range from 0.29 to 10.79 (with a mean of 1.34). For the 
cows in Population 1, with c=0.2 and r2=h2=0.23, following the same formula, the 
weight can be calculated as 0.94. Therefore, in a weighted regression analysis using 
these weights, the cows in Population 1 would get a considerably lower weight 




dataset and given that two different SNP chips were used for the two populations, 
only assumptions could be made for the value of c in the combined populations. The 
approach used in the present study, of scaling the phenotypes to have equivalent 
standard deviations, may have resulted in over-weighting the de-regressed EBVs 
from Population 2, but that should not prevent identification of genuine associations.   
4.4.6 Conclusion 
Combining two independent datasets has provided insights into the 
inheritance of bTB resistance, from the level of the genome down to potential 
candidate genes. Interrogation of chromosomal heritabilities suggests that a high 
proportion of the prediction accuracy is due to relatedness between animals. 
Resistance to bTB was found to be a moderately polygenic trait. Loci which affect 
resistance are spread across a number of chromosomes but, critically, not all 
chromosomes, suggesting that there are a few major chromosomes affecting the trait. 
The most significant individual region identified is on BTA6, a region containing 
several plausible candidate genes that are involved in immune response and affect 
the function of the respiratory system, potentially affecting resistance to infection. 
The approaches used in the present study suggest that this chromosome has an 
important contribution to the observed variation in this data. This result was obtained 
through the meta-analysis of the two populations and it was not evident from the 
individual studies. Genomic prediction of bTB resistance in cattle, and in the absence 
of animal phenotypes or pedigree information, does appear to be feasible, even when 
the genotypes available have been obtained using lower density SNP platforms. 
However, across population prediction was not successful due to the small size of the 




populations. Further, despite the common purpose of the phenotypes used, they were 
not defined precisely in the same way. Before implementation, the prediction 
accuracy needs to be improved, and particularly in situations where the populations 
may only be distantly related and where we wish to draw inferences on across-







n animals n SNPs n SNPs after QC 
Population 1 1151 777962  588332 
Population 2 287 54001   41418 
Population 2 (≥8 d) 175 54001   41428 
Combine dataset 
(all animals) QC1 
1438          - 37398 (36690 autosomal) 
Combine dataset 
(all animals) QC2 
1438          - 35459 (35021 autosomal) 
Combined dataset 
(≥8 d Pop. 2) 
1326          - 35427 (34987 autosomal) 
 
Table 1. Number of animals and number of SNPs before and after Quality 
Control (QC), for each population (upper part of the table). Number of 






Figure 1. Histogram of pedigree-free de-regressed EBVs. Higher EBVs 
correspond to higher mean susceptibility, i.e. bulls with daughters of higher 






Figure 2. Principal component analysis for the combined populations 
(n=1,438). In the graph are plotted the first vs. the third Principal 
Components (PC). The blue dots represent the Holstein-Friesian cows of 
Population 1, as presented in the structure graph by Bermingham et al. 
(2014). The red dots represent the Holstein-Friesian bulls of Population 2 as 
presented in the structure graph by Finlay et al. (2012).  The graph on the left 
side shows the structure observed when plotting the combinations for the 







      
 





n Genomic h2 (SE) 
Population 1 
 
- 1151 0.23 (0.06) 
Population 2 EBV/ r2i No 287 0.00 (-) 
 
EBV/ r2i Yes 287 0.11 (0.10) 
Population 2 (≥8 d) EBV/ r2i No 175 0.60 (0.22) 
Combine dataset 
(all animals) EBV/ r2i 
No 1438 0.14 (0.05) 
 
EBV/ r2i Yes 1438 0.11 (0.04) 
Combined dataset 
(≥8 d Pop. 2) EBV/ r2i 
No 1326 0.19 (0.06) 
 
Table 2. Genomic heritability estimates for the two populations and for each 
of the combined datasets and for the different sets of phenotypes analysed 
for Population 2 (where n is the number of animals in the analysis and r2i is 




 Window size and step size (number of SNPs) 
Chr 20, 10   30, 15 50, 25 
1 0.013 0.013 0.012 
2 0.010 0.017 0.010 
3 0.023 0.019 0.027 
4 0.014 0.013 0.017 
5 0.017 0.029 0.011 
6 0.026 0.022 0.027 
7 0.008 0.008 0.009 
8 0.016 0.016 0.014 
9 0.005 0.004 0.006 
10 0.012 0.009 0.006 
11 0.011 0.013 0.008 
12 0.023 0.018 0.022 
13 0.015 0.021 0.011 
14 0.021 0.025 0.028 
15 0.018 0.017 0.012 
16 0.015 0.015 0.015 
17 0.016 0.016 0.026 
18 0.015 0.013 0.015 
19 0.013 0.012 0.014 
20 0.011 0.011 0.010 
21 0.013 0.008 0.008 
22 0.017 0.020 0.023 
23 0.011 0.011 0.014 
24 0.012 0.021 0.016 
25 0.011 0.007 0.008 
26 0.013 0.011 0.008 
27 0.014 0.020 0.015 
28 0.011 0.011 0.010 
29 0.032 0.017 0.015 
 
Table 3. Regional maximum fraction of phenotypic variance explained within 
each chromosome (RHmax) for Dataset 1 (n=1438), for the three window 
sizes tested. For each window size the maximum value is in bold. As 
phenotypes were used the pre-corrected residuals for Population 1 and the 




 Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 5.64 5.64 5.64 
2 2.89 3.20 1.37 
3 6.95 8.01 8.41 
4 2.76 2.42 3.37 
5 6.65 3.46 2.16 
6 9.08 7.51 9.19 
7 3.39 2.52 2.42 
8 6.26 5.80 4.32 
9 1.27 1.14 1.30 
10 4.12 1.63 1.25 
11 2.65 2.08 1.60 
12 7.59 5.92 5.27 
13 3.61 2.88 2.18 
14 5.99 5.84 5.26 
15 6.78 5.57 3.68 
16 3.51 2.25 3.26 
17 5.22 4.85 4.51 
18 6.38 6.20 6.55 
19 4.28 3.45 3.07 
20 4.21 4.06 1.93 
21 1.92 1.07 0.89 
22 9.97 7.07 6.39 
23 2.99 3.31 2.03 
24 1.82 1.94 0.81 
25 2.81 1.80 1.71 
26 1.78 1.48 1.30 
27 5.33 6.27 4.86 
28 5.33 5.18 3.84 
29 4.77 4.19 2.89 
Genome-wide threshold 16.26 15.50 14.53 
Suggestive threshold 10.65   9.90   8.96 
 
Table 4. LRTMAX results within each chromosome for Dataset 1, and LRT 
significance thresholds after the Bonferroni correction, for the three window 
sizes tested. Significant value at the suggestive level is in bold. As 
phenotypes were used the pre-corrected residuals for Population 1 and the 




Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 0.014 0.011 0.011 
2 0.008 0.012 0.006 
3 0.024 0.019 0.019 
4 0.017 0.019 0.017 
5 0.012 0.008 0.008 
6 0.026 0.028 0.027 
7 0.009 0.006 0.006 
8 0.012 0.015 0.015 
9 0.004 0.007 0.005 
10 0.012 0.009 0.007 
11 0.016 0.013 0.011 
12 0.020 0.022 0.024 
13 0.011 0.014 0.019 
14 0.023 0.024 0.021 
15 0.015 0.018 0.013 
16 0.015 0.014 0.016 
17 0.014 0.019 0.023 
18 0.013 0.014 0.015 
19 0.011 0.010 0.012 
20 0.013 0.013 0.012 
21 0.007 0.005 0.004 
22 0.022 0.022 0.026 
23 0.012 0.008 0.023 
24 0.010 0.007 0.011 
25 0.008 0.006 0.006 
26 0.009 0.012 0.006 
27 0.014 0.013 0.016 
28 0.010 0.011 0.010 
29 0.031 0.021 0.013 
 
Table 5. RHmax estimates within each chromosome for Dataset 1 after 
applying the same QC criteria to both samples, for the three window sizes 




Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 6.11 3.56 2.17 
2 3.22 2.29 1.35 
3 8.65 8.86 8.31 
4 3.72 2.79 2.79 
5 3.76 1.83 2.16 
6 9.14         10.30     10.04 
7 2.99 2.27 1.49 
8 5.15 5.89 4.08 
9 1.06 1.82 1.03 
10 2.83 1.75 1.31 
11 2.29 2.05 1.94 
12 8.37 7.56 6.69 
13 2.44 3.02 2.79 
14 6.20 6.03 5.18 
15 4.49 5.81 3.99 
16 2.96 4.61 3.94 
17 5.49 4.69 3.62 
18 5.88 5.39 5.49 
19 3.87 2.34 2.20 
20 5.14 4.25 2.96 
21 1.07 0.93 0.44 
22 8.64 6.64 5.35 
23 3.15 1.66 4.33 
24 1.68 0.89 0.96 
25 1.83 1.89 1.51 
26 2.25 1.71 1.33 
27 5.51 7.12 4.08 
28 4.40 4.36 3.97 
29 4.02 4.47 2.48 
Genome-wide threshold 16.19 15.43 14.46 
Suggestive threshold 10.58   9.83   8.90 
 
Table 6. LRTMAX results within each chromosome for Dataset 1 after applying 
the same QC criteria to both samples and LRT significance thresholds after 
the Bonferroni correction, for the three window sizes tested. Significant 






*The yellow line represents the suggestive significance threshold.  
 
Figure 4. Detailed analysis for Regional Heritability (RH) mapping for 
chromosome 6 (BTA6): (a) Log-likelihood Ratio Test (LRT) results for BTA6 
from the 50-SNP window analysis, on Dataset 1 after QC1, with pedigree-
free de-regressed EBVs for Population 2; (b) Quality control graph of the RH 
vs. the LRT values for all the regions on BTA6, where the arrow denotes the 
significant region. LRT and RH increase together as expected. (c) LRT 
results for BTA6 from the 50-SNP window analysis, on Dataset 1 after QC2; 
(d) Quality control graph of the RH vs. the LRT values for all the regions on 






















Figure 5. The region identified from the RH mapping analysis on Dataset 1, 





Chr Length(Mbp) (a) hc(sep)2 (b) hc2 (c) (c) h(ci+G-ci)2 hc(sep)2 - hc2 
1 161 0.000 0.003 0.000 -0.003 
2 141 0.009 0.000 0.000 0.009 
3 128 0.044 0.035 0.036 0.009 
4 124 0.028 0.008 0.010 0.020 
5 126 0.032 0.003 0.007 0.029 
6 123 0.059 0.051 0.048 0.008 
7 112 0.036 0.011 0.015 0.025 
8 117 0.032 0.023 0.020 0.009 
9 108 0.011 0.000 0.000 0.011 
10 106 0.000 0.000 0.000 0.000 
11 110 0.010 0.001 0.000 0.009 
12 85 0.012 0.000 0.000 0.012 
13 84 0.022 0.000 0.000 0.022 
14 81 0.061 0.037 0.047 0.024 
15 85 0.033 0.013 0.021 0.019 
16 78 0.026 0.004 0.003 0.021 
17 77 0.055 0.030 0.025 0.025 
18 66 0.025 0.003 0.000 0.022 
19 65 0.008 0.000 0.000 0.008 
20 76 0.011 0.001 0.000 0.010 
21 69 0.002 0.000 0.000 0.002 
22 62 0.031 0.021 0.023 0.010 
23 53 0.035 0.018 0.020 0.017 
24 65 0.007 0.000 0.000 0.007 
25 44 0.014 0.001 0.003 0.012 
26 52 0.013 0.003 0.002 0.010 
27 49 0.000 0.001 0.000 -0.001 
28 46 0.022 0.016 0.015 0.006 
29 52 0.023 0.000 0.004 0.023 
 
Table 7. Chromosomal heritability estimation on Dataset 2 from Method (a) 
where every chromosome was fitted one by one, Method (b) where all the 
chromosomes were fitted simultaneously, and Method (c) where every 
chromosome was fitted one by one with the G-c matrix calculated on the 
remaining chromosomes. In the last column are shown the values of the 
difference of the heritability estimates when each chromosome was fitted one 






Figure 6. Chromosomal heritability estimates for Dataset 1, for the 10 
chromosomes which had a non-zero variance in Methods (a), (b) and (c). 
The estimates shown are from the following analyses: Method (a) where 
heritabilities were calculated separately for each chromosome; Method (c) 
where each chromosome was fitted separately plus the whole G matrix; 
Method (b) where all 29 chromosomes were fitted simultaneously, and 
Method (f) where the chromosomes with non-zero variance in Methods (a), 







Figure 7. Regression of the heritability estimates calculated separately for 
each chromosome on the chromosome length, for the combined analysis of 
Dataset 1 (b0(sep)= 0.0149, b1(sep)= 0.00004, R2 =0.0053, P-value: >0.1).  
 
 
Figure 8. Regression of the difference between the heritability when the 
chromosomes were fitted individually in Method (a) and when were fitted 
simultaneously in Method (b) on the chromosomal length, for the combined 
analysis of Dataset 1       (b0 = 0.0126, b1 = -0.00003, R2 = 0.0169, P-value: 
>0.1).  


















Figure 9. Chromosomal heritability estimates for Dataset 2, for the 20 
chromosomes which had a non-zero variance in Method (b) when analysed 
using the model:     cgy e   . The estimates shown are from the 
following analyses: Method (a) when every chromosome was fitted one by 
one; Method (b) where all the 29 chromosomes were fitted simultaneously; 
Method (c) where every chromosome was fitted one by one with the G-c on 
the remaining chromosomes; Method (e) where only the non-zero variance 





   
Figure 10. Regression of the heritability estimates calculated separately for 
each chromosome on the chromosome length with corresponding SE, for the 
combined analysis of Dataset 2 (b0(sep)= 0.018, b1(sep)= 0.00005, R2 = 0.009, 
P-value: >0.1).  
 
 
Figure 11. Regression of the difference between the heritability when the 
chromosomes were fitted individually in Method (a) and when were fitted 
simultaneously in Method (b) on the chromosomal length, for the combined 
analysis of Dataset 2 (b0 = 0.0145, b1 = -0.00002, R2 = 0.005, P-value: >0.1).  























1 0.000 0.195 -0.049 
2 0.000 0.212 -0.220 
3 0.037 0.159 5.795 
4 0.010 0.178 0.536 
5 0.007 0.182 0.237 
6 0.048 0.145 7.829 
7 0.015 0.172 0.980 
8 0.021 0.169 2.066 
9 0.000 0.213 -0.237 
10 0.000 0.222 -1.626 
11 0.000 0.200 -0.045 
12 0.000 0.206 -0.228 
13 0.000 0.191 0.000 
14 0.047 0.145 8.681 
15 0.021 0.167 2.560 
16 0.003 0.186 0.029 
17 0.025 0.167 1.720 
18 0.000 0.190 0.000 
19 0.000 0.195 -0.038 
20 0.000 0.188 -0.001 
21 0.000 0.208 -0.293 
22 0.023 0.175 2.895 
23 0.020 0.163 2.132 
24 0.000 0.204 -0.131 
25 0.003 0.185 0.093 
26 0.002 0.186 0.031 
27 0.000 0.186 0.000 
28 0.015 0.179 1.837 
29 0.004 0.184 0.173 
Genome-wide threshold   9.82 
Suggestive threshold   4.47 
 
Table 8. LRTMAX results for Dataset 2 when fitting each chromosome 
separately and the G-c on the remaining chromosomes with AIREML. The 
hypothesis that the chromosome is contributing variance to the trait is tested 
versus the H0 model where only the genomic matrix excluding the 




  Method (b)  Method (e) 
Chr Vi h2 
 
Vi h2 
chr 1 0.004 0.003 
 
0.003 0.003 
chr 3 0.040 0.035 
 
0.041 0.036 
chr 4 0.009 0.008 
 
0.011 0.010 
chr 5 0.004 0.003 
 
0.003 0.003 
chr 6 0.059 0.051 
 
0.060 0.053 
chr 7 0.013 0.011 
 
0.014 0.012 
chr 8 0.027 0.023 
 
0.025 0.022 
chr 11 0.001 0.001 
 
0.000 0.000 
chr 14 0.043 0.037 
 
0.046 0.040 
chr 15 0.016 0.013 
 
0.017 0.015 
chr 16 0.005 0.004 
 
0.004 0.004 
chr 17 0.034 0.030 
 
0.034 0.030 
chr 18 0.003 0.003 
 
0.003 0.002 
chr 20 0.001 0.001 
 
0.000 0.000 
chr 22 0.024 0.021 
 
0.023 0.020 
chr 23 0.020 0.018 
 
0.021 0.019 
chr 25 0.001 0.001 
 
0.000 0.000 
chr 26 0.004 0.003 
 
0.003 0.003 
chr 27 0.001 0.001 
 
0.001 0.001 
















Table 9.  Variance components (Vi) and corresponding heritability estimates 
when all chromosomes were fitted simultaneously in Method (b) and when 
only the chromosomes with non-zero variance in (b) were fitted together with 
the G-c matrix on the remaining chromosomes (Method e). 17 chromosomes 
are found to explain 29% of the total phenotypic variance, where V20 is the 
sum of the variance explained by those chromosomes. Three chromosomes, 
although they had a non-zero variance in the 29 chromosomes simultaneous 













Cor Accur SD 
Combined 
analysis 
1 + 2 1 + 2 ᵻ 
 
No     0.12 0.33 0.05 
 
1 + 2 1 + 2 ᵻ 
 




1 2 0.20 0.06 No    -0.01 
  
 1 2 0.20 0.06 Yes 0.04 0.10  
 2 1 0.00 
 
No    -0.03 
  




















1 + 2 1 + 2 ᵻ 
 




1 2 0.20 0.06 No 0.01 0.03 
 
 2 1 0.57 0.22 No 0.84 1.11 
 
ᵻ The within-fold heritability for each Cross Validation fold was used 
Table 10.  Average correlation and expected accuracy across 50 randomisations from analysis of Dataset 1 and 






Figure 12. Accuracy values calculated as the mean of the 5 Cross Validation 
sets, across 50 randomisations, on Dataset 1. The red line denotes the mean 
value r(g,ĝ)=0.33 (s.d. 0.05) as given in Table 10.  
 
 
Figure 13. Accuracy values calculated as the mean of the 5 Cross Validation 
sets, across 50 randomisations, on Dataset 2. The red line denotes the mean 
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Table 11. Summary table of candidate genes identified through the Regional Heritability mapping in the present study and 





RHmax estimates within each chromosome for the combined Dataset 1 
(n=1438) for the three window sizes tested. As phenotypes for Population 2 
were used the de-regressed EBVs with pedigree information. 
 Window size and step size (number of SNPs) 
Chr       20, 10    30, 15    50, 25 
1 0.356 0.311 0.091 
2 0.316 0.323 0.009 
3 0.375 0.346 0.317 
4 0.356 0.254 0.022 
5 0.299 0.017 0.010 
6 0.301 0.322 0.238 
7 0.175 0.193 0.014 
8 0.319 0.262 0.224 
9 0.305 0.294 0.179 
10 0.284 0.264 0.013 
11 0.286 0.263 0.024 
12 0.409 0.329 0.353 
13 0.280 0.241 0.082 
14 0.247 0.270 0.019 
15 0.255 0.238 0.085 
16 0.356 0.318 0.219 
17 0.259 0.228 0.188 
18 0.322 0.018 0.020 
19 0.342 0.359 0.007 
20 0.393 0.254 0.021 
21 0.181 0.220 0.141 
22 0.253 0.017 0.010 
23 0.362 0.331 0.211 
24 0.296 0.045 0.038 
25 0.172 0.203 0.010 
26 0.289 0.273 0.253 
27 0.208 0.177 0.177 
28 0.205 0.009 0.008 




LRTMAX results within each chromosome for the combined Dataset 1 
(n=1438) and corresponding LRT significance thresholds after the Bonferroni 
correction, for the three window sizes tested. As phenotypes for Population 2 
were used the de-regressed EBVs with pedigree information. 
                                                                         Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 16.03 6.88 6.88 
2 21.65 17.90 1.08 
3 34.82 36.90 16.52 
4 11.89 4.68 2.52 
5 9.57 4.94 2.13 
6 26.45 19.22 7.16 
7 10.43 4.79 2.93 
8 31.11 24.89 6.51 
9 38.01 24.81 1.11 
10 6.86 5.96 0.79 
11 16.41 6.10 5.08 
12 16.18 11.76 8.56 
13 29.53 4.36 5.51 
14 18.67 7.26 5.75 
15 25.53 13.13 10.75 
16 23.84 17.89 13.54 
17 39.15 12.31 2.54 
18 19.51 5.93 5.14 
19 29.96 47.70 1.99 
20 28.02 12.66 5.54 
21 11.26 6.06 1.84 
22 12.51 3.25 2.44 
23 26.95 15.05 5.51 
24 18.92 5.32 3.49 
25 2.96 7.14 1.57 
26 16.38 17.46 3.53 
27 8.85 4.81 4.12 
28 12.54 3.38 2.27 
29 29.36 32.39 8.04 
Genome-wide threshold 16.26 15.50 14.53 






LRT results for Population 2 analyses and corresponding LRT significance 
thresholds, with the pedigree-free EBVs, and the pedigree-free de-regressed 
EBVs used as phenotypes.  






1                               4.22                        3.21 
2 9.20 2.67 
3 6.58 2.79 
4 6.30 8.74 
5 3.50 7.18 
6 2.28 4.78 
7 1.48 0.83 
8 2.34 3.59 
9 0.50 3.62 
10 3.70 2.20 
11 10.60 1.95 
12 5.62 2.00 
13 3.98 2.70 
14 5.28 3.74 
15 2.24 7.50 
16 2.66 2.88 
17 0.58 5.00 
18 1.50 0.99 
19 3.54 3.26 
20 2.72 2.94 
21 4.74 7.44 
22 6.60 3.59 
23 8.72 2.73 
24 2.02 1.05 
25 1.44 0.89 
26 1.84 2.28 
27 2.20 1.97 
28 2.02 1.13 
29 3.94 5.97 
Genome-wide threshold   4.73 
 
          4.73 
 






RHmax estimates within each chromosome for Dataset 2, for the three window 
sizes tested. Pedigree-free EBVs were used for Population 2 after removing 
the bulls with less than 8 daughters. 
 Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 0.015 0.009 0.012 
2 0.008 0.009 0.007 
3 0.025 0.017 0.024 
4 0.019 0.025 0.019 
5 0.015 0.011 0.011 
6 0.019 0.023 0.024 
7 0.013 0.018 0.015 
8 0.014 0.015 0.015 
9 0.012 0.010 0.009 
10 0.009 0.006 0.006 
11 0.015 0.014 0.010 
12 0.019 0.017 0.015 
13 0.023 0.015 0.024 
14 0.029 0.021 0.022 
15 0.020 0.015 0.017 
16 0.017 0.015 0.016 
17 0.015 0.030 0.036 
18 0.010 0.011 0.012 
19 0.009 0.009 0.009 
20 0.009 0.008 0.013 
21 0.012 0.008 0.007 
22 0.015 0.016 0.016 
23 0.022 0.013 0.039 
24 0.010 0.008 0.008 
25 0.008 0.006 0.009 
26 0.011 0.014 0.017 
27 0.018 0.022 0.018 
28 0.012 0.014 0.012 






LRTMAX results within each chromosome for Dataset 2 and corresponding 
LRT significance thresholds after the Bonferroni correction, for the three 
window sizes tested. Pedigree-free EBVs were used for Population 2 after 
removing the bulls with less than 8 daughters.  
                               Window size and step size (number of SNPs) 
Chr 20, 10 30, 15 50, 25 
1 3.14 2.45 1.65 
2 2.72 1.99 1.64 
3 6.04 7.41 6.36 
4 4.62 5.53 3.83 
5 4.83 2.96 3.51 
6 9.25 8.96 7.85 
7 3.97 4.48 3.56 
8 5.88 5.20 4.38 
9 2.02 2.52 1.31 
10 1.98 1.60 1.30 
11 3.54 3.07 2.64 
12 6.70 4.53 3.69 
13 2.88 4.22 3.52 
14 8.52 7.11 7.33 
15 6.40 4.91 3.45 
16 4.74 2.66 3.45 
17 5.14 4.96 6.88 
18 4.48 3.49 2.65 
19 1.79 1.65 1.54 
20 2.61 1.53 2.13 
21 3.01 1.36 0.72 
22 7.81 7.21 4.40 
23 5.06 2.68 6.88 
24 1.67 1.39 0.55 
25 1.57 1.55 1.65 
26 2.64 2.24 2.74 
27 6.43 8.72 5.96 
28 4.39 3.95 3.35 
29 4.87 4.16 4.02 
Genome-wide threshold        16.19 15.43        14.46 





Regional heritability mapping LRT results for the combined analysis of 
Dataset 2 with zero covariance assumed between the two populations, for 
the 50-SNP window size (25-SNP step).  
 Window size and step size (number of SNPs) 
Chr 50, 25 





























Genome-wide sign threshold  14.46 
 






GWA analysis Manhattan plot using the “egscore” function (GenABEL/R) 
adjusted for 3 principal components for Dataset 1 and Q-Q plot showing 
observed compared to expected x2 values under the null hypothesis of no 
association. The genome-wide and suggestive significance thresholds were 
5.85 and 4.55 respectively. 
   
 
 
Appendix 4.6  
Chromosomal heritability estimates for Dataset 1, for the four different 
methods followed: Method (a) where each chromosome was fitted separately    
(hc(sep)2 ); Method (b) where all chromosomes were fitted simultaneously (hc2); 
Method (c) where each chromosome was fitted with the whole G matrix 
(hc+G2); and Method (f) where only the chromosomes with non-zero variance 
in Methods (a), (b) and (c) were fitted simultaneously (h(non-zero var)2). V10 is the 
sum of the variance explained by the chromosomes whose variance 






(Mbp) hc(sep)2 hc2 hc+G2 h(non-zero var)2 hc(sep)2  - hc2 
1 161 0.000 0.000 0.000 
 
0.000 
2 141 0.004 0.000 0.000 
 
0.004 
3 128 0.046 0.042 0.037 0.043 0.004 
4 124 0.019 0.003 0.000 
 
0.016 
5 126 0.016 0.000 0.000 
 
0.016 
6 123 0.054 0.042 0.039 0.043 0.013 
7 112 0.020 0.000 0.000 
 
0.020 
8 117 0.024 0.018 0.009 0.015 0.006 
9 108 0.004 0.000 0.000 
 
0.004 
10 106 0.000 0.000 0.000 
 
0.000 
11 110 0.010 0.005 0.000 
 
0.004 
12 85 0.019 0.000 0.000 
 
0.019 
13 84 0.013 0.000 0.000 
 
0.013 
14 81 0.061 0.037 0.046 0.042 0.025 
15 85 0.030 0.024 0.020 0.020 0.006 
16 78 0.008 0.000 0.000 
 
0.008 
17 77 0.041 0.015 0.011 0.012 0.026 
18 66 0.018 0.002 0.000 
 
0.016 
19 65 0.011 0.000 0.000 
 
0.011 
20 76 0.016 0.002 0.001 0.000 0.013 
21 69 0.001 0.000 0.000 
 
0.001 
22 62 0.022 0.020 0.014 0.021 0.002 
23 53 0.025 0.010 0.011 0.011 0.015 
24 65 0.002 0.000 0.000 
 
0.002 
25 44 0.011 0.000 0.000 
 
0.011 
26 52 0.006 0.000 0.000 
 
0.006 
27 49 0.004 0.004 0.000 
 
0.000 
28 46 0.018 0.011 0.008 0.013 0.007 
29 52 0.019 0.000 0.003   0.019 







For completeness, in Method (d) for Dataset 2, the chromosomes with non-
zero variance in Method (c) were fitted simultaneously plus the G-c matrix on 
the remaining chromosomes. In the table are presented the variance 
explained by each chromosome (Vi) and the corresponding heritability where 
V16 is the sum of the variance explained by the 16 chromosomes fitted 
simultaneously. In this analysis 16 chromosomes explain 28% of the total 
phenotypic variance.  
 
  Method (c) Method (d) 
Chr Vi h2 Vi h2 
3 0.037 0.036 0.040 0.036 
4 0.010 0.010 0.011 0.010 
5 0.007 0.007 0.002 0.002 
6 0.048 0.048 0.059 0.053 
7 0.015 0.015 0.012 0.011 
8 0.021 0.020 0.023 0.021 
14 0.047 0.047 0.044 0.040 
15 0.021 0.021 0.014 0.013 
16 0.003 0.003 0.004 0.004 
17 0.025 0.025 0.034 0.031 
22 0.023 0.023 0.022 0.020 
23 0.020 0.020 0.021 0.019 
25 0.003 0.003 0.000 0.000 
26 0.002 0.002 0.003 0.003 
28 0.015 0.015 0.020 0.018 
29 0.004 0.004 0.000 0.000 
Venv -   0.803   
VP -   1.115   







Results for mRNA expression for the Solute Carrier family 34 [sodium 
phosphate], member 2 (SLC34A2). The tissue-specific expression pattern 
demonstrates that the SLC34A2 candidate gene in the RH mapping analysis 








Genotype imputation for dairy cattle: a meta-analysis of 
directly genotyped and imputed genotypes for bTB 
resistance 
5.1 Introduction 
In the previous chapter it was shown that resistance to bovine Tuberculosis is 
a moderately polygenic, complex trait controlled by a few major chromosomes. 
Thus, genetic variance for bTB resistance is likely to be explained by several QTLs 
with moderate individual effects. Furthermore, after having demonstrated that 
genomic selection for resistance to bTB in cattle is feasible (Tsairidou et al. 2014), 
both QTL discovery and genomic prediction accuracy are expected to be benefitted 
by larger datasets with more genotyped and phenotyped animals. Therefore, meta-
analysis of different studies can be a powerful method in order to increase the sample 
size. However, one of the constraints when combining individuals originating from 
different studies is that they have often been genotyped using different genotyping 
platforms, and thus, genotypic information is available for different sets of markers. 
In this context, this chapter expands the analyses presented in the previous chapter 
through inferring high density genotypes by means of genotype imputation.  
More specifically, genotype imputation utilises the presence of haplotypes 
originating from a distant common ancestor that are shared between apparently 




distant the common ancestor is the shorter the haplotype stretches will be. Reference 
haplotypes can either be already available in haplotype libraries (e.g. HapMap CEU) 
or they can be calculated from the data. To calculate them from the data a pedigree 
can be used, or alternatively, the haplotypes can be calculated from a reference 
population genotyped at high density. Then, the “most-likely-genotypes” can be 
imputed for the un-typed markers in populations genotyped at lower density, by 
comparison with the reference haplotypes (“in silico genotyping”) (Burdick et al. 
2006; Sanna et al. 2008; Willer et al. 2008; Li et al. 2009; Li et al. 2010). Therefore, 
genotype imputation provides a useful tool facilitating the combination of different 
datasets genotyped for a distinct set of SNPs (Willer et al. 2008), allowing us to 
exploit all the already available information including lower density genotypic data. 
Further, imputation has been successfully used for fine-mapping of candidate regions 
by increasing resolution for those regions (Chambers et al. 2008; Sanna et al. 2008; 
Li et al. 2009), and for improving the power for association analyses (Li et al. 2009). 
The aim of this study was to combine in a meta-analysis data containing high 
density genotypes both directly genotyped and inferred using genotype imputation. 
The two dairy cattle populations described in the previous chapter were analysed 
through the means of Regional Heritability Mapping (RHM) and Cross Validation 
(CV) analysis. We anticipate that these analyses will allow us to identify genomic 
regions associated with bTB resistance and to investigate the impact of the use of 




5.2 Materials and Methods 
5.2.1 Data description 
The dataset comprised merged data from Population 1 comprising Holstein-
Friesian cows and including the outliers from PCA, and Population 2 comprising 
Holstein-Friesian bulls with pedigree-free de-regressed EBVs and including the 
lower reliability bulls, as described in more detail in the previous chapter (section 
4.2.1), however, this time genotypes were those for SNPs on the Illumina BovineHD 
BeadChip. Before imputation was carried out, Population 1 had been genotyped 
using the Illumina high-density Bead Chip, while Population 2 had been genotyped 
with the Illumina Bovine50 SNP chip. The objective was to impute for Population 2 
the SNPs that are present on the HD Beadchip but not on the 50K SNP chip as will 
be described below. Pedigree was not available for either of the populations. 
Consistent labelling across the reference and the study samples was ensured through 
obtaining the Illumina forward strand genotypes for both populations. Quality 
Control (QC) was conducted before imputation with the same quality control criteria 
being applied to both samples: MAF<0.05, call rate per SNP <95%, HWE 
p<0.000001, completely homozygote and completely heterozygote SNPs were 
removed, while, unassigned SNPs and SNPs on chromosomes X, and Y were not 
used for imputation and were excluded from subsequent analysis. The final dataset 





5.2.2 Genotype imputation 
Estimation of the haplotypes and genotype imputation of the un-typed markers for 
Population 2 was conducted for every chromosome using the Markov Chain 
Haplotyping (MaCH 1.0) package in a four-step process as follows: 
5.2.2.1 Selecting the reference panel and calculating the 
haplotypes  
Firstly, the reference haplotypes that will be assumed for the imputation need 
to be calculated. In the present study the haplotypes were inferred from the data 
rather than using haplotype libraries derived from other populations. For this 
purpose, a reference panel of individuals was used, as due to computational 
limitations it was not possible to use the entire dataset. This panel was selected from 
the population with the HD genotypes and was selected to be representative of the 
complete dataset to contain as many as possible of the existing variants and to avoid 
biasing the imputed genotypes due to breed or case-susceptible/control-resistant 
differences that may have a genetic background. Therefore, cases and controls in 
Population 1 were separated in two groups and one animal was selected from each 
herd within each of the groups. For herds with the greatest contribution to the dataset 
a second animal was also selected, with this animal being a Friesian where available. 
This process allowed a selection of 262 animals from 165 herds, from which animals 
were randomly removed to finally generate a reference panel of 200 animals. This 
number was chosen as Li et al. (2009) considered that 200 animals would be 
sufficient for this purpose. The final reference panel selected comprised 160 cases 




series of Markov Chain iterations to update the sampled haplotypes and construct a 
consensus haplotype. The reference haplotypes were calculated from the selected 
subset after 20 iterations (Li et al. 2010).  
5.2.2.2 Estimating model parameters 
The cross over map, which determines the likely sites for transition from one 
haplotype to the next, and the error rate map which flags unusual markers, are model 
parameters required for the imputation. To make the process computationally 
efficient, a single set of estimates for the model parameters was obtained using 20 
iterations and the 200 reference individuals with the haplotypes as calculated in 
(5.2.2.1). This, following the recommendations by Li et al. (2010), to avoid using a 
large number of Markov Chain iterations to simultaneously update the model 
parameters and impute the missing genotypes. 
5.2.2.3 Imputing missing genotypes  
These reference haplotypes from Population 1 as calculated in (5.2.2.1) and 
the model parameters as calculated in (5.2.2.2), were used to infer the most likely 
genotypes for the un-typed SNPs for Population 2. In the end of this process, HD 
genotypes were available for all the individuals. The summary statistic r2 was 
obtained for each SNP, defined by Li et al. (2010) as the squared correlation between 
true allele counts and estimated allele counts. This is defined from the number of 
times each genotype has been sampled after I iterations, where I = nA/A + nA/G + nGG, 
and where e.g nA/G is the number for the heterozygotes.  Following Li et al. (2010) a 
score, e.g. for allele A, was calculated as gA = (2 nA/A + nA/G) / I). The estimated allele 




for that locus. Then r2=var(gA)/[2pA(1-pA)], where the denominator is assumed to be 
the variance of genotype scores if observed without error (Li et al. 2010): it is 
independent of which allele is used for a biallelic locus.  
5.2.2.4 Assessment of imputation quality 
In order to assess the overall performance of the imputation process, a 
proportion of genotypes was randomly masked in MaCH, allowing comparison of 
the imputed genotypes at these locations with the true genotypes. For this purpose, 
2% of the reference genotypes were masked for each chromosome 
(http://csg.sph.umich.edu/abecasis/MACH/tour/), where the number of masked 
genotypes was equal to (the number of SNPs per chromosome) x (the number of 
individuals in the reference population) x 0.02.  The r2 values defined as the squared 
correlations between the imputed genotypes and the true genotypes, the allelic error 
rates after masking, the estimated per genotype error rate, the estimated per allele 
error rate, and the estimated mismatch rate in the Markov model were obtained after 
20 rounds.  
Furthermore, in order to investigate the impact of the quality of the imputed 
genotypes on heritability estimates and on genomic prediction accuracy, the r2 
calculated in (5.2.2.3) was used to identify lower quality imputed genotypes and 
discard them from subsequent analyses. This measure provides an estimate of the 
between replicate variability, and can be used to identify markers that give 
consistently poor values. Two different filters were applied, by setting as “missing” 




(b) an r2 < 0.9 (Filter 2), and consistency of results across the different thresholds 
was examined.  
5.2.3 Data analysis 
The combined data, containing all the directly genotyped SNPs and the 
filtered imputed genotypes, were analysed following the regional heritability 
mapping and the cross validation methodologies in order to identify genomic regions 
associated with bTB resistance and investigate the impact of using imputed 
genotypes on genomic prediction accuracy. 
5.2.3.1 Regional heritability mapping 
Regional heritability mapping methodology was followed as described in the 
previous chapter (section 4.2.2.1) with the difference that for this dataset the selected 
size of the overlapping windows was larger (i.e. 200 SNPs, with a 100-SNP step) to 
account for the denser SNP chip. This method allows us to obtain heritability 
estimates for genomic regions and identify regions associated with the trait of 
interest through the Likelihood Ratio Test (LRT). In order to investigate the impact 
of the imputation quality on the heritability estimates, RH analyses were conducted 
using (a) all the imputed genotypes, (b) filtered imputed genotypes for an r2 threshold 
of 0.7, and (c) filtered imputed genotypes for an r2 threshold of 0.9.   
5.2.3.2 Genomic prediction  
The accuracy of the genomic prediction calculated as E[r(g,ĝ)] ≈ r(y,ŷ)/h, 
using both directly genotyped and imputed genotypes was estimated through a 5-fold 




4.2.2.4). Individuals from both populations were combined and randomly assigned to 
five groups of near-equal size. This process was repeated 50 times to obtain the 
average accuracy across 50 different randomisations of the individuals into groups 
and examine the variability across the repeats.  
To investigate the impact of the quality of the imputed genotypes on the 
prediction accuracy this analysis was repeated using (a) all the imputed genotypes, 
(b) filtered imputed genotypes using Filter 1, (c) filtered imputed genotypes using 
Filter 2, and (d) imputed genotypes only for SNPs on two chromosomes found to 
contribute to the observed variation (Chapter 4 section 4.3.2 and 4.3.4).  
5.2.3.3 Targeted imputation  
As it was demonstrated in the previous chapter, loci which do affect 
resistance are spread across a number of chromosomes but, critically, not all 
chromosomes, suggesting that there are a few major chromosomes affecting the trait. 
Therefore, prediction accuracy might benefit by targeted imputation for the 
chromosomes explaining most of the genetic variation. To test this hypothesis cross 
validated prediction accuracy was estimated using imputed genotypes only for the 
SNPs on BTA6 (after applying Filter 2), while for the rest of the chromosomes were 
used the overlapping genotypes between the low density and the HD SNP chips. 
BTA6 was selected for the following reasons: (a) there was indication that BTA6 
might be associated with the trait in the RH mapping in 5.2.3.1 using the imputed 
genotypes, (b) the RH mapping analysis presented in the previous chapter revealed 
an association of a region on chromosome 6 with bTB resistance at the suggestive 




presented in Chapter 4 (section 4.3.4) has shown that chromosome 6 is explaining a 
large proportion of the observed variation. 
5.3 Results 
5.3.1 Imputation 
Table 2 shows the r2 obtained after masking 2% of the genotypes as a 
measure of imputation quality (section 5.2.2.4 (Table 2). The average r2 after 
masking across all chromosomes was 0.979, ranging from 0.974 (BTA26) to 0.983 
(BTA8), indicating an overall good quality of the imputed genotypes (Fig. 1). In all 
cases the maximum r2 across all SNPs was 1. Further details about the masking 
process including the percentage of markers masked and the time needed for the 
process to be completed are presented in Table 3. The mean allelic error rate after 
masking was 0.0013, further indicating a very good imputation quality. 
The average r2 within each chromosome without masking as calculated in 
5.2.2.3, was found to range from 0.976 (BTA26) to 0.984 (BTA8), with a mean of 
0.981 across all chromosomes. The minimum r2 value was observed on BTA3 
(r2=0.517) (Table 2, Fig. 2). 0.10% of the SNPs was excluded from the data using 
Filter 1 (r2<0.7), and 0.76% using Filter 2 (r2<0.9) which resulted in a marginal 
increase in the average r2 to 0.982 (Table 2). For individual chromosomes the impact 
on the r2 depends on the number of SNPs filtered. These r2 values estimated from the 
genotype scores were slightly higher compared to those after masking, however they 
were in good agreement for all the chromosomes. Unsurprisingly, the r2<0.9 




better estimate compared to the r2 after masking 2% of genotypes (Table 2).  
5.3.2 Genomic heritability estimates 
ASReml analysis on the combined imputed data provided a genomic 
heritability estimate of h2 = 0.129 (SE = 0.048), while after discarding the imputed 
genotypes with r2<0.7 or r2<0.9, genomic heritability remained practically 
unchanged with estimates of h2 = 0.127 (SE = 0.048) and h2 = 0.126 (SE = 0.048) 
respectively (Table 4). This estimate is similar to the heritability obtained in the 
previous chapter (0.14 (SE = 0.05)) when combining Population 1 and Population 2 
and using only the SNPs present in common in the HD and low density SNP chips, 
while it is lower, although within the SE difference, than the h2 of 0.19 (SE = 0.06) 
obtained after removing the lower reliability bulls (section 4.3.1).  
5.3.3 Regional heritability estimates 
Regional heritability estimates are presented in Table 5 and applying the 
filters was not found to have a large impact on the estimates (Table 5). RH mapping 
using all the imputed genotypes did not reveal any significant associations according 
to LRT (Table 6). However, after applying the r2<0.7 and the r2<0.9 filters, there 
was an association of a region on BTA 8, significant at the suggestive level (Fig. 3). 
After applying the filters, BTA6 was also very close to the suggestive significance 
threshold (Fig. 3b and c). For BTA6, RH mapping using imputed genotypes 
confirmed the regions which were identified in Chapter 4 when using only the 
overlapping HD and low density SNPs: (a) the first most significant region on BTA6 




imputation, and (b) the second most significant region after imputation partly 
overlaps with the first most significant region before imputation (Table 7).   
5.3.4 Genomic prediction 
Cross validation when all the imputed genotypes were included in the data 
provided an average prediction accuracy of E[r(g,ĝ)] =0.323 (s.d. 0.058) (Fig. 5a). 
After discarding the SNPs with r2<0.7 and r2<0.9 the prediction accuracy estimates 
were 0.317 (s.d. 0.052) and 0.332 (s.d. 0.046) respectively. Variability across the 
cross validation repeats was reduced when the most stringent filter was applied 
compared to when using all the imputed genotypes (Fig. 5c).  
5.3.5 Targeted imputation 
Following the targeted imputation approach for BTA6, i.e. using imputed 
genotypes for BTA6, while low density genotypes were used for the rest of the 
genome, a prediction accuracy of 0.410 (s.d. 0.052) was obtained, and the variability 
across the CV repeats was reduced with no replicate providing an accuracy less than 
0.3 (Figure 6a). This improvement was not due to changes in the estimate of the 
heritability as the correlation between the predicted breeding value and the observed 
phenotype also improved compared to genome-wide imputation (0.13 vs 0.11).  
Using targeted imputation for BTA8 provided a prediction accuracy of 0.379 
(s.d. 0.052). However, this analysis provided a lower correlation (0.11) and some CV 
repeats provided accuracies lower than 0.3 (Figure 6b). Lastly, imputed genotypes 




were used for the rest of the genome. This analysis provided an accuracy of 0.407 
(s.d. 0.054) (Table 6).  
Further, BTA13 has been previously associated with bTB resistance in a 
study on Population 1 (Bermingham et al. 2014), however, there was no evidence for 
association for this chromosome in this data after combining Population 1 and 
Population 2. The targeted imputation approach as described above was tested for 
BTA13 and provided reduced accuracy (0.341 (s.d. 0.086)) and correlation with 
phenotypes (0.08) compared to BTA6, while the results across the repeats were 
highly variable (Fig. 6c).  
5.4 Discussion 
5.4.1 Overall success of genotype imputation for cattle data  
Genotype imputation for dairy cattle data was found to be successful when 
imputing from the Illumina Bovine SNP50 Bead Chip to the Illumina Bovine HD 
Bead Chip, with a mean r2 across all chromosomes of 0.98. Genotype imputation 
allowed us to exploit all the available information from the low density dataset in a 
cost-effective way, as high density, direct genotyping is required only for a small 
subset of animals which were used as the reference population.  
Each genotype generated through imputation by MaCH is a prediction of the 
“most likely estimate”, and therefore it is calculated with some uncertainty. This 
uncertainty is introduced by several factors including the quality of markers used as 
the reference for the calculation of the haplotypes and the genetic distance between 




events will disrupt the haplotypes and the more distant the populations are, the 
stronger this effect would be. In the present study this is pertinent because high 
density genotypes were available only for one population and imputation was 
conducted across different populations. However, both populations comprised 
Holstein and Friesian cows and these breeds are not expected to be very distantly 
related (http://www.ukcows.com/holsteinuk/publicweb/Services/SrvMain.aspx? 
page=_BriefHistory&cmh=166).  Moreover, Li et al. (2009) demonstrated that 
imputation accuracy increases with reference populations of larger size, with little 
benefit being observed when further increasing the reference panel beyond 200 
individuals. Therefore, in this data, 200 individuals (~14% of the data) were used as 
a reference panel. Lastly, one of the advantages of imputation studies in livestock is 
the use of pedigrees so that long haplotypes can be tracked in the population and 
used in the imputation. However, in the present study pedigree was not available and 
haplotypes were inferred utilising short haplotype stretches inherited from an 
unknown distant common ancestor and shared among apparently unrelated 
individuals, which is the approach commonly adopted for imputation in humans.  
All the factors described above are likely to have a negative impact on the 
imputation accuracy. However, despite those reservations, the apparent accuracy of 
imputation in this study was high. Previously reported imputation accuracy has been 
generally high for cattle. Similarly to our findings, Hoze et al. (2013) have reported 
an imputation accuracy >97% across 16 different cattle breeds, when using the 
Beagle software to impute from the Bovine SNP50 to BovineHD BeadChip, without 
taking into account pedigree information for the haplotyping. While Binsbergen et al. 




size, when imputing to whole-genome sequence data. However, caution should be 
taken in comparing the imputation accuracy values across different studies as the 
methods for the accuracy calculation vary depending on the software, the selected 
imputation quality measure and the method of calculation. Although not directly 
comparable, these values are indicative of an expectation of overall high accuracy 
values for genotype imputation in cattle. 
The imputation software MaCH has been previously used in human studies 
for the identification of loci associated with variation in height, by means of a 
GWAS in a meta-analysis of directly genotyped and imputed genotypes for 
individuals originating from different studies, genotyped using different genotyping 
platforms (Sanna et al. 2008). Genotype imputation was used to facilitate comparison 
between different studies and association analyses of the combined data. Further, in a 
meta-analysis by Willer et al. (2008), a GWAS on combined populations through the 
use of MaCH, identified new loci affecting the risk of coronary artery disease. 
Human height and coronary artery disease risk are complex traits controlled by a 
large number of variants, and genotype imputation was useful in validating or 
identifying new QTLs. However, the imputation in those studies was based on 
relatedness information and HD individuals were available in the same population as 
the individuals-to-be-imputed which were offspring and siblings of the HD 
individuals. Moreover, for humans there are available datasets of reference 
haplotypes (International HapMap CEU Project), while in the present study for bTB 
resistance the reference haplotypes were estimated from the data.  
This study used a much higher threshold for filtering compared to what is 




imputed genotypes is that of r2>0.3 (Sanna et al. 2008; Li Yun et al. 2010). 
However, in the present study the minimum r2 value observed was r2min=0.549 (on 
BTA3) and therefore the thresholds of r2≥0.7 and r2≥0.9 were used. The density of 
SNPs required depends upon the species and the breed i.e. its effective population 
size, the range of the LD, the specific genetic architecture of the trait under study, 
and the trait heritability (Bishop et al. 2010, Chapter 1). Thus, a possible explanation 
why genotype imputation for cattle was found to be more successful compared to 
human studies, is that in Holstein cattle, the smaller effective population size (Ne ≈ 
50-100) and therefore, the longer range LD are expected to allow for longer 
haplotypes. Thus, relatively fewer markers should be required to achieve a 
reasonably good imputation quality. Additionally, the density of 50K SNP chip used 
for genotyping is near the plateau of the curve relating marker density to accuracy 
(Hayes et al. 2010) and thus it is perhaps unsurprising that that it was sufficient to 
deliver good imputation accuracy. 
Specifically for the chromosomes identified in the RH mapping analysis, the 
mean r2 after masking was very close to 1 (r2=0.981) indicating a good imputation 
quality for those chromosomes (Fig. 3 and Fig. 4). However, the masking is likely to 
be an overestimate since the reference haplotypes have been calculated using the 
same reference population. Therefore, for further assessing the imputation quality 
and the model parameters for BTA6, a subset of 200 HD individuals was randomly 
selected (excluding the reference pop to produce an independent validation set) and 
reduced to low density. Then using the haplotypes as calculated from the reference 
panel, and the same error rate and cross over maps as calculated in 5.2.2.2, those 




between the imputed and the observed genotypes for those 200 individuals. This 
approach provided a more objective correlation of 0.955, which is lower than that 
obtained after masking, nevertheless, it still indicates a very good imputation quality 
for this chromosome. This estimate is closer to the estimates reported by Hoze et al. 
(2013) and Binsbergen et al. (2013), although it is unclear whether an independent 
validation set had been used.  
5.4.2 Genotype imputation and heritability estimation 
One of the hypotheses was that higher heritabilities would be obtained by 
using imputed genotypes. However, using imputed genotypes was not found to have 
a large impact neither on the genomic heritability or on the regional heritability 
estimates. Genomic heritability obtained in this chapter was very similar to the 
estimate obtained when using only the overlapping SNPs between the HD and low 
density SNP chips (h2=0.14 (SE = 0.05)) (Chapter 4, section 4.3.1).  
The second hypothesis was that using imputed genotypes might allow 
detecting better association signals. In previous studies genotype imputation has 
either assisted in identifying new independent variants or enhanced formerly 
identified associations (Burdick et al. 2006; Willer et al. 2008).  In the present study 
RH mapping using imputed genotypes (a) identified a region on BTA8 significant at 
the suggestive level which was not detected when using only the overlapping HD and 
low density SNPs (Chapter 4), and (b) confirmed the previously identified 
associations on BTA6. In conclusion, although imputation can be useful to enhance 





5.4.3 Genotype imputation and genomic prediction  
The motivation for this analysis was the same as in Chapter 4 i.e. prediction 
accuracy is expected to be improved by increasing the sample size. While in Chapter 
4 increased sample size was achieved by combining two populations and reducing 
the genotypes to the lowest density to use the overlapping SNPs between the HD and 
the 50K SNP chips, in this chapter, HD genotypes were obtained by means of 
genotype imputation. Greater SNP density would be expected to improve the 
prediction accuracy by providing more information on the relationships. However, 
the set of additional imputed animals was relatively small in this study and arguably 
it was not large enough to have a detectable impact on the prediction accuracy. 
Further, each genotype is a “most likely estimate”, estimated with some uncertainty 
which builds additional errors in the G matrix. Consequently, accuracy was not 
improved when using all the imputed genotypes.  
Filtering out markers based on their r2 did not have a significant impact on 
the genomic prediction accuracy, which can be explained by the fact that since bTB 
resistance is not expected to be controlled by one major gene and control is spread 
over several genes across the genome, even if imputation quality might not be great 
for some SNPs within some of those genes, their effect will be small.  The prediction 
accuracy estimates obtained in this analysis are similar to the estimates obtained 
when using only the overlapping SNPs between HD and low density SNP chips (i.e. 
0.33 (0.05)). The regression of the number of SNPs per chromosome when only the 
overlapping SNPs are used, and when imputed HD markers are used, shows that the 




thus these analyses are directly comparable (Fig. 7).  
These results demonstrate that the limiting factor is not the marker density, 
but the number of animals and the trait definitions. This result is consistent with 
similar findings from previous studies. Sánchez-Molano et al. (2015) observed for a 
UK Labrador retriever population, that the GBLUP prediction accuracy when 
estimated for different numbers of randomly selected markers, did not further 
improve when increasing the number of SNPs above 11K SNPs. A possible 
explanation is that genomic prediction accuracy depends on the genetic structure of 
the species under study i.e. the number of independent chromosome segments which 
depends on the effective population size (Chapter 2, section 2.2.10.2) (Daetwyler et 
al. 2010). Thus, the long-range LD in dogs and in cattle, and the smaller effective 
population sizes, are likely to provide improved prediction accuracies for lower 
density SNP chips i.e. for the same statistical power, the SNP density required is 
reduced (Daetwyler et al. 2010; Quilez et al. 2012).  Other studies in livestock have 
also reported diminishing benefits in GBLUP prediction accuracy by increasing SNP 
density beyond a certain point. Hayes et al. (2010) demonstrated that genomic 
prediction accuracy depends on the genetic architecture of the trait, and when the 
trait is controlled by QTLs with large effects, a very small number of SNPs in LD 
with those QTLs would be required to reach a sufficient accuracy, with very little 
benefit when increasing further the number of SNPs. For a commercial population of 
broiler chickens, Ilska et al. (2014) found that increasing the chip density above the 
19K density generated a negligibly small increase in the accuracy of GEBV 




5.4.4 Genomic prediction with targeted imputation 
BTB resistance was shown in the previous chapter to be a moderately 
polygenic trait with some chromosomes estimated to contribute zero variance and a 
few, major chromosomes contributing considerably more than average. Genomic 
prediction accuracy may be benefitted by taking into account the specific genetic 
architecture of the trait under study. There is a previous example (Serão et al. 2014) 
of a disease resistance trait where region specific analysis taking into account the 
specific genetic architecture of the trait provided more accurate genomic prediction 
and identified associations that were not visible when analysing genome wide and 
looking at all chromosomes simultaneously.  Antibody response to PRRS in pigs was 
found to be largely controlled by two QTLs on SSC7. Serão et al. have reported 
improved prediction accuracy for response to PRRS when only SNPs residing in 
those QTLs were analysed (prediction accuracy of 0.63 when analysing only the 
SNPs on SSC7, versus 0.49 for all the SNPs across the genome) (Serão et al. 2014). 
This indicates that when the trait under study is controlled by a few QTLs with 
relatively large effects, adding to the analysis the remaining chromosomes that have 
no effect may add noise causing dilution of these effects. However, bTB is an 
intermediate situation where there is not a major QTL but genetic variance is 
clustered over only a handful of QTLs with moderate effects, and thus distinguishing 
those effects from noise is more challenging. 
Prediction accuracy was found to be improved when using HD imputed 
genotypes only for the chromosomes for which there was prior indication that it is 




rest of the genome, combined into a single G matrix. The effect of this approach was 
to increase the resolution adding dense genotypes locally, and provided higher 
prediction accuracy and less variability across the cross validation repeats. These 
putative QTLs have been identified in the same population and thus, the results may 
be only reinforcing some cryptic structure within the data. Therefore, in order to 
validate the QTLs, this finding should be confirmed in another independent 
population. Consequently, targeted imputation may be very effective where there is 
independent prior information but should be treated with caution otherwise. 
However, under the assumption that it is a true QTL, in agreement with what was 
shown by Serão et al., this result suggests that accuracy might benefit from adding 
weight on the QTLs associated with the trait under study (Serão et al. 2014). In the 
present analysis, additional weight on the chromosome containing the QTL was 
placed in the calculation of the IBS matrix by including HD genotypes only for that 
chromosome while low density genotypes were used for the rest of the genome.  
An alternative approach would be to calculate two separate IBS matrices, one 
for the HD genotypes for BTA6, and one for the rest of the genome excluding the 
chromosome of interest i.e. y = β + gc + g-c + e. This approach avoids placing 
additional weight to the putatively associated chromosome in the calculation of a 
single IBS matrix and adds insight into the source of the benefit for the prediction 
accuracy. For example, it may be the genetic architecture of the trait or the additional 
information provided by the imputed genotypes. This approach provided a prediction 
accuracy of 0.368 (s.d. 0.05), which was greater than the accuracy obtained when not 
considering BTA6 separately. To test if this value was significantly different than 




separately for BTA6 and for the rest of the genome, but without using the imputed 
genotypes for BTA6. This analysis provided a prediction accuracy of 0.361 (s.d. 
0.04). In both cases there was a small increase in the prediction accuracy of the order 
of a standard deviation. The similarity of the two estimates indicates that the 
observed increase is not due to the use of HD genotypes. Moreover, these accuracy 
estimates are not directly comparable to the estimates described earlier, due to 
differences in the calculation of the heritability and thus the accuracies. For this 
analysis, the accuracy is calculated as the correlation between the phenotypes, 
divided by the square root of the sum of the heritabilities as calculated in ASReml. 
However, in agreement to what was discussed above, even with a putative QTL on 
BTA6, it was not possible to demonstrate in this data a significant improvement by 
using denser SNPs, leading to the conclusion that the limiting factor is not the 
density of the markers.  
Lastly, genomic prediction using directly genotyped and imputed genotypes 
only for BTA6 and ignoring the rest of the chromosomes resulted in an average 
prediction accuracy of 0.55 (s.d. 0.08). When this analysis was repeated using only 
the low density genotypes for BTA6, an accuracy of 0.52 (s.d. 0.08) was obtained. 
Thus, the increase in accuracy could not be shown to originate from the use of 
imputed genotypes but from using BTA6 alone, on which RH mapping and 
chromosomal heritability estimation analyses in the same data have indicated that 
there are putative QTLs. This is the same phenomenon as observed by Serão et al. 
(2014), and whilst it is a striking increase of accuracy which is hard to ignore, 
validation in a different population would be necessary as this result is likely to be 




approach ignores the genetic variance explained by other chromosomes except 
through the similarity of genomic relationships of BTA6 to the remaining 
chromosomes, i.e. arising from family structure. Given the polygenic nature of the 
trait and the results from the chromosomal heritability estimation analyses (see 
previous chapter), most likely there are more QTLs on other chromosomes.  
5.4.5 Conclusion 
Genotype imputation was found to be successful for dairy cattle data, but 
using imputed genotypes genome-wide added little information given the sample size 
and for the trait under study. These findings suggest that the limiting factor is the 
number of animals and the phenotype definitions rather than the density of 
genotypes. As it was demonstrated in the previous chapter, loci which do affect 
resistance are spread across a number of chromosomes but, critically, not all 
chromosomes. With bTB resistance being a moderately polygenic trait controlled by 
a few major chromosomes, genomic prediction accuracy might be improved when 
taking into account this specific genetic architecture of the trait. The approach of 
targeted imputation as presented in this chapter may be beneficial, but the conclusion 






n animals n SNPs after QC 
Population 1 1151 588332 
Population 2   287   41418 
Combined Dataset 1438 588332 (573123 autosomal) 
 
Table 1. Number of animals and number of SNPs after Quality Control (QC), 





Before filtering (a)       r2 ≥ 0.7 (b)   r2 ≥ 0.9 (c)       After masking 
Chr r2mean r2 min % of SNPs filtered out r2mean % of SNPs filtered out r2mean r2mean r2 min 
1 0.983 0.63 0.16 0.984 1.33 0.985 0.981 0.632 
2 0.981 0.607 0.13 0.982 0.53 0.982 0.979 0.614 
3 0.982 0.517 0.09 0.982 0.68 0.983 0.98 0.549 
4 0.981 0.586 0.06 0.981 0.70 0.982 0.979 0.61 
5 0.981 0.602 0.08 0.981 0.54 0.982 0.979 0.618 
6 0.983 0.597 0.10 0.984 1.18 0.985 0.981 0.61 
7 0.981 0.565 0.21 0.982 0.76 0.983 0.979 0.59 
8 0.984 0.659 0.03 0.985 0.44 0.985 0.983 0.656 
9 0.978 0.606 0.23 0.979 0.68 0.98 0.976 0.617 
10 0.979 0.662 0.12 0.98 1.39 0.982 0.978 0.656 
11 0.982 0.571 0.07 0.982 0.77 0.983 0.98 0.556 
12 0.98 0.702 0.00 0.98 0.50 0.981 0.977 0.709 
13 0.984 0.611 0.16 0.984 0.39 0.984 0.983 0.648 
14 0.983 0.552 0.03 0.984 0.45 0.984 0.983 0.571 
15 0.98 0.604 0.41 0.982 1.47 0.983 0.978 0.608 
16 0.979 0.645 0.08 0.979 1.52 0.981 0.976 0.665 
17 0.982 0.604 0.02 0.982 0.45 0.983 0.981 0.621 
18 0.981 0.691 0.01 0.981 1.13 0.982 0.979 0.708 
19 0.98 0.654 0.01 0.98 0.22 0.98 0.978 0.676 
20 0.982 0.595 0.06 0.982 0.34 0.982 0.98 0.599 
21 0.981 0.561 0.08 0.981 1.08 0.983 0.979 0.576 
22 0.979 0.606 0.13 0.98 0.61 0.98 0.977 0.615 
23 0.982 0.556 0.33 0.983 0.51 0.983 0.98 0.587 
24 0.98 0.633 0.06 0.98 0.66 0.981 0.979 0.66 
25 0.979 0.831 0.00 0.979 0.38 0.98 0.978 0.835 
26 0.976 0.685 0.02 0.976 1.09 0.978 0.974 0.687 
27 0.978 0.703 0.00 0.978 0.39 0.979 0.976 0.703 
28 0.981 0.739 0.00 0.981 0.08 0.981 0.979 0.743 
29 0.98 0.638 0.08 0.98 0.26 0.98 0.979 0.658 








Table 2. Mean r2 for every chromosome with the minimum r2 that was 
observed within the chromosome, as resulted from the imputation process 
before and after filtering out the markers with (a) r2<0.7 and (b) r2<0.9, and 
(c) after masking 2% of the genotypes. 
 
 
Figure 1. Mean imputation accuracy (r2) for every chromosome estimated as 
the squared correlation between the imputed genotypes and the true 
genotypes, after 2% masking.  
 
Figure 2. Mean imputation accuracy (r2) for every chromosome as estimated 
































SNPs per chr 




Allelic error     
rate *10-3 
Mismatch                
rate *10-3 
Time (h) 
1 36196 158376 2.1  1.1  0.9  36.8 
2 30659 133178 2.3  1.2  0.8  29.9 
3 27653 120396 2  1  0.9  27.3 
4 27491 119981 2.6  1.3  0.8  28.1 
5 26592 114875 2  1  0.9  25.6 
6 28539 124516 2.1  1.1  0.8  28.5 
7 25338 110314 2.6  1.3  0.8  24.6 
8 21415 94514 2.3  1.2  0.8  21.3 
9 24358 105366 2.4  1.2  0.9  24.0 
10 24489 106349 2.1  1.1  0.9  24.0 
11 25956 112716 2  1  0.9  25.2 
12 20493 88629 2.1  1.1  1  19.8 
13 15882 70489 3  1.5  1  15.7 
14 16290 72550 2.9  1.5  1  16.3 
15 19782 85600 2.3  1.2  0.9  19.2 
16 18880 81605 2.1  1.1  1  18.1 
17 18055 78732 2.5  1.3  0.9  18.5 
18 16077 69493 2.3  1.2  0.9  15.8 
19 15402 66756 2.3  1.2  1  15.1 
20 17725 77206 2.5  1.3  1  17.7 
21 16416 71050 2.2  1.1  0.9  15.7 
22 15098 65344 3  1.6  1  14.6 
23 12477 54021 1.9  1  1.2  12.3 
24 14588 63308 2.6  1.3  1  14.3 
25 10817 47062 3.1  1.6  1.1  10.5 
26 12598 54605 2.6  1.4  1.1  12.8 
27 10991 47835 3.2  1.7  0.9  11.4 
28 11007 47811 3  1.5  1.1  10.7 
29 11859 51504 3  1.5  1  11.5 




Table 3. Descriptive values of the masking process with information on the 
number of markers masked, the estimated per genotype error rate, the 
estimated per allele error rate, the estimated mismatch rate in the Markov 







Population 1   0.23 0.06 
Population 2  0.00 0.22 
Overlapping SNPs 0.14 0.05 
All SNPs with imputation 0.1286 0.0479 
Filter 1 (r
2
≥0.7) 0.1267 0.0476 
Filter 2 (r
2
≥0.9) 0.1264 0.0475 
 
Table 4. Genomic heritability estimates for the two populations and for the 















Figure 3. LRTMAX values identified by the RH mapping for every 
chromosome (a) when using all imputed genotypes, (b) after applying Filter 1 
hence removing all SNPs with r2<0.7, and (c) after applying Filter 2 hence 
removing all SNPs with r2<0.9. The horizontal green lines represent the 





























































Figure 4. r2 histograms after masking 2% of the genotypes for BTA6 and 
BTA8 identified in the RH mapping analysis on the combined imputed data. 







All imputed         
(200, 100) 
Filter 1     
(200, 100) 
Filter 2                  
(200, 100) 
1 0.022 0.023 0.023 
2 0.008 0.008 0.008 
3 0.024 0.025 0.025 
4 0.026 0.027 0.027 
5 0.012 0.012 0.012 
6 0.016 0.035 0.089 
7 0.012 0.012 0.012 
8 0.018 0.019 0.019 
9 0.010 0.010 0.010 
10 0.012 0.012 0.012 
11 0.020 0.020 0.020 
12 0.023 0.022 0.022 
13 0.008 0.009 0.009 
14 0.050 0.051 0.051 
15 0.016 0.015 0.015 
16 0.015 0.015 0.015 
17 0.026 0.023 0.023 
18 0.013 0.013 0.013 
19 0.013 0.013 0.013 
20 0.007 0.007 0.007 
21 0.009 0.009 0.009 
22 0.019 0.019 0.019 
23 0.014 0.015 0.015 
24 0.016 0.016 0.016 
25 0.011 0.011 0.011 
26 0.011 0.011 0.011 
27 0.018 0.018 0.018 
28 0.017 0.017 0.017 
29 0.028 0.027 0.027 
 
Table 5. RHmax estimates within each chromosome for the combined dataset 
from the RH mapping analysis (200-SNP window size and 100-SNP step 
size) when (a) using all the imputed genotypes, (b) after applying Filter 1, and 







All imputed       
(200, 100) 
Filter 1     
(200, 100) 
Filter 2      
(200, 100) 
1 4.510 4.886 4.876 
2 3.478 3.280 3.280 
3 6.154 6.026 6.036 
4 6.640 6.726 6.730 
5 3.210 3.246 3.250 
6 6.796 9.678 9.690 
7 4.880 5.056 5.060 
8      11.386     11.594   11.598 
9 4.984 5.118 5.122 
10 3.438 3.314 3.316 
11 3.444 3.558 3.546 
12 7.490 7.476 7.464 
13 2.276 2.278 2.278 
14 7.024 7.092 7.084 
15 7.850 7.542 7.550 
16 5.882 5.614 5.614 
17 7.824 8.048 8.042 
18 6.266 6.244 6.242 
19 3.770 3.546 3.554 
20 3.584 3.296 3.292 
21 3.262 3.274 3.282 
22 6.498 6.240 6.252 
23 3.708 3.670 3.672 
24 3.278 3.452 3.446 
25 4.432 4.698 4.720 
26 2.024 1.918 1.924 
27 5.904 5.922 5.920 
28 4.692 4.598 4.610 
29 8.960 8.762 8.770 
Genome-wide threshold 17.131 17.131 17.131 
Suggestive threshold 11.495 11.495 11.495 
 
Table 6. LRTMAX results within each chromosome with 200-SNP window size 
and 100-SNP step size, for the combined dataset when (a) using all the 
imputed genotypes, (b) after applying Filter 1, and (c) after applying Filter 2, 




RH mapping  Chr 
Start SNP 
position (bp) 
End SNP      
position (bp) 
(1) All imputed 
genotypes 
(a) 6 72,915,853 73,645,837 
 
(b) 6 72,473,700 73,272,164 
(2) Filter 1 (a) 6 72,069,674 72,913,684 
 
(b) 6 45,153,840 45,981,562 
(3) Filter 2 (a) 6 72,069,674 72,913,684 
 
(b) 6 45,153,840 45,981,562 
(4) Dataset 1 
(Chapter 4) 
(a) 6 45,216,251 48,752,176 
 (b) 6 70,581,495 73,639,640 
 
Table 7. Positions of regions identified on BTA6 from the RH mapping using 
imputed data (http://www.ncbi.nlm.nih.gov/): (1) when using HD genotypes 
directly genotyped for Population 1 and imputed for Population 2; (2) after 
removing imputed genotypes for Population 2 with r2<0.7; (3) after removing 
imputed genotypes for Population 2 with r2<0.9. (4) Positions obtained without 
imputation and results from RH mapping as described in Chapter 4 (section 
4.3.2) for Dataset 1. In the table, (a) and (b) represent the 1st and 2nd 








Figure 5. The accuracy of predicting the phenotypes after imputation for 
Population 2 from 50 Cross Validation randomisations when (a) using all the 
imputed genotypes, (b) after discarding all SNPs with r2<0.7 (Filter 1) and (c) 
after discarding all SNPs with r2<0.9 (Filter 2). The green lines represent the 















































   
 
Figure 6. The accuracy of predicting the phenotypes after imputation for 
Population 2 from 50 Cross Validation randomisations when using (a) 
imputed genotypes only for BTA6 (after applying Filter 2) and the overlapping 
HD and low density SNPs for the rest of the genome, (b) imputed genotypes 
(after applying Filter 2) only for BTA8 and the overlapping HD and low 
density SNPs for the rest of the genome, (c) imputed genotypes (after 
applying Filter 2) only for BTA13 and the overlapping HD and low density 
SNPs for the rest of the genome, and (d) imputed genotypes were used 
simultaneously for BTA6 and BTA8 and the overlapping HD and low density 
























































Overlapping SNPs 0.116 0.33 0.050 
All imp 0.108 0.323 0.058 
Filter 1 0.104 0.317 0.052 
Filter 2 0.110 0.332 0.046 
Overlapping SNPs  & Chr6 imp 0.131 0.410 0.052 
Overlapping SNPs & Chr8 imp 0.105 0.379 0.052 
Overlapping SNPs  & Chr13 imp 0.082 0.341 0.086 
Overlapping SNPs  & Chr6 and 8 imp 0.129 0.407 0.054 
Gen – Chr6 + Chr6 imp 0.125 0.368 0.050 
 
Table 6. Cross Validation prediction accuracies summary table from analysis 
on the combined directly genotyped and imputed genotypes, and after 
applying filters.  
 
 
Figure 7. Regression of the number of HD SNPs per chromosome on the 
number of SNPs per chromosome appearing in both the HD and low density 
SNP Chips and retained in the analysis presented in Chapter 4 (sections 








A comprehensive quantitative genetic analysis of the bTB 
diagnostic skin test SICCT  
6.1 Introduction 
BTB diagnosis in the UK has traditionally relied on the Single Intradermal 
Comparative Cervical Test (SICCT) (de la Rua-Domenech et al. 2006). The test, 
because of its comparative nature, allows differentiating true bTB infection from 
false positives due to exposure to M. avium sbsp. avium, and has a very good 
specificity (>99% Sp), however, it has a relatively poor sensitivity (~55-70% Se) 
(Neil et al. 1994; Olea-Popelka et al. 2004; De la Rua-Domenech et al. 2006). 
Previous studies have demonstrated the feasibility of genomic selection for 
bTB resistance by (a) showing that there is heritable genetic variation for this trait 
(Bermingham et al. 2009; Brotherstone et al. 2010), and by (b) providing initial 
estimates of the accuracy for genomic selection (Tsairidou et al. 2014). Genomic 
selection of cattle for increased resistance to bTB might assist in the control of bTB. 
However, such selection will be partially informed by SICCT-based diagnosis of 
infection. Further, given the central role of SICCT in bTB control in the UK, it is 
important to know what would be the impact of genomic selection for bTB resistance 
on the SICCT test i.e. whether, in addition to increasing bTB resistance, this might 
also genetically alter actual SICCT values in both infected and uninfected cattle and, 
if it does, the likely magnitude of change. Therefore, understanding the genetic basis 




Genetic analyses previously conducted have demonstrated that resistance to 
bTB in first and in repeat breakdowns has a strong and positive genetic correlation, 
and although skin thickness itself was found to be highly heritable, there was strong 
indication that the heritability of the skin test is very low (DEFRA Evidence Project 
Final Reports SE3040 (2008) and SE3042 (2012)). Utilising field data in quantitative 
analyses is a challenging process, especially when identifying infected and healthy 
individuals relies upon imperfect diagnostics (Bishop and Woolliams 2010). During 
bTB testing, individuals that are non-reactors to the SICCT are classified as healthy, 
however, this class may also contain some misclassified bTB cases due to the 
imperfect sensitivity of the SICCT; reactors to the SICCT are classified as cases and 
they most likely have not been confirmed by other diagnostic means. Repeated 
measurements are available only for the animals classified as non-reactors or 
inconclusive reactors, while the reactors get a unique measurement and are 
immediately culled. Additionally, the presence of animals that are initially classified 
as healthy but become reactors at a repeated SICCT, raises questions on whether 
these animals may have been infected all the time and were false negatives due to the 
imperfect sensitivity of SICCT. Furthermore, SICCT records are collected by routine 
testing across the UK and the herds might either be undergoing a bTB breakdown or 
there might not be a confirmed breakdown, in which case the exposure status to bTB 
of the animals is unknown.  The herds undergoing a breakdown might be in their first 
or later bTB breakdowns. All these difficulties in data structure introduce further 
challenges in the modelling of this data.  
The aim of this study is to do a thorough quantitative genetic analysis of 




have been based so far on confirmed cases and not on the SICCT itself. This chapter 
describes the modelling of SICCT utilising field data. The analysis that will be 
presented here aims to address an important preliminary question, namely the extent 
to which SICCT values are heritable in healthy or diseased cattle. Genetics can offer 
an effective tool for the control of bTB in cattle and since selection for bTB 
resistance will be based on diagnosis of the infection using the SICCT, this study 
investigates if such selection is likely to have an impact on the SICCT. 
6.2 Materials and Methods 
The genetic control of the response to the test was explored by means of 
fitting linear mixed models in ASReml. Data analysis comprised (a) heritability 
estimation analyses using SICCT data as collected, (b) heritability estimation after an 
appropriate transformation to normalise the residuals, (c) heritability estimation after 
attempting to remove the component of resistance to bTB (R) by taking into account 
the health status according to the indicator trait (i.e. reactor or not), (d) investigation 
of the impact of age on the heritability estimates, and (e) investigation of the 
correlation between the health status and the magnitude of response to SICCT. 
6.2.1 Description of data 
6.2.1.1 Data description and derived traits 
The dataset comprises 117,356 Holstein-Friesian female cattle with 130,626 
test records originating from 646 herds. Repeated measurements were available for 
11,910 animals (10,678 animals with 2 records, 1,104 with 3 records, and 128 with 4 




been tested over a period of 9 years (2002-2010), from herds undergoing their 1st, 
2nd, 3rd or 4th bTB breakdown with the majority of animals being tested during the 1st 
breakdown within a herd (n= 112,116) (Fig. 1). The age of the animals tested ranges 
from 43 to 6,605 days, with a mean of 1,397 days. 
Four skin thickness measurements were available: skin thickness in 
millimetres at the site of avian tuberculin injection before inoculation (a1), skin 
thickness in millimetres at the site of bovine tuberculin injection before inoculation 
(b1), skin thickness in millimetres at the site of avian tuberculin injection after 
inoculation (a2), and skin thickness in millimetres at the site of bovine tuberculin 
injection after inoculation (b2) (Fig. 2). Three derived traits were of interest (i) 
da=a2-a1, which is the responsiveness to M. avium; (ii) db=b2-b1 which is the 
responsiveness to M. bovis; (iii) the skin test defined as SICCT = db-da. A detailed 
description of the data is presented in Table 1. The total number of non-reactors 
(NRs), inconclusive reactors (IRs), and reactors (Rs) according to (a) the standard 
interpretation (i.e. SICCT<1mm  NR, SICCT=1-4mm  IR, and SICCT>4mm  
R), and (b) the severe interpretation (SICCT<1mm  NR, SICCT=1-2mm  IR, and 
SICCT>2mm  R) (Morrison et al. 2000) are presented in Figure 3. Due to the 
distribution of SICCT in this data with ~86% of the SICCT values being zero, a 
derived SICCT (logSICCT) was calculated as log10(SICCT)+1, after setting all 
SICCT ≤0 values to 0.1. All values were made positive by adding 1, which did not 
make any difference to the ASReml analysis. The transformed data had a variance of 




6.2.1.2 Data cleaning 
This data had previously been cleaned to remove all records satisfying the 
following criteria: cows born before 1990; cows with a test carried out with a 
negative age or an age of ≤42 days; male animals after sex validation; and cows with 
no sire recorded (Brotherstone S., personal communication, October 18, 2013). 
Additionally in the present analysis, 2 animals with extreme a2 and b2 
measurements of 77.00 and 99.00 respectively (considered to be arbitrary entries, 
either wrong or missing) were removed. According to the standard interpretation and 
using the individual a1, a2, b1, and b2 measurements in the data, 2 herds were found 
to have no standard Rs and less than 2 IRs, and 9 herds were found to have no Rs and 
no IRs (in total 418 records). For this analysis those herds were retained in the data. 
Further, based on the year of testing and the three tests available in the data for each 
record, 12 animals (25 records) appeared to have been re-tested after being diagnosed 
as reactors. According to the re-testing protocol, once an animal is diagnosed as a 
reactor it is immediately culled, and therefore, these 12 animals were removed from 
the data. This left, 130,599 records for 117,342 animals that were retained in 
subsequent analyses. 
6.2.1.3 Pedigree exploration  
The animals in the data were offspring of 7,714 sires, out of which 5,510 sires 
had more than one daughter and the number of daughters per sire ranged with Q0= 
Q1=1, Q2=3, Q3=9, and Q4=2,028 where the Q values denote the quartiles (Fig. 5). 
Pedigree with both dam and sire known was available for 7,376 of those sires. 




calculated using the ENDOG software (Gutiérrez et al. 2005), defined as the sum of 
(1/2)n terms over all known ancestors, where n is the number of generations 
separating the individual from the ancestor. The number of equivalent generations 
was estimated to be 4.27 in the pedigree provided. 
6.2.2 Description of heritability estimation analyses 
6.2.2.1 Preliminary analysis 
(a) Analysis was conducted on all the 130,626 records. Heritability estimates 
were obtained in ASReml (Gilmour et al. 2002) for the three derived traits SICCT, da 
and db. The herd (644 d.f.), test year (8 d.f.), test month (11 d.f.), and the interaction 
between test year and test month (62 d.f.) were identified as fixed effects. The age 
and an indicator variable to account for the sequence of breakdowns within herd 
were included as covariates. The interaction of herd, date of breakdown and lactation 
group and the effect of sires were fitted as random effects. The pedigree file was 
used to account for relationships between sires. A sire model was fitted in ASReml 
as follows: 
 
   m  +  W  Z          1 X h u ey   (1) 
 
where y is the response variable (i.e. SICCT, da or db), m is the overall mean, 
1 is a vector of ones, β is the vector of fixed effects, h is the vector of the interaction 
term of herd, date of breakdown and lactation group fitted as a random effect with h 
~ MVN (0, Iσh
2), u is the vector of random sire effects with u ~ MVN (0, Aσs
2), X, 




e ~ MVN (0, Iσe







Locally Weighted Regression (LOESS) analysis was conducted on age and 
the SICCT, da, and db in order to assess the effect of age on the positive outcome of 
the skin test i.e. in the reactors (Fig. 6). In order to capture the age-related differences 
that were observed in the models, age was fitted as a polynomial. To select for the 
appropriate polynomial order for age, ANOVA analyses were conducted (a) for the 
SICCT and (b) for the da, where the herd, the test year, the test month, and the 
interaction between the test year and month were fitted as factors, and the age was 
fitted as a polynomial. Using the Akaike Information Criterion (AIC) the second 
order polynomial was selected for age in the da model. For consistency, the second 
order polynomial was also used for the SICCT model, despite the linear term 
appearing sufficient for SICCT based on AIC (Table 2).  
Furthermore, variations in (a) were explored. Firstly, smoothing splines for 
age were fitted following model 2 below: 
   m  + f (ag e) W  Z          1 X h u ey  (2) 
where y is the response variable (i.e. SICCT, da or db), m is the overall mean, 
1 is a vector of ones, β is the vector of fixed effects, f (age) is a cubic spline with 
smoothing parameter calculated using ASReml and included in the random effects in 
ASReml, h is the vector of the interaction term of herd, date of breakdown and 
lactation group fitted as a random effect with h ~ MVN (0, Iσh
2) and u is the vector 
of random sire effects with u ~ MVN (0, Aσs
2), X, W and Z are the incidence 
matrices, and e is the residual error with e ~ MVN (0, Iσe




the test in days starting from a reference date (the minimum test year i.e. 2002), and 
calculated as tyrd=(tyr-2002)*365, was fitted as a covariate replacing the test year. 
For a detailed presentation of the models used see Appendix 6.1a.  
(b) Secondly, the analysis was repeated on the 130,599 records retained after 
data cleaning (section 6.2.1.2). Heritability estimates were obtained for the four 
derived traits SICCT, logSICCT, da and db. Further, in addition to the interaction 
term, the seasonality effect was also taken into account by calculating the “day 
within year” as season=((tmn - 1)30 + tday) and including that in the fixed effects as 
a covariate.  
As described above, LOESS analysis for the reactors showed a distinct 
pattern for animals younger than 3 years, deriving from db (bovine tuberculin) (Fig. 
5). Therefore, and in order to assess the effect of age, three contemporary age groups 
were distinguished as follows: Group 1: age≤ 750d, Group 2: age > 750d & age ≤ 
1100d, and Group 3: age > 1100d) (Table 3). These age groups approximately 
correspond to different management groups for a ~25 months average age at first 
calving, and a voluntary waiting period of ~50 days, plus ~30 days until second 
successful conception (age at second calving ~1100 days). A new composite variable 
with the contemporary age group was fitted as a random effect (i.e. interaction of 
herd, date of breakdown and contemporary age group) which replaced the interaction 
of herd, date of breakdown and lactation group previously fitted as a random effect 




6.2.2.2 Comprehensive analysis 
This analysis was conducted on the 130,599 records retained after data 
cleaning. Heritability estimates were obtained in ASReml for the four derived traits 
SICCT, logSICCT, da and db. The herd and the interaction between test year and test 
month were fitted as fixed effects. The “season” term was not considered in the 
model as it is likely to be redundant since the interaction term between the year of 
the test and month of the test already captures seasonality. Age was fitted as a second 
order polynomial and the breakdown within herd was included as a covariate. The 
interaction of herd, date of breakdown and contemporary age group as described in 
6.2.2.1 (b), and the effect of sires were fitted as random effects. Pedigree was used to 
account for relationships between sires and heritability for the sire models was 
calculated as previously. The general form of the models used was as in model (1) 
(for a detailed description of the models see Appendix 6.2). Further, analyses were 
repeated after additionally fitting a smoothing spline for age as in model (2) (see 
Appendix 6.2). 
A hypothesis of interest is that the heritability that we detect is in part due to 
the health status classification of the individual (i.e. if it is a reactor or not) and it 
does not entirely correspond to genetic variation controlling response to the test. 
Therefore, in order to investigate the impact on the heritability after removing the 
resistance (R) component, the health status (S) was additionally fitted as a fixed 
effect having two levels: S=1 if SICCT>4 (i.e. for the Rs), and S=0 if SICCT≤4 (i.e. 




6.2.2.3 Across-ages analyses 
The aim of this analysis was to investigate the impacts of age on the 
heritability of the traits of interest and test whether the heritability estimates change 
with age.  Following the three different age-groups observed (see 6.2.2.1 (b)), the 
data was subdivided by age in three subsets (Table 3), each subset containing only 
records of animals of age corresponding to that age-group. Heritability analyses were 
conducted in ASReml following the sire models described above, for SICCT, 
logSICCT, da and db, within each of the three age-groups. Furthermore, the analysis 
was repeated as a series of bivariate analyses between the different age-groups in 
order to obtain genetic correlations for the SICCT in the different age-groups. 
Subsequently, the health status was additionally fitted as a fixed effect, as 
described in 6.2.2.2. As ASReml did not reach convergence, an alternative approach 
was followed to obtain correlations between the different age-groups using the EBVs 
for the sires obtained from the univariate analyses within each age-group and 
following the same model. This approach provides only approximate values for the 
genetic correlations as these EBVS are shrunk depending on the amount of 
information available for each sire, i.e. its reliability, and the less information is 
available the more the correlations obtained will be influenced by the environmental 
variance. 
6.2.2.4 First records analyses 
 The aim of this approach was to obtain heritability estimates for a1, b1, and 




and retaining in the data only the first record for the animals that had repeated 
measurements. 
(a) The first record was identified for each animal using the exact test date in 
days from a reference date (the earliest date observed in the data i.e. 14.10.2002), 
taking into account the leap years and the exact number of days in each month. The 
constructed dataset comprised 117,342 records. Moreover, the breakdowns were re-
numbered continuously across herds (728 new breakdowns) and the new breakdown 
describing every new mini epidemic was fitted as a fixed effect. The exact test date 
as described above and the age were fitted as cubic splines, and the sire was fitted as 
a random effect, as follows: 
1 2   m  + f (age) f (date) Z           1 X u ey  (3) 
where y is the response variable (i.e. SICCT, da or db), m is the overall mean, 
1 is a vector of ones, β is the vector of fixed effects,  f1 (age) is a cubic spline for age 
and f2(date) is a cubic spline for the test date with smoothing parameters calculated 
using ASReml and included in the random effects in ASReml, u is the vector of 
random sire effects with u ~ MVN (0, Aσs
2), X and Z are the incidence matrices, and 
e is the residual error with e ~ MVN (0, Iσe
2). The splines used were either with 50 or 
with 100 knots. These analyses were repeated after additionally fitting the health 
status as a factor with two levels (see Appendix 6.3a). 
(b) In the second part of this approach the dataset was further reduced to 
contain only the first known test within each of the new breakdowns and ignoring 
later tests. 88,932 records were retained in this analysis. This removed any 




age, had indicated some cryptic structure in repeated tests giving unreasonable 
results for the effect of date on SICCT values (Fig. 8). The new breakdown was fitted 
as a fixed effect and a smoothing spline was fitted for age. The sire was fitted as a 
random effect. The sire models were fitted for a1, b1, da, db, and SICCT as follows 
(see Appendix 6.3b): 
   m  + f ( age) Z         1 X u ey  (4) 
where y is the response variable (i.e. SICCT, da or db), m is the overall mean, 
1 is a vector of ones, β is the vector of fixed effects, f (age) is a cubic spline for age 
with smoothing parameters calculated using ASReml and included in the random 
effects in ASReml, u is the vectors of random sire effects with u ~ MVN (0, Aσs
2), 
X, V, and Z are the incidence matrices, and e is the residual error with e ~ MVN (0, 
Iσe
2). The analysis was repeated after removing the reactors after the standard 
interpretation (i.e. SICCT>4). This left 87,671 records and the same models as 
described above were fitted in ASReml. Lastly, these analyses were repeated after 
removing the reactors under the severe interpretation (i.e. SICCT>2). 86, 893 records 
were retained in the analysis.  
Further, bivariate analyses were conducted between a1 and b1, a1 and a2, b1 
and b2, da and db. Phenotypic, genetic and environmental correlations were obtained 
as well as regression slopes of b1 on a1, a2 on a1, b2 on b1, and db on da. 
Additionally, the analysis on the first known test within each of the new 
breakdowns, was conducted within each of the three age-groups as defined above, 
following model (4). A multivariate analysis was conducted to obtain genetic 




Lastly, a bivariate analysis was conducted between the health status under the 
standard interpretation and SICCT to obtain a genetic correlation between the SICCT 
outcome and the healthy state (i.e. NRs and IRs).  In this analysis the animals 
classified as reactors under the standard interpretation are treated as with missing 
SICCT measurement, while the non-reactors and the inconclusive reactors had their 
corresponding SICCT value. Further, this analysis was repeated after additionally 
removing records of SICCT <-4. This left 86,041 records in the analysis.  
6.2.2.5 Supplementary analysis 
The SICCT data calculated as described above, was analysed using an 
alternative approach. Following the model proposed by Hinger et al. (2008), two 
variables were created out of SICCT: QPOS and QNEG. In the QPOS variable the 
inconclusive reactors were included in the reactors (i.e. QPOS: <1mm  NR, and ≥ 
1 mm  R), while in the QNEG the IR were considered to be negative (i.e. QNEG: 
≤4mm  NR and > 4 mm  R). 
ASReml analyses were conducted either using a linear model for the SICCT, 
the QPOS (‘TB status’ as a binary trait) and QNEG (‘TB status’ as a binary trait), or 
using a threshold model and the logit link function for QPOS and QNEG. For all the 
approaches a sire model was used and tested either including relationship among 
sires or without considering relationship among sires. Age was fitted as a 
polynomial, the breakdown was fitted as fixed effect, the herd, test year, test month 
and test year by test month interaction were fitted as fixed effects, and the herd by 





For the linear models, h2 on the observed scale (ho
2) was calculated using 
ASReml and then transformed to the liability scale using the formula hL
2=ho
2 p(1-
p)/z2, with z=pi (Robertson and Lerner 1949) where i is the mean deviation of 
individuals with values exceeding T and p is the prevalence defined as the proportion 
of infected animals in the sample. 
6.3 Results 
6.3.1 Preliminary analysis 
Variance components and heritability estimates obtained from the different 
models used are presented in Table 4a. Heritabilities of SICCT were always less than 
0.1. Fitting a spline for age removed some of the variance explained by the sire 
component for the SICCT and for the da models, resulting in reducing the total 
genetic variance explained (Table 4a, SICCT (c) and (d), da (b)). The genetic 
variance for the db model was 0.186 (SE=0.029) and was larger than the genetic 
variance from all the SICCT models.  
Variance components and heritability estimates obtained from the analysis 
following the additional cleaning of the data are presented in Table 4b. The 
heritability estimates obtained following data cleaning were slightly increased. The 
change in the heritability of db was greater compared to the other traits primarily due 
to an increase in σA
2. For SICCT and da, the changes in the estimates were within the 




6.3.2 Comprehensive analysis 
Variance components and heritability estimates obtained from the different 
models used are presented in Table 5a. These findings are in close agreement with 
the results from previous analysis reported in SE3042 (2012). The estimates 
corresponding to the heritability of the response to the test were very low, 
nevertheless detectable in data of this size. 
When adding the observed health status as a fixed effect, which aims to 
remove the resistance component and thus may be closer to analysing the properties 
of the skin test, the heritability estimates for SICCT and db were reduced with both 
the genetic and the phenotypic variances being reduced. The heritability of da 
remained practically unchanged suggesting that the resistance component does not 
influence the measurements concerning reaction to the avian tuberculin. 
Fitting a spline for age slightly reduced the heritability estimates obtained for 
all the traits (Table 5b). Similarly to what was observed above, accounting for the 
health status provided substantially lower heritability estimates for SICCT and db 
(Tables 5a and b, lower parts of the tables).  
6.3.3 Across-ages analysis 
ASReml heritability estimates for each of the three age-groups are presented 
in Tables 6a, 6b, and 6c. Heritability estimates for SICCT and db were increased for 
age-group 2 compared to age-group 1 or age-group 3 (Fig. 7). However, all the 
heritability estimates are very low and differences between the age-groups need to be 




second age-group compared to the third age-group, while db seemed to follow a 
similar pattern being more heritable in the second age-group compared to the first 
and third age-groups.  The da follows a different pattern, being more heritable in the 
first age-group, nevertheless providing more similar heritability estimates across all 
the age-groups. Heritability estimates for the SICCT and logSICCT followed similar 
patterns, with estimates for the log-transformed data being relatively inflated. 
Although a1 and b1 were highly heritable for young animals, their heritabilities 
reduced in the second and third age-groups. Similarly to what was observed in the 
comprehensive analysis of the full dataset, all heritability estimates obtained were 
reduced when the health status was fitted as a fixed effect.  
Between the first and the second age-group, a genetic correlation of 0.43 (SE 
=0.17) was observed, while the third age-group had low genetic correlation with any 
of the other two groups (Tables 7a and 7b). Despite the volume of data, large 
standard errors are observed due to the low magnitude of the estimates of the 
heritabilities. When accounting for the health status, ASReml did not reach 
convergence and therefore, the correlations were obtained from the sire EBVs (Table 
8). These correlations were larger than when not taking the health status into account 
(Tables 7a and 7b), however, the EBVs correlations only approximate the underlying 
genetic correlations.  
6.3.4 First records analysis 
(a) Analysis after retaining only the first record for each animal provided the 
estimates presented in Table 9, and the shape of the fitted values for the splines for 




increased heritabilities compared to those obtained from analyses including the 
repeated records, however, the differences observed in the estimates were not 
significant given their standard errors, and all the estimates for SICCT were <0.1. 
Heritability estimates for a1 and b1 show that the skin thickness per se is a highly 
heritable trait (estimates in agreement with SE3042), with estimates for a1 and b1 
being very similar. The heritability estimate for the db was higher compared to the 
estimate for the da. This db heritability includes the presence of genetic variance 
underlying bTB susceptibility and it would be expected to be captured by this model 
which does not take into account the health status and thus db heritability is 
estimated from data also containing truly infected individuals.  
The models where the health status was additionally fitted as a fixed effect 
provided reduced heritability estimates for SICCT and db. However, taking the health 
status into account had no effect on a1 or b1, in agreement with the expectation as a1 
or b1 are independent from infection. Further, fitting the health status had very little 
impact on da. 
(b) Analysis after retaining only the first known test within each of the new 
breakdowns provided the estimates presented in Table 10. The results from the 
bivariate analyses between a1 and b1, a1 and a2, b1 and b2, da and db, can be seen in 
Table 13. The variances obtained in the bivariate analyses were similar to the 
estimates from the univariate analyses. The SICCT heritability was similar to 
previous estimates from analysis on the full dataset, and db provided an estimate 
similar to da as from analysis on full data. In the bivariate analyses a1 and b1 were 




After removing the reactors under the standard interpretation, the estimates 
obtained from univariate and bivariate analyses are presented in Tables 11 and 14 
respectively. Removing Rs had no impact on a1 or b1, and no impact on da. The 
heritability of the SICCT was slightly increased, while the heritability of db was 
slightly reduced compared to before removing reactors, but these differences were 
within the range of the standard errors of the estimates. Removing the reactors 
slightly increased the genetic correlations between a1 and a2, and b1 and b2. 
However, from the likelihood profile for the bivariate analysis of b1 and b2, it can be 
observed that the support interval for the genetic correlation is 0.93-0.98, which is 
very high, but excludes a genetic correlation of 1.     
Results after removing the reactors under the severe interpretation, for 
univariate and bivariate analyses are presented in Tables 12 and 15.  The heritability 
of SICCT was slightly increased and the heritability of db was slightly reduced, with 
the differences observed being within the range of their standard errors. The 
estimates for a1, b1, and da remained practically unchanged. The genetic correlation 
between a1 and a2 increased to 1. The genetic correlation between b1 and b2 was 
0.97, which is increased, but is within the above support interval. 
The results of the analysis within each of the three age-groups, when using 
the first known test within each of the new breakdowns, are presented in Tables 16a, 
b, and c. The second age-group provided higher heritability estimates for SICCT and 
db but not for the da (Fig. 9). Similar to what was observed in the across-ages 
analyses on all the records (i.e. including repeated records), although a1 and b1 are 
highly heritable in the first age group, the heritability becomes very small in age-




however, by utilising da and db, this change is less important as the genetic variances 
for da and db are more consistent across age-groups.  
The genetic correlations obtained from the multivariate analysis across the 
three age-groups can be found in Table 17. Due to the very low genetic variances, 
this analysis had low power for estimating between-age-groups correlations and the 
ASReml analysis provided a genetic correlation between age-groups 1 and 2 that was 
on the boundary. The log likelihood of this model was -1223.17. Under the null 
hypothesis that SICCT among the different age groups are not genetically correlated, 
the genetic correlations for all three traits was fixed to 0 and the new likelihood was -
1225.16 (LRT=2*(L1-L0)=2*(-1223.17 - (-1225.16)) = 3.98, which is  not 
significantly different than the H0 (X
2=7.815, for 3 d.f. p=0.05). Thus, zero cannot be 
excluded and the correlation between the different age-groups is possible to be zero. 
Conversely, the genetic correlation between all the age-groups was fixed to be 0.99, 
and this model provided a likelihood of -1226.35 and LRT=6.36, again not 
significantly different. These results indicate that for this analysis, there is very little 
information in the data.  
The bivariate analysis between the healthy status and SICCT provided a 
genetic correlation of -0.01(SE = 0.14). This correlation can be interpreted, with 
caution, as the genetic correlation of the SICCT in healthy individuals, with 
susceptibility to disease. The caution arises from the identification of “healthy” with 
not being a standard reactor and reactor status as a measure of disease. This value 
close to zero indicates that the magnitude of response to the SICCT in healthy 
individuals is not genetically correlated with susceptibility to disease. The bivariate 




records with SICCT <-4 provided again a very small genetic correlation with a value 
of 0.07 (SE = 0.16).  
6.3.5 Supplementary analysis 
The results of this analysis can be found in Tables 18 and 19. Estimates of the 
heritability on the observed scale (h2O) and on the liability scale (h
2
L) were provided 
from the ASReml analysis for the linear and the threshold models respectively (Table 
18). For the estimates to be comparable h2O was transformed to the liability scale, 
however, h2L was highly dependent on the definition of prevalence used, i.e if it had 
assigned values assumed for the population (p=10% or p=6%) (Table 18), if it was 
the proportion of reactors in the entire sample (pSICCT), or if the apparent p was used 
(i.e. QPOS and QNEG specific p, as whether the IRs are considered to be bTB 
negative or positive changes the prevalence, with pQNEG=pSICCT) (Table 19). 
QPOS and QNEG categorisations provided very different h2L estimates from 
the linear models depending on the assumed population prevalence. This difference 
was smaller when the apparent p was used. Comparing threshold models and linear 
models for the binary traits (i.e. QPOS and QNEG), the threshold model for QPOS 
provided lower estimates than the linear model, while for QNEG the threshold model 
provided greater estimates than the linear model. For the binary QPOS and QNEG, 
the sire models including relationships between sires provided greater estimates 
compared to sire models without relationships between sires, as it has been 
previously observed in the analysis by Hinger et al. (2008) on Paratuberculosis data. 




considered as a linear trait, were generally lower than the estimates when it was 
considered as a binary trait (QPOS or QNEG). 
6.4 Discussion 
6.4.1 The genetics of SICCT  
For a bTB control strategy based on genetics and informed at least in part from the 
SICCT, one of the critical questions arising is what the likely impacts of such 
selection would be on the SICCT itself. In other words, when selecting for 
genetically bTB resistant animals based on the SICCT, a danger might be the 
unintentional selection for animals that respond less to the SICCT. This ambiguity 
haunts decision makers when it comes to bTB control. Therefore, understanding the 
genetic control of the response to the SICCT is crucial in designing a bTB control 
strategy. The extent to which genetics control the SICCT outcomes can be 
investigated through its heritability. In the present study, the genetics of SICCT were 
explored through the systematic modelling of SICCT data and through conducting a 
thorough variance component analysis on the SICCT itself. For this purpose, 
extensive field data was utilised collected during bTB breakdowns across UK herds. 
6.4.1.1 Development of models 
In this Chapter, alternative models were tested sequentially for the SICCT and 
its components da, db, a1, b1, a2, and b2. Initially, the interaction of herd, date of 
breakdown and contemporary age group was fitted as a random effect 
(Comprehensive analysis and Preliminary analysis). However, the herds might be 




systematic way. These systematic differences can be for example the geographic 
location of the herd or management differences e.g. the grazing system or the milk 
yield, which might affect the bTB prevalence in specific herds introducing some 
structure. Given the information available, the exact sources of such structure are 
unknown and thus cannot be directly accounted for. If the herd was fitted as a 
random effect assuming randomly distributed herds, the possibility of such structure 
would be ignored and re-interpreted by terms in the model including genetic terms, 
neglecting the possibility that hidden structure may be confounded to some degree 
with genetics. Therefore, because of the operational importance of the issue and to 
avoid any ambiguity, it was preferred to fit the herd as a fixed effect which allows 
recovering information within herds and avoids making assumptions on the nature of 
the herd differences.  
In later models (First-records analysis), the herd was implied within the “new 
breakdown” variable which considers every breakdown in every herd as a new mini-
epidemic. The “new breakdown” was fitted as a fixed effect to account for 
systematic differences among breakdowns and recover information within 
breakdowns but not between breakdowns.  
The logSICCT provided slightly higher heritability estimates compared to the 
non-transformed SICCT, as the transformation influences the variance. By setting all 
SICCT ≤0 values to 0.1, more weight is applied on the contrast between being a non-
reactor (NR) and being a reactor (IRs and Rs), and thus more emphasis is applied on 




Modelling bTB field data is further challenged by ambiguities in the records, 
such as measurement recording errors. The need for improving the quality of 
readings  and the importance of better consistency across testings  has been 
demonstrated in previous studies (Clegg et al. 2015),  and has been recognised by the 
UK government by introducing quality control in bTB test recording. However, 
given the data currently available, the confidence in some of the conclusions drawn 
reflects the uncertain quality of the data. Reviewing and restructuring the testing and 
recording practices is one of the critical challenges that need to be met in bTB 
control.   
6.4.1.2 The hierarchy of the test 
The heritability of the different components of the test is a source of different 
types of information about the underlying genetics. In the UK, the comparative 
version of the tuberculin test, i.e. the SICCT, has been employed for the surveillance 
of bTB, in the belief that exposure to M. avium sbsp avium can generate false 
positive reactions. Following the studies by Lesslie et al. (1975), the comparative test 
has better specificity compared to its non-comparative equivalent, and thus, 
improved power to identify the true bTB case. However this assertion has not been 
adequately tested. One of the novelties in the present study is that the individual 
components of SICCT, are investigated at the genetic level aiming to provide a better 
understanding of the genetic background of the SICCT. More specifically, the 
hierarchy in the design of SICCT, i.e. going from four individual a1, b1, a2, and b2 
skin thickness measurements, to da=a2-a1 and db=b2-b1 and ultimately SICCT 




but are exposed to M. avium sbsp. avium will be identified as reactors to the test (i.e. 
false positives) and, as it was demonstrated in the present study, this hierarchy is also 
of paramount importance at the genetic level. The interpretation of the genetic 
control of the individual components of the SICCT will be presented in the following 
paragraphs. 
The a1 and b1 provide information on the skin thickness as a trait, and in the 
present study a1 and b1 were found to be highly heritable, as will be discussed below 
in more detail. The a2 and b2 are the skin thickness measurements after inoculation of 
the avian and bovine antigens respectively. Under the polygenic trait assumption, the 
genetic correlation informs on the strength of the relationship between the traits, and 
thus, what fraction of loci they have in common, while the regressions informs on 
how the scale of the response in the one trait relates to the scale of response in the 
second trait.  In the first-records analysis and when the reactors are included, the a1 
and a2 were positively correlated, and had a stronger correlation compared to b1 and 
b2 (Table 13). Removing the reactors increases the genetic correlation between b1 
and b2, making the pattern observed between a1 and a2, and b1 and b2, more similar. 
From the regression of a2 on a1 it can be explored whether a2 depends on a1, and 
similarly for b2 and b1. These regressions were not much greater than 1, which 
demonstrates that da and db are independent to a1 and b1. The “post-bovine antigen 
inoculation” and “post-avium antigen inoculation” are not being scaled by a1 and b1 
i.e. SICCT does not depend on the initial skin thickness. Therefore, whether different 
genetic groups have different genetic variances for a1, becomes less important as a1 




dependence on skin thickness. This is stressing the importance of the hierarchy 
within the SICCT and the value of using a2-a1 and not a2 alone. 
Further insight into the importance of the hierarchy of the test at the genetic 
level, can be gained if we consider the genetic variances captured by each of the 
SICCT components and what these variances represent. If using only a2 and b2, their 
genetic variance would capture the genetic variance of the skin thickness which is a 
highly heritable trait. Therefore including a1 and b1 and calculating da and db makes 
the test more stable with respect to the genetics of the skin thickness. The da and db 
provide information on the genetics of the responsiveness to the avian and the bovine 
tuberculins, separately from one another. While response to the SICCT refers to the 
magnitude of the SICCT outcome, responsiveness to the avian and bovine tuberculins 
captured by the da and db, refers to the ability of the immune system to respond to 
the antigens. For example in humans, reactivity to the non-comparative tuberculin 
skin test and immune response to Mycobacterium tuberculosis antigens with respect 
to IFN-γ, TNAa and antigen-specific cells production, has been shown to be 
moderately to highly heritable (Jepson et al. 2001; Stein et al. 2003; Stein et al. 2005; 
Cobat et al. 2010), while a linkage analysis has identified major loci associated with 
TB skin test reactivity (Cobat et al. 2009), and genetics have been linked to the 
outcome of infection (Stein et al. 2008). Therefore for bTB, using SICCT defined as 
db-da, is crucial not only for reducing the false positive reactions, but also at the 
genetic level. To demonstrate this further, although da and db are highly genetically 
correlated (Tables 13, 14, and 15), they both provided higher heritabilities than the 
SICCT.  By employing db-da, the common genetic part of da and db is removed and 




comparative SICCT is a more stable test compared to a non-comparative equivalent 
at the genetic level. An important outcome is that if selection was based on db alone, 
there would be a greater risk of response to selection compared to the use of SICCT 
because of the higher heritability of db. Therefore, the analysis presented in this 
Chapter, confirmed at the genetic level the wisdom of the hierarchy of SICCT. 
6.4.1.3 The impacts of the health status on SICCT 
In this Chapter, an approach is presented that allows disentangling the 
genetics of bTB resistance from the genetics of response to the SICCT. The skin test 
is simply a measurement (i.e. an indicator trait), and not the trait, thus, as the 
heritability of resistance to bTB (R) is non-zero (h2O=0.23 (SE=0.06), see Chapter 
2), even if the heritability of the skin test itself in infected and uninfected animals 
was truly zero, we would still observe a non-zero heritability for the SICCT as it 
captures part of R.  
This was addressed by fitting the health status as a fixed effect, therefore 
removing the R component from the genetics, which is closer to analysing the 
properties of the skin test. The R component is fitted as a factor with two levels 
corresponding to a healthy or a diseased health status without implying a genetic 
correlation between resistance and the magnitude of the SICCT. Conclusions are 
drawn within the classes of R, however, the genetic parameters of responses to 
SICCT in non-reactors are assumed to be the same as the genetic parameters of 
responses to SICCT in reactors. Additionally, how reliable is the health status needs 
to be considered with respect to the sensitivity of the SICCT. Since the classification 




SICCT, and consequently some of the animals classified as healthy will be false 
negatives. Due to these weaknesses, this approach is a first step in taking into 
account the health status, but may be statistically and biologically naïve, and thus 
needs to be considered in more depth. 
6.4.1.4 The impacts of age at test on the outcome of SICCT 
The consistency of heritability estimates across the identified age-groups was 
examined to test whether the heritability changes with age. The SICCT and the db 
seem to follow a similar pattern being more heritable in the second age-group. This 
could indicate that in older cattle SICCT and db responses are more sensitive to 
management changes and less controlled by genetics. From the genetic correlation of 
SICCT across the different age-groups the likely selection intensity across different 
ages was examined. If SICCT is not genetically correlated between the different age-
groups, then selection intensity arising from culling false positives, is different 
among different age-groups and any unintentional selection is diluted and possibly 
not in the same direction (Table 17). However, this data was not found to have 
enough information for obtaining reliable estimates of genetic correlations across the 
different age-groups.  
In the previous report (DEFRA Evidence Project Final Reports SE3042, 
2012), skin thickness itself was found to be highly heritable. Skin thickness is a 
characteristic that varies between different cattle breeds (Dowling 1955; Dowling 
1963) and has been studied in relation to heat tolerance (Alfonzo et al. 2015) and tick 
resistance (Riek et al. 1962; Marufu et al. 2013), although neither study was 




retaining only the first record for each animal, a1 and b1 were shown to be highly 
heritable in the first age-group, however, the heritability of a1 and b1 was low in age-
groups 2 and 3. This possibly reflects that the skin thickness increases until maturity 
is reached (Dowling 1964). Growth in cattle is a heritable trait, with heritabilities 
varying between different breeds, and with heritability decreasing with increasing 
age (Lin et al. 1985; Groen and Vos 1995; Coffey et al. 2006).  The animals in age-
group 1 are still in development, thus, the rate of increasing their skin thickness is 
controlled by genetics i.e. how early-maturing they are is under genetic control. 
When they reach maturity their skin thickness reflects the breed standard and thus 
their genetic differences are reduced since all the animals in the data are of the same 
breed. Additionally, from the age distribution in the data (Fig. 6a) it becomes 
apparent that the majority of records in this data are from younger animals where the 
phenotypic variance is greater. Furthermore, when breaking down the data into age-
groups, the heritability estimates for a1 and b1 are reduced in age-groups 2 and 3, 
while the heritabilities for a1 and b1 are high in the entire data where the estimates 
are dominated by the most variable group, i.e. age-group 1, which has the highest 
heritability for a1 and b1. Thus, although a1 and b1 estimates change quite 
dramatically over age-groups, using da and db minimises the age-group differences 
as the genetic variances of da and db are less influenced by age and are more 
consistent across age-groups, controlling better for some of this change.  
Lastly, an important environmental confounder that currently is not taken into 
account by SICCT, is the Paratuberculosis status. Paratuberculosis caused by M. 




between Paratuberculosis infection and Paratuberculosis vaccination status, with the 
SICCT might also be time-dependent.  
6.4.2 Comparison with previous report 
 In the previous report (DEFRA Evidence Project Final Reports SE3042, 
2012) there was strong indication that the SICCT has a very low heritability. In 
agreement with those findings, after fitting systematically a series of alternative 
models, the heritability of the skin test SICCT was detectable in data of this size but 
was very low for all the models tested. 
More specifically, when using all the records (see Preliminary analysis 
(Tables 4a and 4b) and Comprehensive analysis (Tables 5a and 5b)), the heritability 
estimates obtained for the SICCT, the da and the db, were very close to the estimates 
presented in SE3042 (2012, Table 2). In addition to what was done in the previous 
report, this analysis considered the likely impact of the presence of repeated records 
for the animals that were not initially classified as reactors, and the presence of 
records from multiple breakdowns, on the heritability estimates. The issues arising 
from the repeated measurements in the data can be dealt with either fitting the 
individual animals as a random effect or removing repeated measurements and 
retaining only the first record for each animal in the data. However, in the present 
data some measurements are repeated after a few weeks and sometimes repeated 
tests might occur after years. Models that attempted to include repeated records 
provided unrealistic time-trends for the mean skin test response (Fig. 8), i.e. a 4mm 




weakness in the models adopted for the repeated records. Therefore, it was preferred 
to remove the repeated records from the data. 
In the first-record analyses, the estimates obtained for the SICCT and 
especially for the db, were higher compared to the estimates from the analyses on the 
entire dataset (Table 9). For the SICCT and the db, having the repeated records in the 
data did not influence the error variance but it provided reduced estimates of the 
genetic variance. A possible explanation for this is that due to the structure of the 
data with only the healthy animals having repeated measurements, the healthy 
individuals get additional weight in the analysis on the full dataset as they are more 
often represented in the data. This results in truncating the distribution and diluting 
the estimates of the genetic variance, as this variance comes from the individuals 
without repeated records (i.e. the identified bTB infected animals). However, after 
keeping only the first test within each breakdown (Table 10), SICCT and db 
heritabilities were reduced with both the error and the genetic variances being 
reduced (Table 10).  
In the first-records analyses removing the reactors slightly increased the 
heritability of SICCT, which can be attributed to the reactors being highly variable in 
this data, and therefore by removing them, a source of considerable variance is 
removed. The heritability increased due to changes in the phenotypic variance i.e. the 
residual variance. For db, the phenotypic variance decreased and consequently also 




6.4.3 SICCT and selection for bTB resistance  
In the present study, response to the SICCT diagnostic test was found to be 
lowly heritable, indicating that any risk of unintentional selection for low response to 
the skin test is very small.  
In a previous study (Amos et al. 2013), a microsatellite marker genotype was 
linked with reduced immunological reaction to tuberculins and was found to be more 
frequent among non-reactor animals, from which the authors concluded that there is 
a genetic predisposition for some animals to pass the standard SICCT although 
infected with bTB, and these animals are selected through the test-and-slaughter 
policy. However, that study was conducted on a mixed population of designated 
breeds and crosses with very small sample sizes for some breeds which would 
substantially reduce the power to detect associations, and the analysis was conducted 
without correcting for population structure which might lead to spurious associations. 
Microsatellite markers are less suitable for association analyses as they are highly 
polymorphic, and unless very dense, they are not likely to have high LD between the 
marker and the causative mutation, which is the basis of any association analysis. 
Especially in a multi breed analysis the same linkage phase across all the breeds 
would be required but it would be highly unlikely to occur unless the causative 
mutation was very close to the marker. Moreover in Amos et al. (2013), the 
phenotypes comprised records of animals that tested negative to the SICCT and thus 
there was no information on animals that were identified as reactors, which would 




The importance of the hierarchy and the comparative structure of the SICCT 
has been highlighted above (section 6.4.1.1), and in the present study the genetics of 
SICCT as well as the genetics of its components da, db, a1, a2, b1, and b2 were 
explored. Although, Amos et al. (2013) modelled the components of SICCT, 
concluding that a certain genotype was associated with da, the SICCT itself was not 
included in the models. As it has been demonstrated in this Chapter, the genetic 
properties of da, db and SICCT differ. To extrapolate from da and db to SICCT, 
evidence on the genetic correlation of da with db is needed. It is only the SICCT that 
captures the comparative test result used for identifying reactors, and the heritability 
of SICCT was found to be very low, and lower than the heritability of db. Thus, the 
likely selection intensity to SICCT is very small, and smaller than the likely selection 
if we were using db alone. 
The specificity of the test is very high, thus the test is removing only a very 
small proportion of healthy animals. Even in the unlikely case that there would be 
some selection pressure on SICCT, given its very low heritability, any response to 
such selection would be weak and highly unlikely to occur within a reasonable time 
period. Further, even if the test was heritable, selection would remove the extremes, 
and thus heritability of SICCT and subsequently response to selection on SICCT 
would further decline.  
In Tsairidou et al. (2014), it was demonstrated the feasibility of genomic 
selection for bTB resistance based on confirmed cases, i.e. diagnosed with bTB 
through the SICCT and with lesions in the abattoir. The greatest impact of genomic 
selection informed by the SICCT will be to reduce the susceptibility of the general 




implementing genetic selection for bTB resistance is unlikely to compromise the 
integrity of the test in the near future. Conceivably over time, some response to 
selection might occur in the response to SICCT and some individuals might be less 
responsive, i.e. might reduce the sensitivity of SICCT as infected animals might be 
less likely to be identified. Individuals carrying genotypes that might give responses 
to SICCT when diseased that are below the threshold for declaring a reactor, already 
exist in the population and already go undetected. Moreover, these genotypes are 
currently open to genetic drift, and chance selection of Holstein bulls carrying these 
genotypes might increase their frequency through drift. Given that at present there is 
no monitoring, there is no ability to assess these effects. Although the risks for 
unintentional selection on the response to SICCT are small, monitoring SICCT while 
conducting selection for bTB resistance, will allow any changes in the magnitude of 
response to be monitored, and if judged beneficial, the classification thresholds of 
SICCT can be adopted appropriately to provide the desired test sensitivity.   
Given the very low heritability of SICCT, any such effects might only be 
observed after a long period of time, when there will already be effects of selecting 
for bTB resistance i.e. the average bTB resistance of the population will have been 
already increased and the bTB prevalence will be much lower. While increasing 
resistance and as the epidemic declines, it will be more difficult to detect bTB using 
SICCT, and bTB infected animals might become more difficult to identify. However, 
by increasing the average population resistance, R0 will be eventually brought below 
1, so the risk of an epidemic will become negligible (Bishop 2010). Genetically 
susceptible cattle that might be more difficult to detect using SICCT, and thus remain 




epidemics that might start, will die out on their own. The issue of the environmental 
reservoir is discussed in the general discussion.  
In the literature, it has been argued that selection using the skin test as a 
threshold for culling standard reactors, may change the properties of SICCT in 
healthy animals (Amos et al. 2013). In the analysis presented in this Chapter, in 
individuals classified as healthy, the magnitude of response to SICCT was not found 
to be genetically correlated with those that pass the threshold. This result indicates 
that selection for individuals less susceptible to bTB is not likely to change the 
magnitude of the response to SICCT in the healthy individuals. However, due to the 
imperfect sensitivity of SICCT, the group of healthy animals also contains the 
animals classified as healthy although they are diseased, i.e. the false negatives. 
Dealing with the imperfect sensitivity of the SICCT is another critical challenge for 
bTB control. 
6.4.4 Conclusion 
The cow’s response to the SICCT skin test was found to be very lowly 
heritable, thus, genetic selection for bTB resistance is unlikely to compromise the 
integrity of the diagnostic test in any reasonable time period. Removing the 
component of resistance to bTB had no impact on a1, b1, or da, but reduced the 
heritability estimates for the SICCT and the db, showing that the estimated 
heritability for SICCT partially captures the component of genetic resistance to bTB 
and thus the true heritability of SICCT itself is even lower. Therefore, any risk of 
unintentional selection for low response to the skin test is very small, and it is the 




contributing to the difficulties in the control of bTB.  Investigation of the impact of 
age on the heritability estimates showed that SICCT and db are more heritable in the 
second age group i.e. cows in their first lactation, while given the information 
available in this data, limited conclusions could be drawn about the genetic 
correlation of SICCT across the different age groups. Lastly, the magnitude of 
response to the SICCT was not found to be genetically correlated with the healthy 
status indicating that selection for individuals less susceptible to bTB is not likely to 
change the magnitude of response to the SICCT in healthy individuals. The hierarchy 





Figure 1. Percentages of the test records during the 1st, 2nd, 3rd and 4th 
breakdown within a herd. 
 
Min Median Mean Max Var SD Mode 
a1 1.00 6.00 6.17 16.00 2.33 1.53 6.00 
a2 0.00 6.00 6.83 50.00 6.31 2.51 6.00 
b1 1.00 6.00 6.19 16.00 2.33 1.53 6.00 
b2 0.00 6.00 6.97 90.00 10.46 3.23 6.00 
da -7.00 0.00 0.66 43.00 3.54 1.88 0.00 
db -7.00 0.00 0.78 81.00 7.53 2.74 0.00 
SICCT -43.00 0.00 0.12 81.00 5.72 2.39 0.00 
 
Table 1. Descriptive statistics for the four skin thickness measurements, 
before (a1 and b1), and after (a2 and b2) inoculation of the tuberculin antigens, 
and for the derived traits da=a2-a1, db=b2-b1, and the skin test SICCT=db-da 

























Figure 3.  Fractions of non-reactors (NR), inconclusive reactors (IR), and 




Figure 4. Distribution of SICCT results (a) before transformation, (b) after 
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Figure 5. Cumulative distribution of the number of daughters per sire for the 






Figure 6.  (a) Age distribution in the data; (b) relationship of SICCT with age 
and fitted line using LOESS for the reactors; (c) relationship of da with age 
and fitted line using LOESS for the reactors; (d) relationship of db with age 
and fitted line using LOESS for the reactors; where reactors are defined 
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Table 2.  AIC results from ANOVA with age fitted as a polynomial of different 




 Group 1 Group 2 Group 3 Total 
 age≤ 750 750 < age ≤ 1100 age > 1100  
# records 40788 18438 71373 130599 
 





  σA2 (SE) σP2 (SE) h2 (SE) 
SICCT (a) 0.070 (0.016) 5.110 (0.020) 0.014 (0.003) 
 (b) 0.064 (0.015) 5.109 (0.020) 0.013 (0.003) 
 (c) 0.059 (0.014) 5.102 (0.020) 0.012 (0.003) 
 (d) 0.061 (0.015) 5.135 (0.020) 0.012 (0.003) 
da (a) 0.138 (0.017) 2.942 (0.012) 0.047 (0.006) 
 (b) 0.088 (0.013) 2.942 (0.012) 0.030 (0.004) 
db  0.186 (0.029) 6.598 (0.026) 0.028 (0.004) 
 
Table 4a. Variance components and heritability estimates from the 
preliminary analysis. The age and breakdown are fitted as covariates; test 
year, test month, test year and test month interaction, and herd are fitted as 
fixed effect; the composite variable with herd, date of breakdown and 
lactation group interaction, and the sire are fitted as random effects. For 
SICCT (b) and da (a) the age is fitted as a second order polynomial. For 
SICCT (c) and (d), da (b), and db, age is fitted using a smoothing spline. For 
SICCT (d), da (b) and db the test year in days has replaced the test year (see 




  σA2 (SE) σP2  (SE) h2 (SE) 
SICCT (a) 0.074 (0.016) 5.001 (0.020) 0.015 (0.003) 
 (b) 0.076 (0.016) 5.034 (0.020) 0.015 (0.003) 
logSICCT  0.011 (0.001) 0.137 (0.001) 0.081 (0.008) 
da  0.121 (0.015) 2.875 (0.012) 0.042 (0.005) 
db  0.414 (0.046) 6.472 (0.027) 0.064 (0.007) 
 
Table 4b. Variance components and heritability estimates obtained from 
preliminary analysis following the additional cleaning of the data (section 
6.2.1.2).  The age and breakdown are fitted as covariates; test year, test 
month, test year and test month interaction, the herd, and the season are 
fitted as fixed effects; Herd by date of breakdown by age group interaction, 
and sire are fitted as random effects. For SICCT (b) the test year in days is 
fitted in the model. For da the age is fitted as a second order polynomial (see 





 σA2 (SE) σP2   (SE) h2 (SE) 
SICCT 0.067 (0.015) 4.998 (0.020) 0.013 (0.003) 
logSICCT 0.009 (0.001) 0.137 (0.001) 0.064 (0.007) 
da 0.122 (0.015) 2.875 (0.012) 0.042 (0.006) 
db 0.323 (0.040) 6.442 (0.026) 0.050 (0.006) 
SICCT 0.009 (0.004) 2.728 (0.011) 0.003 (0.001) 
logSICCT 0.001 (0.000) 0.069 (0.000) 0.015 (0.003) 
da 0.107 (0.014) 2.831 (0.011) 0.038 (0.005) 
db 0.057 (0.011) 3.484 (0.014) 0.016 (0.003) 
 
Table 5a. Variance components and heritability estimates from the 
comprehensive analysis. Age was fitted as a polynomial; breakdown was 
fitted as a covariate; test year by test month interaction and herd were fitted 
as fixed effects; herd by date of breakdown by age group interaction and sire 
were fitted as random effects. For the lower part of the table the health status 
was additionally fitted as a fixed effect (see Appendix 6.2).  
 
 σA2 (SE) σP2    (SE) h2 (SE) 
SICCT 0.060 (0.014) 4.993 (0.020) 0.012 (0.003) 
logSICCT 0.007 (0.001) 0.136 (0.001) 0.050 (0.006) 
da 0.092 (0.013) 2.853 (0.011) 0.032 (0.005) 
db 0.218 (0.032) 6.390 (0.026) 0.034 (0.005) 
SICCT 0.009 (0.004) 2.727 (0.011) 0.003 (0.001) 
logSICCT 0.001 (0.000) 0.068 (0.000) 0.012 (0.003) 
da 0.082 (0.012) 2.811 (0.011) 0.029 (0.004) 
db 0.037 (0.009) 3.466 (0.014) 0.011 (0.003) 
 
Table 5b. Variance components and heritability estimates obtained from the 
comprehensive analysis after fitting a smoothing spline for age. For the lower 




 σA2 (SE) σP2     (SE) h2 (SE) 
SICCT 0.155 (0.036) 4.178 (0.030) 0.037 (0.009) 
logSICCT 0.004 (0.001) 0.055 (0.000) 0.077 (0.013) 
da 0.091 (0.019) 1.806 (0.013) 0.050 (0.010) 
db 0.166 (0.037) 4.624 (0.033) 0.036 (0.008) 
a1 1.154 (0.070) 1.503 (0.019) 0.768 (0.038) 
b1 1.202 (0.072) 1.540 (0.019) 0.780 (0.038) 
SICCT 0.000 (0.005) 2.200 (0.016) 0.000 (0.002) 
logSICCT 0.000 (0.000) 0.016 (0.000) 0.011 (0.005) 
da 0.086 (0.018) 1.765 (0.013) 0.049 (0.010) 
db 0.012 (0.007) 2.050 (0.014) 0.006 (0.003) 
 
Table 6a. ASReml heritability analysis for age-group 1. The models used are 
the same as described in the comprehensive analysis (see Appendix 6.2). 
For the lower part of the table health status is additionally fitted as a fixed 
effect. 
  
 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.426 (0.108) 5.291 (0.058) 0.081 (0.020) 
logSICCT 0.016 (0.004) 0.149 (0.002) 0.110 (0.023) 
da 0.114 (0.046) 3.207 (0.035) 0.036 (0.014) 
db 1.193 (0.222) 6.991 (0.083) 0.171 (0.031) 
a1 0.143 (0.027) 1.052 (0.012) 0.136 (0.025) 
b1 0.126 (0.026) 1.092 (0.012) 0.116 (0.023) 
SICCT 0.016 (0.019) 2.702 (0.029) 0.006 (0.007) 
logSICCT 0.002 (0.001) 0.073 (0.001) 0.026 (0.011) 
da 0.095 (0.042) 3.151 (0.034) 0.030 (0.013) 
db 0.058 (0.035) 3.502 (0.037 0.016 (0.010) 
 
Table 6b. ASReml heritability analysis for age-group 2. The models used are 
the same as described in the comprehensive analysis (see Appendix 6.2). 





 σA2 (SE) σP2  (SE) h2 (SE) 
SICCT 0.045 (0.017) 5.266 (0.028) 0.009 (0.003) 
logSICCT 0.004 (0.001) 0.170 (0.001) 0.023 (0.005) 
da 0.109 (0.019) 3.271 (0.018) 0.033 (0.006) 
db 0.161 (0.036) 6.941 (0.037) 0.023 (0.005) 
a1 0.068 (0.008) 0.944 (0.005) 0.072 (0.009) 
b1 0.072 (0.009) 0.956 (0.005) 0.075 (0.009) 
SICCT 0.006 (0.005) 2.896 (0.015) 0.002 (0.002) 
logSICCT 0.001 (0.000) 0.094 (0.000) 0.008 (0.003) 
da 0.106 (0.019) 3.239 (0.017) 0.033 (0.006) 
db 0.059 (0.016) 3.980 (0.021) 0.015 (0.004) 
 
Table 6c. ASReml heritability analysis for age-group 3. The models used are 
the same as described in the comprehensive analysis (see Appendix 6.2). 






Figure 7. Genomic heritability estimates for each of the three age-groups, 
corresponding to each of the models tested. The vertical bars represent the 
SE. The (S) denotes that for those models the health status was additionally 
fitted as a fixed effect.  
 
CorG Group 1 Group 2 Group 3 
Group 1 1 0.43 (0.17) -0.19 (0.25) 
Group 2 0.43 (0.17) 1  0.27 (0.24) 
Group 3 -0.19 (0.25) 0.27 (0.24) 1 
 
Table 7a. Genetic correlations obtained between the three age-groups from 






 Group 1 Group 2 Group 3 
SICCT1 SICCT2 0.036 (0.008) 0.082 (0.020) - 
SICCT2 SICCT3 - 0.083 (0.020) 0.009 (0.003) 
SICCT1 SICCT3 0.036 (0.009) - 0.009 (0.003) 
 
Table 7b. Genomic heritability estimates from the bivariate analyses for each 
of the age-groups, where SICCT1, SICCT2 and SICCT3 are the SICCT values 
within age-group 1, age-group 2, and age-group 3 respectively. 
 
 
CorG EBV 1 EBV 2 EBV 3 
EBV 1 1 0.61 0.11 
EBV 2 0.61 1 0.41 
EBV 3 0.11 0.41 1 
 
Table 8. Approximate genetic correlations calculated from the EBVs for each 




  σA2 (SE) σP2   (SE) h2 (SE) 
SICCT (a) 0.198 (0.030) 5.146 (0.022) 0.039 (0.006) 
 (b) 0.196 (0.029) 5.121 (0.022) 0.038 (0.006) 
a1  0.664 (0.028) 1.312 (0.008) 0.506 (0.019) 
b1  0.680 (0.029) 1.339 (0.008) 0.508 (0.019) 
da  0.215 (0.023) 3.019 (0.013) 0.071 (0.007) 
db  0.911 (0.075) 6.762 (0.031) 0.135 (0.011) 
SICCT  0.014 (0.005) 2.772 (0.011) 0.005 (0.002) 
a1  0.664 (0.028) 1.312 (0.008) 0.506 (0.019) 
b1  0.680 (0.029) 1.338 (0.008) 0.508 (0.019) 
da  0.181 (0.020) 2.966 (0.013) 0.061 (0.007) 
db  0.136 (0.020) 3.572 (0.015) 0.038 (0.006) 
  
Table 9.  Heritability estimates and variance components from the first-
records analyses. Age is fitted as a covariate, test date and the new 
breakdown are fitted as fixed effects. Smoothing splines are fitted for age 
(with 50 knots in (a) and 100 knots in (b)), and for test date. The sire is fitted 
as a random effect. For the lower part of the table the health status was 






Figure 8. Fitted cubic smoothing splines for age vs. the predicted value from 
the ASReml analysis with (a) 50, and (b) 100 knot points. Smoothing spline 






 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.038 (0.012) 3.645 (0.017) 0.010 (0.003) 
a1 0.540 (0.026) 1.105 (0.008) 0.489 (0.021) 
b1 0.557 (0.027) 1.128 (0.008) 0.493 (0.021) 
da 0.155 (0.020) 2.759 (0.013) 0.056 (0.007) 
db 0.257 (0.035) 4.349 (0.021) 0.059 (0.008) 
 
Table 10. Heritability estimates after retaining only the first known test within 
each new breakdown (see Appendix 6.3b). New breakdown is fitted as a 
fixed effect, age is fitted using a smoothing spline, and sire is fitted as a 
random effect.   
 
 
 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.029 (0.006) 1.414 (0.007) 0.020 (0.004) 
a1 0.544 (0.026) 1.103 (0.008) 0.493 (0.021) 
b1 0.562 (0.027) 1.128 (0.008) 0.498 (0.022) 
da 0.132 (0.018) 2.628 (0.013) 0.050 (0.007) 
db 0.060 (0.009) 1.407 (0.007) 0.043 (0.006) 
 
Table 11. Heritability estimates after retaining only the first known test within 
each new breakdown (see Appendix 6.3b) and after removing the reactors 




 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.032 (0.006) 1.306 (0.006) 0.025 (0.005) 
a1 0.549 (0.027) 1.102 (0.008) 0.498 (0.022) 
b1 0.566 (0.027) 1.126 (0.008) 0.502 (0.022) 
da 0.116 (0.017) 2.555 (0.013) 0.045 (0.006) 
db 0.043 (0.007) 1.069 (0.005) 0.040 (0.006) 
 
Table 12.  Heritability estimates after retaining only the first known test within 
each new breakdown (see Appendix 6.3b) and after removing the reactors 
































































Table 13.  Results from the first-records bivariate analysis after retaining only 




































































Table 14. Results from the first-records bivariate analysis after retaining only 
the first known test within each new breakdown and after removing the 
reactors under the standard interpretation. 
 



























































Table 15.  Results from the first-records bivariate analysis after retaining only 
the first known test within each new breakdown and after removing the 





 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.005 (0.013) 2.983 (0.027) 0.002 (0.004) 
a1 0.742 (0.058) 1.156 (0.016) 0.642 (0.043) 
b1 0.817 (0.061) 1.194 (0.017) 0.684 (0.044) 
da 0.095 (0.025) 1.964 (0.018) 0.048 (0.013) 
db 0.030 (0.016 2.893 (0.026) 0.010 (0.005) 
 
Table 16a. Heritability analysis on the first known test within each new 
breakdown for age-group 1.  
 
 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.077 (0.056) 4.145 (0.054) 0.019 (0.014) 
a1 0.089 (0.022) 0.938 (0.013) 0.095 (0.023) 
b1 0.071 (0.020) 0.969 (0.013) 0.073 (0.020) 
da 0.039 (0.037) 2.882 (0.038) 0.013 (0.013) 
db 0.157 (0.079) 4.728 (0.062) 0.033 (0.017) 
 
Table 16b. Heritability analysis on the first known test within each new 
breakdown for age-group 2. 
 
 σA2 (SE) σP2 (SE) h2 (SE) 
SICCT 0.053 (0.018) 3.660 (0.023) 0.015 (0.005) 
a1 0.074 (0.010) 0.853 (0.006) 0.087 (0.011) 
b1 0.082 (0.010) 0.867 (0.006) 0.094 (0.012) 
da 0.096 (0.020) 2.941 (0.019) 0.033 (0.007) 
db 0.115 (0.031) 4.652 (0.029) 0.025 (0.007) 
 
Table 16c. Heritability analysis on the first known test within each new 






CorG Group 1 Group 2 Group 3 
Group 1 1 0.999   (B) -0.643 
Group 2 0.999   (B) 1 -0.329 
Group 3 -0.643 -0.329 1 
 
Table 17. Genetic correlations for SICCT across the different age-groups 
from the multivariate analysis, where in the parentheses are reported the 
approximate standard errors of the estimates and B indicates that the 




Figure 9. Genomic heritability estimates for the SICCT, da and db, from the 
analysis on the first known test within each of the new breakdowns, for each of 











Age Group 1: ≤ 750d
Age Group 2: >750d & ≤1100d





Model Pedigree σA2  SE σP2 SE hO2 SE hL2 (p=10%) h2L (p=6%) SE 
LM SICCT No 0.086 0.016 5.109 0.020 0.017 0.003 0.049 0.067 - 
LM SICCT Yes 0.064 0.015 5.109 0.020 0.013 0.003 0.037 0.050 - 
LM QPOS No 0.003 0.000 0.056 0.000 0.052 0.006 0.153 0.208 - 
LM QPOS Yes 0.003 0.000 0.056 0.000 0.058 0.007 0.169 0.230 - 
LM QNEG No 0.000 0.000 0.021 0.000 0.021 0.004 0.060 0.082 - 
LM QNEG Yes 0.000 0.000 0.021 0.000 0.021 0.004 0.060 0.082 - 
TM QPOS No 0.439 0.065 3.410 0.016 - - 0.129 0.019 
TM QPOS Yes 0.470 0.075 3.417 0.019 - - 0.137 0.021 
TM QNEG No 0.569 0.120 3.442 0.030 - - 0.165 0.033 
TM QNEG yes 0.583 0.131 3.446 0.033 - - 0.169 0.036 
 
Table 18. The additive variance, phenotypic variance and heritability estimates on the observed and liability scale for the 
different models used, using two different values for the assumed population prevalence (Supplementary analysis). In the 
Table, LM and TM represent the linear and the threshold (logit link function) models used, where for the threshold model σA2 
is the additive genetic variance on the liability scale. hL2 is calculated using the assumed population prevalence p=10% or 





Model Pedigree hO2 Apparent p i hL2 
1 LM SICCT No 0.017 0.023 2.386 0.125 
2 LM SICCT Yes 0.013 0.023 2.386 0.094 
3 LM QPOS No 0.052 0.069 1.918 0.192 
4 LM QPOS Yes 0.058 0.069 1.918 0.212 
5 LM QNEG No 0.021 0.023 2.386 0.154 
6 LM QNEG Yes 0.021 0.023 2.386 0.154 
 
Table 19. Heritability estimates on the observed and liability scale for the different models used, using the apparent 






Preliminary analysis  
(a) ASReml models used in the preliminary analysis on all 130,626 records 
(Table 4a). 
1) SICCT ~ mu age outbreak tyr tmn tyr.tmn herd !r herd_breakdate_lact sire 
2) SICCT ~ mu pol(age,2) outbreak tyr tmn tyr.tmn herd !r herd_breakdate_lact sire 
3) da ~ mu pol(age,2) outbreak tyr tmn tyr.tmn herd !r herd_breakdate_lact sire 
4) SICCT ~ mu age outbreak tyr tmn tyr.tmn herd !r herd_breakdate_lact sire spl(age) 
5) SICCT ~ mu age outbreak tyrd tmn tyrd.tmn herd !r herd_breakdate_lact sire spl(age) 
6) da ~ mu age outbreak tyrd tmn !r herd_breakdate_lact sire spl(age) 
7) db ~ mu age outbreak tyrd tmn !r herd_breakdate_lact sire spl(age) 
 
(b) ASReml models used in the preliminary analysis on the 130,599 records 
retained after data cleaning (Table 4b).  
1) SICCT ~ mu age outbreak tyr tmn tyr.tmn herd season !r herd_breakdate_group sire 
2) SICCT ~ mu age outbreak tyrd tmn tyrd.tmn herd season !r herd_breakdate_group sire 
3) logSICCT ~ mu age outbreak tyr tmn tyr.tmn herd season !r herd_breakdate_group sire 
4) da ~ mu pol(age,2) outbreak tyr tmn tyr.tmn herd season !r herd_breakdate_group sire 






(a) ASReml models used in the comprehensive analysis (Table 5a).  
(1) SICCT ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire 
(2) logSICCT ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire 
(3) da ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire 
(4) db ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire  
 
 
(b) ASReml models used in the comprehensive analysis after additionally 
fitting the health status (“S”) as a fixed effect (Table 5a).  
(5) SICCT ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire 
(6) logSICCT ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire 
(7) da ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire 
(8) db ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire 
 
(c) ASReml models used in the comprehensive analysis after fitting a 
smoothing spline for age as a random effect (Table 5b).  
1) SICCT ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire spl(age) 
2) logSICCT ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire spl(age) 
3) da ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire spl(age) 
4) db ~ mu pol(age,2) outbreak tyr.tmn herd !r herd_breakdate_group sire spl(age) 
 
5) SICCT ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire spl(age) 
6) logSICCT ~ mu pol(age,2) outbreak tyr.tmn herd S !r 
herd_breakdate_group sire spl(age) 
7) da ~ mu pol(age,2) outbreak tyr.tmn herd S !r herd_breakdate_group sire spl(age) 






First records analysis 
(a) ASReml models used in the first-records analysis (Table 9). 
 
1) SICCT ~ mu age tdate !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
1b)  SICCT ~ mu age tdate !r sire spl(age,100) spl(tdate,100) !f newoutbreak 
2) a1 ~ mu age tdate !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
3) b1 ~ mu age tdate !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
4) da ~ mu age tdate !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
5) db ~ mu age tdate !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
 
6) SICCT ~ mu age tdate S !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
7) a1 ~ mu age tdate S !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
8) b1 ~ mu age tdate S !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
9) da ~ mu age tdate S !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
10) db ~ mu age tdate S !r sire spl(age,50) spl(tdate,50) !f newoutbreak 
 
 
(b) ASReml models used in the first-records analysis when only the first known 
test within each of the new outbreaks was retained (Tables 10, 11 and 12). 
1) SICCT ~ mu age !r sire spl(age) !f newbreakdown 
2) a1 ~ mu age !r sire spl(age) !f newbreakdown  
3) b1 ~ mu age !r sire spl(age) !f newbreakdown  
4) da ~ mu age !r sire spl(age) !f newbreakdown 







7.1 Aims of Thesis and overview of outcomes 
The objectives of this Thesis were to study the genetic architecture of 
resistance to bTB and investigate the genomic control of bTB resistance in cattle, at 
different levels of the genome, ranging from identifying individual QTLs and groups 
of SNPs collectively controlling the trait, through exploration of the variance 
contributed by entire chromosomes, to genomic prediction at the whole genome 
level. This Thesis aimed to investigate the feasibility of genomic selection for 
livestock populations that will be more resistant to disease and test the potential of 
genomic prediction when using high density genotypes and when populations that 
are only distantly related are combined. Further, this Thesis explored the important 
issue of an impact of genomic selection for bTB resistance on the response to the 
diagnostic Single Intradermal Comparative Cervical Test (SICCT) that is 
traditionally used in the UK for the identification of bTB infected animals.  
The results of this PhD have demonstrated that whole genome prediction for 
disease resistance traits is feasible. Through using dense genetic markers, genomic 
selection for bTB resistance provided an estimate of prediction accuracy of r(g, ĝ) = 
0.33 and a heritability of h2 = 0.23(SE = 0.06) in this data. It was shown that by 
using SNP genotypes, animals that are genetically more resistant to bTB infection 
can be identified, and selection candidates lacking bTB phenotypes can be selected 




specific QTLs and the causative mutations. A novel approach is presented that 
expands the standard GWA analysis to capture underlying non-additive genetic 
variation, and following this technique a locus displaying heterozygote disadvantage 
associated with resistance to M. bovis was identified on BTA6,  with the 
heterozygotes being significantly more in the cases than in the controls (p<0.001).   
However, bTB resistance was found to be unlikely to be controlled by a 
single gene and therefore, my analysis was extended by combining two populations 
only distantly related in a meta-analysis aiming to provide insight into the genetic 
architecture of the trait.  This analysis revealed that bTB resistance is a moderately 
polygenic trait, with a few major chromosomes collectively controlling the trait. The 
results of my meta-analysis have also shown that genomic prediction for bTB is 
feasible even when only distantly related populations are combined. The prediction 
accuracy was found to arise from the SNPs capturing Linkage Disequilibrium (LD) 
between markers and QTLs, as well as additive relationships between animals. 
Further, Regional Heritability (RH) mapping identified a region on BTA6, putatively 
associated with bTB resistance. This region was found to contain several plausible 
candidate genes, including DHX15, which has been shown to be expressed at higher 
levels in M. bovis infected macrophages (Widdison et al. 2008; Mühlbauer L., 
personal communication, July 8, 2015).  High density genotypes were inferred by 
means of genotype imputation, which is a cost-effective method that facilitates 
combining populations that have been originally genotyped using different 
genotyping platforms and allows for the SNPs to be more closely linked to the QTLs. 




limiting factor was the number of animals and the trait definitions, rather than the 
density of genotypes.   
Finally, quantitative genetic analysis of field data comprising SICCT values 
collected during routine bTB herd testing, demonstrated that SICCT has a very low 
heritability of h2=0.0104 (SE = 0.0032). Thus, genomic selection that will increase 
bTB resistance is unlikely to genetically alter the SICCT outcome, and any effect on 
the response to the test is likely to be small.  
7.2 Opportunities and implications 
7.2.1 Controlling bTB 
7.2.1.1 Selection based on phenotypes and genomic 
selection 
Breeding for disease resistance can be considered as a complementary tool 
for the control of infectious diseases where conventional control strategies have not 
been successful. Selection based on phenotypes and pedigrees has been effective for 
endemic diseases where the challenge of infection and exposure to infection can be 
more predictable, e.g. for nematode infections in sheep (Bishop and Stear 1997; 
Karlsson et al. 2006), and for mastitis in cattle (Heringstad et al. 2000; 
http://dairy.ahdb.org.uk/technical-information/breeding-genetics/%C2%A3pli/holst 
ein-reports/#.Vf0pHmeFMeH). However, collecting phenotypes becomes 
problematic when the population is required to be undergoing an epidemic. BTB is 
an intermediate situation where although it is an endemic disease, it is not present in 




based on phenotypes, i.e. EBVs, remains a possibility for bTB, collection of enough 
phenotypic data to accurately estimate EBVs across the entire population would be 
challenging and would require the presence of an epidemic. Even if pedigree-
recorded herds were affected providing complete and good quality data, analysing 
this data would only provide results with an application to specific sub-populations, 
i.e. animals that are more closely related to the herd. For animals that are more 
distantly related by pedigree to the ones in the epidemic, accuracy of the pedigree-
based EBVs would be poor. Moreover, as bTB prevalence declines e.g. at later stages 
of an eradication programme, identifying cases of bTB based solely on phenotypes 
will be even more difficult.  Thus, selection for bTB resistance using DNA markers 
becomes a particularly appealing approach as it does not require exposure to 
infection, and can be potentially very useful even if prediction accuracy is only 
modest. An important consequence of this is the need for building an adequate 
training dataset with both phenotypes and genotypes that will allow enhancing the 
genomic prediction accuracy. 
7.2.1.2 On the epidemiology of bTB: reducing the number of 
secondary cases 
Controlling bTB through genomic selection does not necessarily require to 
drive the beneficial allele to fixation. The basic reproductive number (R0) defined as 
the average number of cases generated by one infectious individual, can be 
informative on whether a control strategy can be successful i.e. if the R0 can be 
brought below 1, the epidemic would die out on its own. Genomic selection for more 




thus, reducing R0. For bTB in the UK, it has been estimated that the R0 in cattle is 
only slightly greater than 1 (R0 = 1.07) (Cox et al. 2005), and thus, even a modest 
intervention would be sufficient to substantially reduce the risks or severities of bTB 
breakdowns. Using complementary control strategies such as herd management, 
control of cattle movements and biosecurity measures can substantially contribute 
towards bringing an epidemic under control. 
This use of complementary control strategies is even more important in the 
presence of a wildlife reservoir, which is the case for bTB. For heterogeneous 
populations comprising different host species, such as cattle and badgers in bTB, it is 
beneficial in the design of control strategies to consider the entire network of 
infections. Such a framework is provided by the Type-reproduction number (T), i.e. 
the expected number of cases in one epidemiologically distinct type (e.g. host) 
generated by one infectious individual of the same type (Roberts et al. 2003; 
Heesterbeek et al. 2007).  For bTB, the secondary cases in cattle generated by one 
infected cow can be caused either directly or through a sequence of infection events 
through the badger population.  From Brooks-Pollock et al. (2015) it can be derived 
that the type reproduction number for cattle is Tc=Rcc+[(Rcb Rbc)/(1-Rbb)], where Rbc 
and Rcb are the number of secondary cases in cattle due to badger-to-cattle 
transmission and the number of secondary cases in badgers due to cattle-to-badger 
transmission. Thus, Tc accounts for the amplification effect that might occur after 
several cycles from entry into the badger population (i.e. Rcb) of infection in badgers 
parameterised by Rbb, before infection returns to cattle (i.e. Rbc). Similarly, the 
number of secondary cases in badgers generated by one infected badger can be 




R0<1 (Heesterbeek et al. 2007). T coincides with R0 when the population is 
considered homogeneous and differential transmission from the e.g. the wildlife 
reservoir, is not taken into account (Heesterbeek et al. 2007; Brooks-Pollock et al. 
2015). However, if T in one of the host species is less than 1, it does not necessarily 
mean that R0 will also be less than 1. For example, an R0>1 and a major epidemic in 
the network might occur when Tc in cattle is small but Tb in badgers is large. Further, 
if both Tc and Tb are greater than 1 but Tc<Tb<∞, then cattle must have the highest 
reproduction number (i.e. Rcc>Rbb) (Brooks-Pollock et al. 2015), and thus it would be 
more efficient to control the disease in cattle. Bringing Tc below 1 would result in the 
control of the epidemic in cattle, however given the data currently available, a wide 
range of values can be estimated for the Rcb, Rbc, Rcc and Rbb (Brooks-Pollock et al. 
2015) and thus, explicitly accounting for the individual routes of possible infections 
that contribute to Tc remains a challenge.  
7.2.2 Genetic architecture of bTB resistance: QTL-based selection 
and genome-wide prediction 
The degree of success of Marker Assisted Selection (MAS) based on 
individual QTLs depends on the proportion of the total genetic variation explained 
by the QTL. In the present study the hypothesis that it is a single QTL affecting bTB 
resistance was tested, similarly to what has been observed for the Infectious 
Pancreatic Necrosis in the Atlantic salmon (Houston et al. 2010). Putative QTLs 
were identified, however, their individual effects were only small to moderate, and 
thus, a single QTL is unlikely to explain the total genetic variance seen in bTB 




intermediate situation where although there is not a major QTL, it is not 
infinitesimally polygenic. BTB resistance was found to be moderately polygenic with 
a handful of QTLs controlling the trait spread across a few chromosomes.  
With bTB resistance being more complex than a single gene, genomic 
selection can assist in improving resistance to disease by means of whole genome 
prediction. Genomic selection offers a black-box approach to improve health without 
relying on specific QTLs, and allows genome wide selection (GWS), with a certain 
accuracy, without requiring specific knowledge on the individual genes and 
pathways involved. In other words, with genomic selection it is not necessary to 
know where the QTLs are and what they do.  
Nevertheless, genomics provide the opportunity for investigating individual 
QTLs and causative mutations that are identified, and provide the means for 
disentangling the exact sources of genetic variation. This can be useful for various 
scientific purposes, e.g. to provide candidate targets for drug discovery, for exploring 
the genetic background of response to vaccines, for identifying the individual 
pathways involved etc. This can be achieved through the use of dense markers that 
will be more closely linked to the QTLs, or through whole-genome sequence data 
containing the actual QTLs. For the purposes of EBVs estimation and breeding for 
bTB resistance in the population as a whole, such information is not required and 
QTL specific knowledge is not necessary.  
Genomic prediction may benefit from taking into account the genetic 
architecture of the trait. In the present study, results obtained from targeted 




benefit from being informed by the specific genetic architecture of the trait. Such 
knowledge can be exploited in genetic evaluations, either through MAS if it was a 
major QTL segregating, or through Bayesian techniques using genetic architecture as 
prior information for the estimation of EBVs. It has been previously highlighted in 
the literature that the genetic architecture of the trait has an impact on the genomic 
prediction accuracy and incorporating such information in the analyses might be 
beneficial (Daetwyler et al. 2010; Hayes et al. 2010). For bTB resistance and under a 
moderately polygenic scenario it would be tempting to utilise such information. 
However, prediction accuracy still relies on relatedness between animals, while 
linkage between QTLs and SNPs might differ across different populations. Therefore 
in conclusion, unless the QTLs have been validated across independent populations, 
“weighting” for potentially false QTLs could have an undue influence on the 
predictions by adding noise, and eventually losing selection gain through wasting 
selection intensity (Sales and Hill 1976).  
7.3 Future challenges 
7.3.1 Utilising field data in analyses: improving the quality of data  
Analyses at present utilise field data opportunistically collected from bTB 
breakdowns. This data mainly comprise the test values, outcomes of the SICCT. 
SICCT data currently available is rather noisy, incomplete, and often, with 
inconsistencies and errors across the records. The need for quality control in bTB test 
recording has now been recognised by the UK government. Restructuring the 
recording system, for example by accounting for the relative performance of the 




recording system directly informing a national database, can improve the consistency 
across the records and assist in collecting better quality data. The quality of the data 
determines the information that can be extracted in analysis, and is of paramount 
importance for drawing solid conclusions.  
Furthermore, SICCT suffers from certain weaknesses that limit its 
effectiveness in bTB control and reduce its potential in being used as an indicator 
trait.  Mainly due to its imperfect sensitivity, SICCT has not been successful in 
identifying infected animals at the individual level. SICCT has been used essentially 
in the same format as it was originally developed and has been only marginally 
updated (for example in 1975 the mammalian tuberculin was replaced by VLA 
Weybridge bovine PPD tuberculin, and from 2005 bovine and avian tuberculins from 
Prionics ID-Lelystad are used). Thus, as will be discussed below in more detail, 
SICCT could be modified to better reflect the infection status of the modern UK 
herds. Having a closer look at the test, two important properties can be identified: (a) 
the 60 days interval in the retesting protocol, and (b) the thresholds for identifying a 
reactor, an inconclusive reactor, and a non-reactor animal. 
The 60 days interval in the modern retesting protocol aims to overcome the 
suppressive effect of an initial test on the skin reactivity when retesting. Radunz and 
Lepper (1985) demonstrated that when the animals were retested 4 or 7 days after the 
initial skin test, there was a suppression of skin reactivity to bovine tuberculin, while 
at 60 days, reactivity was restored. Doherty et al. (1995) reported a reduced reactivity 
to a second SICCT within 7 days from the first test, in SICCT-positive M. bovis 
infected cattle. However, in a more recent study it was observed that multiple testing 




(2004) reported that multiple testing before infection did not have an impact on the 
test outcome post infection. Nevertheless, in the same study it was observed that 
reactivity to a second test conducted 15 weeks post-challenge with M. bovis was 
reduced compared to reactivity at 7 weeks post-challenge (Thom et al. 2004). Those 
two tests were ~56 days apart, however, the reduced reactivity could be due to either 
the first test that took place 56 days earlier, or it could be the effect of time-post-
infection, or both. However, limitations in the design of those studies such as the 
small sample sizes, do not allow for drawing robust conclusions. Additionally, the 
testing protocols used are different from the modern protocol, and human tuberculin 
was used instead for bovine tuberculin. Thus, these studies are not directly 
comparable with the modern SICCT, and they do not reflect accurately its values and 
limitations. The desensitisation effect remains imperfectly understood and with the 
view to use vaccines against bTB, it would be crucial to fully disentangle the 
desensitisation mechanisms which might not be that different from the impacts of a 
vaccine on the test outcome, potentially compromising SICCT. Hence, it would be 
beneficial to design studies that will follow the testing protocols currently used in the 
UK and will have the statistical power to examine the possibility of retesting at 
shorter intervals.  Such studies could be orientated towards the development of a test 
that its criteria vary with time from the last testing, thus changing SICCT to have a 
reliable discrimination earlier.  This would assist in prompt identification of the 
infected animals. 
The necessity of re-defining SICCT becomes even more apparent if we 
consider that the thresholds currently used in diagnosing reactors, inconclusive 




be outdated and two possible reasons for that may be tabled. Firstly, although the 
comparative nature of the test takes into account the presence of M. avium sbsp 
avium and reduces drastically the false positives, the presence of Paratuberculosis 
(Johne’s disease) in the UK herds, caused by M. avium sbsp paratuberculosis, and 
the vaccinations against paratuberculosis, need also to be considered. It is likely that 
SICCT should be adapted e.g. by modifying the thresholds for classification of 
animals into diseased and healthy, to take into account the presence of 
Paratuberculosis which could affect the final value of SICCT. For example, the 
Paratuberculosis test and the time from the last Paratuberculosis testing could be 
taken into account as covariates for the SICCT, and that would be anticipated to 
improve the sensitivity and specificity of the SICCT.  
Secondly, although bTB eradication strategies, such as the National 
Eradication Programme (1950) or the Randomised Badger Culling Trial (1998-
2005), might have not been successful in eliminating bTB UK-wide, locally or for a 
certain period of time they altered bTB prevalence and introduced changes to the 
infection networks. Moreover, it is possible that M. bovis infectiousness might have 
also changed. This dynamic process of changes that have taken place over time needs 
to be accounted for by the diagnostic test and therefore SICCT, cannot be static and 
defined once, but it needs to be re-calibrated. A properly designed diagnostic test 
would be crucial in bTB control as it would (a) inform more accurately on the 
progress of the eradication programmes and serve better the purpose of bTB 
eradication, and (b) be vital in the collection of more informative phenotypes that can 




7.3.2 Improving the prediction accuracy  
The results presented in this Thesis demonstrate the feasibility of genomic 
selection for resistance to infectious diseases. Using genome-wide markers it is 
possible to predict the risk of infection at the individual level, and select animals 
more resistant to bTB improving bTB resistance of the population as a whole. The 
accuracy of prediction presented here, is only a preliminary result. As opposed to 
selection based on progeny testing and traditional BLUP, the GBLUP accuracy is 
dynamic, i.e. the value obtained here is not “the prediction accuracy” but it is only 
the accuracy that could be recovered given the size of the training sets. As the 
amount of genomic information available increases, this accuracy will also increase, 
with a theoretical maximum of 1.  
Marker effects are estimated in a training population based on the Linkage 
Disequilibrium (LD) between markers and QTLs. The results of the meta-analysis 
presented in Chapter 4 provided evidence that relatedness plays an important role in 
the proportion of genetic variance captured by the markers.  LD between markers 
and QTLs breaks down over generations due to recombination. Therefore, prediction 
accuracy over generations declines and marker effects need to be re-calibrated with 
new phenotypic information. Further, when using markers and not the QTLs 
themselves, although a marker may be beneficial at present, its effect might change 
over time due to recombination.   
Genomic selection has the potential to assist with overcoming both these 
limitations. For this purpose, larger datasets with more phenotyped and genotyped 




reasonable to obtain more samples of cases and controls, for example 5,000 
cases/controls, to test if the prediction accuracy will be improved as expected, and 
then, it would be appropriate to implement genomic selection for bTB control. This 
scale of ambition is already underway in the RoI as part of their National genomics 
programme launched in 2014, which aims to collect genomic information on the Irish 
beef cattle population (http://www.agriculture.gov.ie/press/pressreleases/2014/ 
february/title,73884,en.html). Such information would be of strategic value in 
deriving genetic evaluations for beef cattle breeding. It would be beneficial to 
undertake a similar initiative for bTB in the UK, given that the disease has been a 
long-term problem in the UK cattle industry.  In this context, cost-effective methods 
are available for generating high density genotypes increasingly cheaply, which 
allows exploitation of all the already available information such as datasets 
genotyped at lower density. HD genotyping will reduce the impact of recombination 
across generations as prediction will rely less on relatedness and thus, the prediction 
accuracy will not decline as quickly. This can be tested once large scale data 
covering multiple generations is available. Genotyping the entire population at HD 
and having pedigrees for all the animals will allow for markers more closely linked 
to the QTLs and less vulnerable to recombination. To take this one step further, 
progressing to whole genome sequencing will allow prediction based not on the LD 
between QTLs and markers, but on the QTL itself. Whereas marker effects might 
change over generations due to recombination, the QTLs remain the same, and thus, 
there will be no need for re-calibrating the estimated effects.  
In the chapters of this Thesis several factors affecting genomic prediction 




architecture of the trait including the number of the QTLs affecting the trait under 
study and the distribution of the effects of the QTLs; (ii) the genetic structure of the 
species, i.e. the effective population size, the number of independent genome 
segments, and whether there is long-range LD, as the density of markers required to 
closely capture QTLs will depend on the amount of LD; (iii) the size of the training 
sets; (iv) the trait heritability; (v) the definition of the phenotypes used and the study 
design which will have an impact on the estimated marker effects, for example the 
case/control study design,  the imperfect sensitivity and specificity of the diagnostic 
test, de-regressed EBVs after being weighted and with or without accounting for 
parent average effects; (vi) the method of estimation of the EBVs, for example 
BLUP, GBLUP, Bayesian methodology; (vii) relatedness and population structure in 
the sample, and when proceeding to genomic selection, the genetic distance between 
the training population and the selection candidates.  All these factors determine both 
the initial prediction accuracy estimates and how genomic selection will progress.  
7.3.3 Improving the experimental design  
A study can benefit by a carefully chosen experimental design, notably how 
cases and controls are selected.  In Chapter 1, the analysis of a case-control dataset 
was presented and it was discussed how the case-control design can have an impact 
on the estimated marker effects, and the genetic (e.g. h2) and epidemiological (e.g. Se 
and Sp) parameters estimated. Analysing field data for endemic livestock diseases or 
data collected over the course of an epidemic, allow for limited freedom in selecting 




environments (e.g. in aquaculture). In both cases, there are various approaches that 
can be followed and will be discussed below. 
 With regard to the way that controls are selected from the epidemiologist’s 
point of view, controls can be sampled from higher prevalence herds to maximise the 
probability of exposure. Similarly, controls ideally should be sampled from later 
stages of an epidemic where the infection pressure and the proportion of animals 
exposed to the pathogen are high and therefore, those individuals will be more likely 
to be genuinely resistant (Bishop et al. 2012). In the worst case, these controls will 
have not been exposed yet or will have been misdiagnosed. The probability of 
misclassification of a control can be predicted as it depends on the imperfect Sp of 
the diagnostic test used, i.e. (1-p)(1-Sp) (Bishop et al. 2010). Nevertheless, in both 
the cases of unexposed or misdiagnosed controls, these animals will be 
representative of the herd average animal, given the exposure status of the herd. 
Although having controls that are true negatives and have been exposed to disease 
would provide a more powerful contrast, comparing cases to the average can still be 
useful for extracting information (Bishop et al. 2012). When the controls are a 
random sample from the whole population, then the experimental design coincides 
with the “Wellcome Trust design”. The “Wellcome Trust design” has been used in 
human genetic studies, in the context of non-infectious diseases, and the comparison 
being made is between cases, and controls that represent the population average 
(Browning and Browning 2008). However, for infectious disease, such a contrast 
would be even weaker as the comparison of interest is with individuals that have 




However in statistical analyses, balanced designs, i.e. with one control 
matched with each case, are more robust. For example, when herds vary considerably 
with some herds having more controls compared to other herds, if the herd is fitted as 
a fixed effect, the model will be less efficient and information from herds that do not 
have both cases and controls will be lost; if the herd is fitted as a random effect some 
of the inter-herd variation on genetics might be recovered but additional assumptions 
would have to be made about the validity of the differences between the herds being 
genetic. A balanced design would allow fitting the herd either as a fixed effect or a 
random effect and information would be recovered more efficiently in either case. In 
a genetic analysis, unbalanced designs would not allow consideration in the analysis 
that different herds might introduce genetic differences which we might want to 
estimate, i.e. genetic stratification due to different herds and between herds genetic 
variation. Alternatively, the herd can be considered as a fixed effect and thus 
removed from genetic interpretation in order to recover information only within 
herds. However, when for example the controls are selected to originate from higher 
prevalence herds, then the herd cannot be considered as a fixed effect as it might 
have an undue influence on the results i.e. results might be potentially biased to a 
particular subset with specific differences. Either a balanced or an unbalanced design 
can be used depending on the issues to be addressed in the analysis, and these 




7.4 Perspectives for future research and practical 
considerations 
7.4.1 Genomic selection sustainability and multidrug resistance  
One of the new challenges arising for disease control is multidrug resistance, 
i.e. the developed ability of pathogens to be resistant to therapeutic agents, e.g. 
resistance to antibiotics or anthelminthic resistance (Bennett et al. 2008; Laurenson 
et al. 2013; Magiorakos et al. 2014). Approaches that will tackle disease while 
requiring fewer therapeutic treatments need to be developed. Thus, the sustainability 
of breeding for disease resistance in livestock can be considered with respect to (a) 
reducing disease without relying on the effectiveness of chemical treatments, (b) 
pathogen evolution, and (c) improving simultaneously resistance to multiple 
diseases.  
Firstly, genetic selection for disease resistance will improve the average 
disease resistance of the livestock population. Therefore, it will reduce reliance on 
treatment-based disease control and assist in dealing with multidrug resistance. 
Breeding for improved resistance will assist with reducing the in-herd level disease 
incidence, reducing the likelihood of a breakdown, and reducing the severity of 
breakdowns. Further, genetic selection is concordant with the modern farming and 
herd health management strategies which focus on disease prevention, and it can be 





Secondly, an acknowledged theoretical risk is that some pathogen evolution 
might occur as a response to selection pressure imposed by genetic selection for 
disease resistance in the host i.e. host-pathogen coevolution. However, such a 
response should be compared to pathogen evolution caused by the other disease 
control strategies that are currently used (e.g. antibiotics, anthelmintic drugs. While 
the risks deriving from the currently used control strategies are known and drug 
resistance has developed quickly and dangerously, the potential scale of such a 
problem due to genetic selection is unknown. Thus at the moment, it remains only a 
theoretical risk and if it did occur it may only occur over a very long time-scale. 
Another option is to use knowledge on the genome sequence of the pathogens. 
However, such approaches are also likely to introduce direct selection pressure on 
the pathogens, while emerging subtypes of pathogens would require continuous re-
calibration. Furthermore, whole-genome based selection for disease resistance in the 
host, that utilises a large number of QTLs, is likely to be more sustainable compared 
to single-gene based approaches as pathogens will have to overcome resistance due 
to multiple loci simultaneously. Alternatively, as will be discussed below in more 
detail, breeding for disease tolerance is an approach for improving the host’s ability 
to counteract infection without imposing selection pressure on the pathogens.  
Lastly, genetic selection for resistance to one disease may be linked to 
resistance to other diseases. For example, aiming at candidate genes involved in 
innate immune response has the potential to improve resistance for a wider range of 
pathogens, while adaptive immune response is more pathogen-specific and prone to 
increase susceptibility to other pathogens while selecting for resistance to a target-




to be resistant to M. bovis BCG and control its intracellular growth, as well as other 
intracellular pathogens such as Brucella abortus and Salmonella dublin (Qureshi et 
al. 1996). Resistance might be possible to be improved simultaneously for pathogens 
that follow the same route of infection and where the same mechanisms and 
pathways are involved. Moreover, selection on immunological parameters through 
e.g identifying genotypes conferring improved immunocompetence and 
immunoresponsiveness, could be an alternative approach for improving animal 
health, and models describing these mechanisms have been suggested in the 
literature (Ask et al. 2007).    
7.4.2 Breeding for disease tolerance and reduced infectivity 
An alternative approach for disease control is the genetic selection for 
improved host tolerance, i.e. the ability of the host to limit the damage caused by the 
pathogen (Kause et al. 2012). Tolerance relates the rate of change in host 
performance (reproduction and survival (fitness), or production) due to the pathogen, 
to the pathogen burden within the host (Doeschl-Wilson et al. 2012b), and can be 
defined either at the group level (Kause 2011) or at the individual level (Doeschl-
Wilson et al. 2012b). Improving tolerance presents certain advantages compared to 
improving resistance, as it is more host-specific and thus likely to be effective 
against a wider range of pathogens, and it does not place direct selection pressure on 
the pathogens. However, determining reliable tolerance phenotypes can be 
challenging and especially when this information needs to be extracted from field 
data where resistance and tolerance are often confounded (Doeschl-Wilson et al. 




performance and pathogen burden trajectories, which have been used to describe the 
host-pathogen interaction while capturing the dynamic time-dependent interactions 
between resistance and tolerance over the course of infection (Lough et al. 2014; 
Lough et al. 2015). Insight into the genetic control of tolerance will allow 
disentangling the relationship between resistance and tolerance, e.g. if they are 
antagonistically related, and this knowledge can then be used to inform disease 
control strategies. Choosing to breed for disease resistance or tolerance will be 
determined by the aim of a specific disease control programme. For example, 
breeding for disease resistance would be preferred over tolerance when the aim is to 
eradicate a disease or when the disease is zoonotic, while breeding for tolerance 
would be preferred when the disease is endemic with a prevalence approaching unity 
(Doeschl-Wilson et al. 2012a; Bishop 2012). BTB is a zoonotic disease, and the aim 
is to eradicate it from the population, therefore, for bTB, breeding for resistance 
would be preferred over breeding for tolerance. 
The presence of genetic variation in infectivity, i.e. differences in the ability 
of individuals to transmit infection, can be potentially exploited in genetic selection 
for disease resistance. The impacts of such differences become more apparent if we 
consider the system of dynamic interactions within a group of animals comprising a 
mixture of infected and susceptible individuals: the disease status of a member of the 
group, additionally to its own genetics (own resistance and tolerance), will depend on 
the infectivity of the other group-members as the latter will influence the levels of 
exposure to infection for that individual. An extreme example is the case of super-
spreaders where only a few individuals are responsible for a large proportion of 




capture the genetic variation in infectivity while accounting for disease dynamics 
such as the individual’s disease status and the time that an individual became 
infected (Lipschutz-Powell et al. 2012a and b), and the probability of infection was 
derived, taking into account the force of infection for an individual (i.e. own 
susceptibility and group members’ infectivity) (Lipschutz-Powell et al. 2013). Future 
studies on the variation in infectivity for specific diseases can potentially inform 
genomic selection for disease resistance. 
7.5 Conclusions 
The results presented in this Thesis demonstrate the feasibility of genomic 
selection for bTB resistance in dairy cattle. Genomic selection holds the promise that 
given availability of data, it is possible to utilise host genetic variation and breed for 
resistance to infectious diseases in livestock populations. This approach can be used 
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